run_accession	experiment_accession	sample_accession	study_accession	secondary_sample_accession	secondary_study_accession	BioSample	BioProject	experiment_title	sample_title	study_title	sample_description	library_name	library_strategy	library_source	library_layout	instrument_model	read_count	base_count	scientific_name	collection_date	first_public	last_updated	project_name	submission_accession	library_min_fragment_size	bam_md5	assembly_software	library_prep_longitude	library_selection	pcr_isolation_protocol	chip_protocol	sequencing_primer_provider	serotype	environment_feature	submitted_galaxy	extraction_protocol	germline	secondary_project	culture_collection	submission_tool	sra_bytes	read_strand	rna_purity_280_ratio	hi_c_protocol	collected_by	submitted_ftp	restriction_enzyme_target_sequence	isolate	fastq_bytes	instrument_platform	variety	sequencing_date_format	temperature	sra_aspera	ecotype	submitted_aspera	sampling_campaign	bam_ftp	tissue_lib	environmental_sample	control_experiment	sex	submitted_md5	checklist	fastq_galaxy	library_gen_protocol	specimen_voucher	library_prep_latitude	submitted_bytes	taxonomic_identity_marker	run_date	country	ncbi_reporting_standard	sra_galaxy	sample_prep_interval	fastq_md5	experimental_protocol	bio_material	rna_prep_5_protocol	host_body_site	local_environmental_context	assembly_quality	collection_date_end	sample_capture_status	host_genotype	host_phenotype	environmental_medium	cultivar	faang_library_selection	target_gene	bam_bytes	library_max_fragment_size	experiment_target	sequencing_date	description	nominal_sdev	chip_ab_provider	environment_material	host_tax_id	sample_material	sample_storage_processing	sra_md5	cell_type	fastq_ftp	disease	sample_prep_interval_units	broker_name	sub_strain	restriction_site	serovar	investigation_type	location	sra_ftp	age	experimental_factor	sequencing_primer_catalog	environment_biome	rna_purity_230_ratio	dnase_protocol	dev_stage	library_prep_date_format	bam_aspera	binning_software	datahub	rna_integrity_num	library_prep_date	location_start	marine_region	aligned	file_location	sample_collection	chip_target	nominal_length	broad_scale_environmental_context	sequencing_location	status	completeness_score	lon	fastq_aspera	tax_lineage	host_sex	library_pcr_isolation_protocol	sample_alias	mating_type	collection_date_start	sub_species	contamination_score	run_alias	restriction_enzyme	depth	submitted_read_type	library_construction_protocol	host_growth_conditions	experiment_alias	host_gravidity	center_name	identified_by	cell_line	sampling_site	host	tag	first_created	lat	strain	host_status	tax_id	submitted_format	submitted_host_sex	surveillance_target	bisulfite_protocol	altitude	rt_prep_protocol	host_scientific_name	bam_galaxy	accession	sample_storage	cage_protocol	sampling_platform	taxonomic_classification	location_end	protocol_label	elevation	salinity	sequencing_method	sequencing_primer_lot	transposase_protocol	study_alias	library_prep_location	rna_prep_3_protocol	ph	sequencing_longitude	tissue_type	isolation_source	ReleaseDate	LoadDate	spots	bases	spots_with_mates	avgLength	size_MB	AssemblyName	download_path	Experiment	LibraryName	LibraryStrategy	LibrarySelection	LibrarySource	LibraryLayout	InsertSize	InsertDev	Platform	Model	SRAStudy	Study_Pubmed_id	ProjectID	Sample	SampleType	TaxID	ScientificName	SampleName	g1k_pop_code	source	g1k_analysis_group	Subject_ID	Sex	Disease	Tumor	Affection_Status	Analyte_Type	Histological_Type	Body_Site	CenterName	Submission	dbgap_study_accession	Consent	RunHash	ReadHash
SRR3880241	SRX1936486	SAMN05861197	PRJNA343146	SRS1743920	SRP091431	SAMN05861197	PRJNA343146	Illumina HiSeq 2000 sequencing: Simul-seq:LCM tumor RNA	Esophageal Neoplasms tumor RNA sample from Esophagus of a human male participant in the dbGaP study DNA and RNA Profiling Using Simultaneous Sequencing (Simul-seq)	Comprehensive Genome and Transcriptome Profiling Using Simultaneous DNA and RNA Sequencing (Simul-seq)	Esophageal Neoplasms tumor RNA sample from Esophagus of a human male participant in the dbGaP study DNA and RNA Profiling Using Simultaneous Sequencing (Simul-seq)	Sim_LCM_RNA	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	0	0	Homo sapiens		2016-11-02	2016-11-02	Homo sapiens	SRA483669					RANDOM						Protected file(s). Go to dbGap											Protected file(s). Go to dbGap				ILLUMINA						Protected file(s). Go to dbGap						male											Generic																						Illumina HiSeq 2000 sequencing: Simul-seq:LCM tumor RNA																																									public				1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			1214-EAC1416_tumor_RNA					160105_BRISCOE_0274_AC8C4RACXX_L4_GGCTAC-TATCCTCT_2_pf.fastq.gz						Sim_LCM_RNA							env_tax;env_tax:terrestrial	2016-11-02				9606	PROTECTED								SRR3880241												phs001214							2016-10-31 09:44:40	2016-10-21 21:58:28	195316550.0	39453943100.0	0.0	202.0	23898.0		@dbgap@:reads/SRP091431/SRS1743920/SRX1936486/SRR3880241/SRR3880241.sra	SRX1936486	Sim_LCM_RNA	RNA-Seq	RANDOM	TRANSCRIPTOMIC	PAIRED	0.0	0.0	ILLUMINA	Illumina HiSeq 2000	SRP091431		343146.0	SRS1743920	simple	9606.0	Homo sapiens	EAC1416_tumor_RNA				1755811.0	male		yes		RNA	Adenocarcinoma	Esophagus	STANFORD UNIVERSITY	SRA483669	phs001214	GRU-IRB-PUB	33D0034B2BF11CD538C51BD4F45FA485	F5D12FC16D38E88FDB3905C8E40BE2F0
SRR27477615	SRX23149108	SAMN39328787	PRJNA1063201	SRS20099742	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK050	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK050	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A49, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	14183045	2796282785	Homo sapiens	2019-02-08	2024-01-11	2024-01-11		SRA1782421					PolyA												753125395.0							JK050	453718126;456653580	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/015/SRR27477615/SRR27477615.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/015/SRR27477615/SRR27477615_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/015/SRR27477615/SRR27477615_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/015/SRR27477615/SRR27477615.lite		5f49d74c0dd788115d7035f2f0bcb7d4;4f088fc776c3675c76ff305d614103cf							2019-02-08												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							7f0918e9fdf11eef29f7cf5c374c1930		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/015/SRR27477615/SRR27477615_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/015/SRR27477615/SRR27477615_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/015/SRR27477615/SRR27477615.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/015/SRR27477615/SRR27477615_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/015/SRR27477615/SRR27477615_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK050		2019-02-08			JK050_S217_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A49, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477615												PRJNA1063201					esophagus																																													
SRR27477616	SRX23149107	SAMN39328786	PRJNA1063201	SRS20099741	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK049	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK049	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A48, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	19162079	3822592294	Homo sapiens	2019-02-06	2024-01-11	2024-01-11		SRA1782421					PolyA												1020971958.0							JK049	750392721;730048337	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/016/SRR27477616/SRR27477616.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/016/SRR27477616/SRR27477616_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/016/SRR27477616/SRR27477616_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/016/SRR27477616/SRR27477616.lite		55a5f739b66ace509f458d239d9a1797;ef8da63bd8bedc247ea3905f8c870130							2019-02-06												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							b2fdb2f8c97324f214a25007de6ec238		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/016/SRR27477616/SRR27477616_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/016/SRR27477616/SRR27477616_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/016/SRR27477616/SRR27477616.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/016/SRR27477616/SRR27477616_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/016/SRR27477616/SRR27477616_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK049		2019-02-06			JK049_S45_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A48, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477616												PRJNA1063201					esophagus																																													
SRR27477617	SRX23149106	SAMN39328785	PRJNA1063201	SRS20099740	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK048	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK048	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A47, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	14688607	2928103104	Homo sapiens	2019-01-24	2024-01-11	2024-01-11		SRA1782421					PolyA												783853527.0							JK048	537666016;529216063	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/017/SRR27477617/SRR27477617.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/017/SRR27477617/SRR27477617_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/017/SRR27477617/SRR27477617_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/017/SRR27477617/SRR27477617.lite		1c43b3e78fc256dc44c7bf4dbc0422d8;8cbb7a2f09692a035b1915ec488f7e61							2019-01-24												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							04de15c1eaf6b7867fcc252e8294d4eb		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/017/SRR27477617/SRR27477617_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/017/SRR27477617/SRR27477617_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/017/SRR27477617/SRR27477617.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/017/SRR27477617/SRR27477617_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/017/SRR27477617/SRR27477617_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK048		2019-01-24			JK048_S44_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A47, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477617												PRJNA1063201					esophagus																																													
SRR27477618	SRX23149105	SAMN39328784	PRJNA1063201	SRS20099739	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK047	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK047	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A46, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	13231105	2567536935	Homo sapiens	2019-01-15	2024-01-11	2024-01-11		SRA1782421					PolyA												695828494.0							JK047	460692135;459710263	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/018/SRR27477618/SRR27477618.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/018/SRR27477618/SRR27477618_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/018/SRR27477618/SRR27477618_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/018/SRR27477618/SRR27477618.lite		c65e02fea2a534c3afb29e9ae69a4ca9;e8de7774dd06f267ba8bdd1b3bf3b120							2019-01-15												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							bcfbfc213e04e6751d9c2cc707d48a9d		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/018/SRR27477618/SRR27477618_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/018/SRR27477618/SRR27477618_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/018/SRR27477618/SRR27477618.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/018/SRR27477618/SRR27477618_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/018/SRR27477618/SRR27477618_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK047		2019-01-15			JK047_S216_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A46, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477618												PRJNA1063201					esophagus																																													
SRR27477619	SRX23149104	SAMN39328783	PRJNA1063201	SRS20099738	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK046	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK046	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A45, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	16307116	3252947890	Homo sapiens	2019-01-14	2024-01-11	2024-01-11		SRA1782421					PolyA												869838998.0							JK046	654967303;611492361	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/019/SRR27477619/SRR27477619.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/019/SRR27477619/SRR27477619_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/019/SRR27477619/SRR27477619_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/019/SRR27477619/SRR27477619.lite		5e8b68965a3675d99374899e93edb684;a4b40c7f4c8d4bd8dee7b2a0a08886eb							2019-01-14												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							99f25bbb74d2ab3918d4727d5e216e64		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/019/SRR27477619/SRR27477619_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/019/SRR27477619/SRR27477619_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/019/SRR27477619/SRR27477619.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/019/SRR27477619/SRR27477619_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/019/SRR27477619/SRR27477619_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK046		2019-01-14			JK046_S43_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A45, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477619												PRJNA1063201					esophagus																																													
SRR27477620	SRX23149103	SAMN39328782	PRJNA1063201	SRS20099737	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK045	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK045	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A44, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	11827343	2354566114	Homo sapiens	2019-01-11	2024-01-11	2024-01-11		SRA1782421					PolyA												631488148.0							JK045	352661728;364732639	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/020/SRR27477620/SRR27477620.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/020/SRR27477620/SRR27477620_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/020/SRR27477620/SRR27477620_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/020/SRR27477620/SRR27477620.lite		7cb182e315100f734c1963ef770684e0;265a02e48bfd17b51756c76933fc87bf							2019-01-11												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							67e5299c00cf2c1ffc7294db80b8384b		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/020/SRR27477620/SRR27477620_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/020/SRR27477620/SRR27477620_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/020/SRR27477620/SRR27477620.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/020/SRR27477620/SRR27477620_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/020/SRR27477620/SRR27477620_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK045		2019-01-11			JK045_S42_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A44, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477620												PRJNA1063201					esophagus																																													
SRR27477621	SRX23149102	SAMN39328781	PRJNA1063201	SRS20099735	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK044	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK044	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A43, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	17194292	3427451512	Homo sapiens	2019-01-07	2024-01-11	2024-01-11		SRA1782421					PolyA												916527090.0							JK044	538497681;553264308	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/021/SRR27477621/SRR27477621.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/021/SRR27477621/SRR27477621_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/021/SRR27477621/SRR27477621_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/021/SRR27477621/SRR27477621.lite		e74627a0192712fb03de4c6783cdd4b7;7ffecd3b0ef056b7e6157806dcc9d234							2019-01-07												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							b73fb0d6b2f9d8e232c1b1b9d230ae05		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/021/SRR27477621/SRR27477621_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/021/SRR27477621/SRR27477621_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/021/SRR27477621/SRR27477621.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/021/SRR27477621/SRR27477621_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/021/SRR27477621/SRR27477621_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK044		2019-01-07			JK044_S41_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A43, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477621												PRJNA1063201					esophagus																																													
SRR27477622	SRX23149101	SAMN39328780	PRJNA1063201	SRS20099736	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK043	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK043	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A42, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	17441195	3478879258	Homo sapiens	2019-01-03	2024-01-11	2024-01-11		SRA1782421					PolyA												929855295.0							JK043	655565796;637627237	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/022/SRR27477622/SRR27477622.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/022/SRR27477622/SRR27477622_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/022/SRR27477622/SRR27477622_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/022/SRR27477622/SRR27477622.lite		9145f316b80d3e6722f3a5cff59b3543;06f9939c09196ccdf30e0a7627405bc5							2019-01-03												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							48e2266ffde7ef3eef996b403fa30620		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/022/SRR27477622/SRR27477622_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/022/SRR27477622/SRR27477622_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/022/SRR27477622/SRR27477622.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/022/SRR27477622/SRR27477622_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/022/SRR27477622/SRR27477622_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK043		2019-01-03			JK043_S40_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A42, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477622												PRJNA1063201					esophagus																																													
SRR27477623	SRX23149100	SAMN39328744	PRJNA1063201	SRS20099734	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK005	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK005	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A6, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	21115071	4209671220	Homo sapiens	2018-05-15	2024-01-11	2024-01-11		SRA1782421					PolyA												1124109711.0							JK005	764058650;752916352	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/023/SRR27477623/SRR27477623.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/023/SRR27477623/SRR27477623_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/023/SRR27477623/SRR27477623_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/023/SRR27477623/SRR27477623.lite		f693d2968776a67151d6eefde4de0699;df4912de7d24f81456c13dc52d49ea89							2018-05-15												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							cd47e5b4f419af21fc431d527b5b3d69		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/023/SRR27477623/SRR27477623_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/023/SRR27477623/SRR27477623_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/023/SRR27477623/SRR27477623.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/023/SRR27477623/SRR27477623_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/023/SRR27477623/SRR27477623_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK005		2018-05-14			JK005_S5_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A6, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477623												PRJNA1063201					esophagus																																													
SRR27477624	SRX23149099	SAMN39328779	PRJNA1063201	SRS20099733	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK042	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK042	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A41, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	18142197	3612893149	Homo sapiens	2019-01-02	2024-01-11	2024-01-11		SRA1782421					PolyA												966484266.0							JK042	706472624;682927618	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/024/SRR27477624/SRR27477624.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/024/SRR27477624/SRR27477624_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/024/SRR27477624/SRR27477624_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/024/SRR27477624/SRR27477624.lite		ecce95b2d719904f73383867f5038fa4;00f3fe61cbb9d8a4ec292be2a82a4a9a							2019-01-02												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							aab8dfcd9e9c97b469396bdb4b2f418b		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/024/SRR27477624/SRR27477624_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/024/SRR27477624/SRR27477624_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/024/SRR27477624/SRR27477624.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/024/SRR27477624/SRR27477624_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/024/SRR27477624/SRR27477624_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK042		2019-01-02			JK042_S39_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A41, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477624												PRJNA1063201					esophagus																																													
SRR27477625	SRX23149098	SAMN39328778	PRJNA1063201	SRS20099732	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK041	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK041	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A40, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	19893061	3961270095	Homo sapiens	2018-12-20	2024-01-11	2024-01-11		SRA1782421					PolyA												1059008739.0							JK041	801957046;767006052	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/025/SRR27477625/SRR27477625.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/025/SRR27477625/SRR27477625_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/025/SRR27477625/SRR27477625_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/025/SRR27477625/SRR27477625.lite		220c4ae0ce40caccb05ba0f247dbe88f;ace5f5ac1b5cde1de55ca28367a61c5c							2018-12-20												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							815be8ba8322f3799fe24a96df5aa172		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/025/SRR27477625/SRR27477625_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/025/SRR27477625/SRR27477625_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/025/SRR27477625/SRR27477625.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/025/SRR27477625/SRR27477625_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/025/SRR27477625/SRR27477625_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK041		2018-12-20			JK041_S38_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A40, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477625												PRJNA1063201					esophagus																																													
SRR27477626	SRX23149097	SAMN39328777	PRJNA1063201	SRS20099731	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK040	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK040	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A39, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	16779094	3329793350	Homo sapiens	2018-12-12	2024-01-11	2024-01-11		SRA1782421					PolyA												893102144.0							JK040	543328330;550306361	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/026/SRR27477626/SRR27477626.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/026/SRR27477626/SRR27477626_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/026/SRR27477626/SRR27477626_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/026/SRR27477626/SRR27477626.lite		f1c39e78a55d75208f3651195f9f94a8;032714bba6c27c392cc9856b5a9de890							2018-12-12												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							503df686bb2692f4a9aa48b045dbc979		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/026/SRR27477626/SRR27477626_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/026/SRR27477626/SRR27477626_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/026/SRR27477626/SRR27477626.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/026/SRR27477626/SRR27477626_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/026/SRR27477626/SRR27477626_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK040		2018-12-12			JK040_S37_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A39, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477626												PRJNA1063201					esophagus																																													
SRR27477627	SRX23149096	SAMN39328776	PRJNA1063201	SRS20099730	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK039	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK039	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A38, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	12914602	2511340576	Homo sapiens	2018-11-30	2024-01-11	2024-01-11		SRA1782421					PolyA												680406793.0							JK039	329041593;342290928	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/027/SRR27477627/SRR27477627.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/027/SRR27477627/SRR27477627_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/027/SRR27477627/SRR27477627_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/027/SRR27477627/SRR27477627.lite		29c750f6edb471b135c3855a2818f860;1193730f013a8e030a02cd119897947c							2018-11-30												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							d8a70bece77740e89b621a8e557b9fca		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/027/SRR27477627/SRR27477627_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/027/SRR27477627/SRR27477627_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/027/SRR27477627/SRR27477627.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/027/SRR27477627/SRR27477627_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/027/SRR27477627/SRR27477627_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK039		2018-11-30			JK039_S215_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A38, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477627												PRJNA1063201					esophagus																																													
SRR27477628	SRX23149095	SAMN39328775	PRJNA1063201	SRS20099729	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK037	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK037	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A37, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	31627026	6314040271	Homo sapiens	2018-11-01	2024-01-11	2024-01-11		SRA1782421					PolyA												1680740615.0							JK037	1195756116;1184635518	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/028/SRR27477628/SRR27477628.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/028/SRR27477628/SRR27477628_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/028/SRR27477628/SRR27477628_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/028/SRR27477628/SRR27477628.lite		9662d0c86e4ea762fe2bd20fec1000ab;69aaaa2485282a5ed0a360ba07b2634b							2018-11-01												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							1efcf6401473785f9a76105ce770d69f		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/028/SRR27477628/SRR27477628_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/028/SRR27477628/SRR27477628_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/028/SRR27477628/SRR27477628.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/028/SRR27477628/SRR27477628_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/028/SRR27477628/SRR27477628_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK037		2018-11-01			JK037_S36_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A37, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477628												PRJNA1063201					esophagus																																													
SRR27477629	SRX23149094	SAMN39328774	PRJNA1063201	SRS20099728	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK036	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK036	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A36, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	21227345	4228985696	Homo sapiens	2018-10-26	2024-01-11	2024-01-11		SRA1782421					PolyA												1130004157.0							JK036	799645624;787236344	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/029/SRR27477629/SRR27477629.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/029/SRR27477629/SRR27477629_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/029/SRR27477629/SRR27477629_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/029/SRR27477629/SRR27477629.lite		7780bb81b95928ee2690cabf2b029ab3;513e77c63c26012f18da2b41f42e9487							2018-10-26												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							11825a09287a8476f190c6d239196f33		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/029/SRR27477629/SRR27477629_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/029/SRR27477629/SRR27477629_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/029/SRR27477629/SRR27477629.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/029/SRR27477629/SRR27477629_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/029/SRR27477629/SRR27477629_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK036		2018-10-25			JK036_S35_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A36, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477629												PRJNA1063201					esophagus																																													
SRR27477630	SRX23149093	SAMN39328773	PRJNA1063201	SRS20099727	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK035	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK035	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A35, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	20337532	4047544603	Homo sapiens	2018-11-12	2024-01-11	2024-01-11		SRA1782421					PolyA												1082392545.0							JK035	846882272;806478406	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/030/SRR27477630/SRR27477630.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/030/SRR27477630/SRR27477630_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/030/SRR27477630/SRR27477630_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/030/SRR27477630/SRR27477630.lite		cc833f133d5ad62718766b55cbe250d2;b2842716799e42bbc1e9b48150baa1e9							2018-11-12												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							90d3e33a671775f80daa2629fc872608		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/030/SRR27477630/SRR27477630_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/030/SRR27477630/SRR27477630_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/030/SRR27477630/SRR27477630.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/030/SRR27477630/SRR27477630_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/030/SRR27477630/SRR27477630_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK035		2018-11-12			JK035_S34_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A35, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477630												PRJNA1063201					esophagus																																													
SRR27477631	SRX23149092	SAMN39328830	PRJNA1063201	SRS20099726	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK102	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK102	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A92, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	18308288	3650071826	Homo sapiens	2018-04-11	2024-01-11	2024-01-11		SRA1782421					PolyA												975711936.0							JK102	760722709;716808026	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/031/SRR27477631/SRR27477631.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/031/SRR27477631/SRR27477631_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/031/SRR27477631/SRR27477631_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/031/SRR27477631/SRR27477631.lite		d924cd18960d42ae9ff9b451bf7f6fde;e64b68d57b929c178d08e9d1920773bf							2018-04-11												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							aec2a50980c10db3bc8421a81fc3c207		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/031/SRR27477631/SRR27477631_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/031/SRR27477631/SRR27477631_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/031/SRR27477631/SRR27477631.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/031/SRR27477631/SRR27477631_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/031/SRR27477631/SRR27477631_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK102		2018-04-10			JK102_S168_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A92, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477631												PRJNA1063201					esophagus																																													
SRR27477632	SRX23149091	SAMN39328749	PRJNA1063201	SRS20099725	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK010	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK010	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A11, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	20019351	4002250784	Homo sapiens	2018-06-12	2024-01-11	2024-01-11		SRA1782421					PolyA												1066880966.0							JK010	818302388;765354849	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/032/SRR27477632/SRR27477632.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/032/SRR27477632/SRR27477632_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/032/SRR27477632/SRR27477632_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/032/SRR27477632/SRR27477632.lite		7e80c91c2ca837ab60504985d1b676f2;8cde6f281bdc729d449cbc78fa887f93							2018-06-12												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							9a60345be7cecf9b722ed65da5689263		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/032/SRR27477632/SRR27477632_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/032/SRR27477632/SRR27477632_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/032/SRR27477632/SRR27477632.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/032/SRR27477632/SRR27477632_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/032/SRR27477632/SRR27477632_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK010		2018-06-11			JK010_S10_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A11, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477632												PRJNA1063201					esophagus																																													
SRR27477633	SRX23149090	SAMN39328829	PRJNA1063201	SRS20099724	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK101	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK101	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A91, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	26306671	5238251715	Homo sapiens	2018-03-28	2024-01-11	2024-01-11		SRA1782421					PolyA												1398192780.0							JK101	1098123968;1047095200	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/033/SRR27477633/SRR27477633.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/033/SRR27477633/SRR27477633_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/033/SRR27477633/SRR27477633_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/033/SRR27477633/SRR27477633.lite		f84777ca68ca07904d55b97701f29243;959dd0dc09488ea635ef4cfbbe61d233							2018-03-28												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							1be4ff6fbc5306072820b65b350222b2		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/033/SRR27477633/SRR27477633_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/033/SRR27477633/SRR27477633_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/033/SRR27477633/SRR27477633.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/033/SRR27477633/SRR27477633_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/033/SRR27477633/SRR27477633_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK101		2018-03-27			JK101_S167_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A91, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477633												PRJNA1063201					esophagus																																													
SRR27477634	SRX23149089	SAMN39328828	PRJNA1063201	SRS20099723	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK099	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK099	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A90, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	19128389	3804589545	Homo sapiens	2021-04-01	2024-01-11	2024-01-11		SRA1782421					PolyA												1018347189.0							JK099	574150904;598291767	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/034/SRR27477634/SRR27477634.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/034/SRR27477634/SRR27477634_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/034/SRR27477634/SRR27477634_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/034/SRR27477634/SRR27477634.lite		89b07be0b5425249ab47f6b1293c0a19;4d771bfa1ff447151d32bef01be8c5fc							2021-04-01												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							8d348471e4a8dda1242924e9469fbc75		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/034/SRR27477634/SRR27477634_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/034/SRR27477634/SRR27477634_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/034/SRR27477634/SRR27477634.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/034/SRR27477634/SRR27477634_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/034/SRR27477634/SRR27477634_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK099		2021-03-31			JK099_S166_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A90, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477634												PRJNA1063201					esophagus																																													
SRR27477635	SRX23149088	SAMN39328827	PRJNA1063201	SRS20099722	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK098	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK098	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A89, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	24858680	4966028091	Homo sapiens	2021-03-16	2024-01-11	2024-01-11		SRA1782421					PolyA												1322947371.0							JK098	862408737;851175748	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/035/SRR27477635/SRR27477635.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/035/SRR27477635/SRR27477635_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/035/SRR27477635/SRR27477635_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/035/SRR27477635/SRR27477635.lite		e357a6f8f02b633b0e1af32a2fb349bc;3d005c992cec6094ae1d6433828b4709							2021-03-16												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							67534ef3851046523fed335788c4f1c7		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/035/SRR27477635/SRR27477635_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/035/SRR27477635/SRR27477635_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/035/SRR27477635/SRR27477635.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/035/SRR27477635/SRR27477635_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/035/SRR27477635/SRR27477635_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK098		2021-03-16			JK098_S85_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A89, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477635												PRJNA1063201					esophagus																																													
SRR27477636	SRX23149087	SAMN39328826	PRJNA1063201	SRS20099721	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK096	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK096	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A88, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	24040922	4804723017	Homo sapiens	2021-03-10	2024-01-11	2024-01-11		SRA1782421					PolyA												1280006299.0							JK096	986682640;919192035	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/036/SRR27477636/SRR27477636.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/036/SRR27477636/SRR27477636_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/036/SRR27477636/SRR27477636_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/036/SRR27477636/SRR27477636.lite		1d916fa95996e08164a42e1980bff51f;29041553dc79a7edfe7c3666a0091d0d							2021-03-10												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							a6009de13ed2b97fb3b70a513cf64d50		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/036/SRR27477636/SRR27477636_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/036/SRR27477636/SRR27477636_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/036/SRR27477636/SRR27477636.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/036/SRR27477636/SRR27477636_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/036/SRR27477636/SRR27477636_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK096		2021-03-10			JK096_S84_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A88, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477636												PRJNA1063201					esophagus																																													
SRR27477637	SRX23149086	SAMN39328825	PRJNA1063201	SRS20099720	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK095	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK095	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A87, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	20011710	4000641780	Homo sapiens	2021-01-25	2024-01-11	2024-01-11		SRA1782421					PolyA												1066377835.0							JK095	755162016;746038456	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/037/SRR27477637/SRR27477637.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/037/SRR27477637/SRR27477637_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/037/SRR27477637/SRR27477637_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/037/SRR27477637/SRR27477637.lite		447fcceb3cc1396cfea8aab4e5624875;1b1a49ed82be74174a32e6f1d867cb0f							2021-01-25												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							b621e3330223aaa431e5868e83d9435f		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/037/SRR27477637/SRR27477637_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/037/SRR27477637/SRR27477637_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/037/SRR27477637/SRR27477637.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/037/SRR27477637/SRR27477637_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/037/SRR27477637/SRR27477637_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK095		2021-01-25			JK095_S83_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A87, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477637												PRJNA1063201					esophagus																																													
SRR27477638	SRX23149085	SAMN39328824	PRJNA1063201	SRS20099719	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK093	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK093	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A86, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	22659659	4530254771	Homo sapiens	2020-10-13	2024-01-11	2024-01-11		SRA1782421					PolyA												1206714316.0							JK093	932139578;888530469	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/038/SRR27477638/SRR27477638.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/038/SRR27477638/SRR27477638_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/038/SRR27477638/SRR27477638_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/038/SRR27477638/SRR27477638.lite		72af239826ad43f830032ca131e70925;04080cd53de92156a8b29a5b0c53e398							2020-10-13												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							7e589652fca3f5954330a84a1c8ad395		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/038/SRR27477638/SRR27477638_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/038/SRR27477638/SRR27477638_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/038/SRR27477638/SRR27477638.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/038/SRR27477638/SRR27477638_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/038/SRR27477638/SRR27477638_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK093		2020-10-12			JK093_S82_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A86, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477638												PRJNA1063201					esophagus																																													
SRR27477639	SRX23149084	SAMN39328823	PRJNA1063201	SRS20099718	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK092	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK092	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A85, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	17020420	3404070731	Homo sapiens	2020-10-01	2024-01-11	2024-01-11		SRA1782421					PolyA												907979909.0							JK092	701259564;670219805	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/039/SRR27477639/SRR27477639.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/039/SRR27477639/SRR27477639_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/039/SRR27477639/SRR27477639_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/039/SRR27477639/SRR27477639.lite		478ae4dbce01d67f21fcd446798b7c58;708d4f9000887ac957bb5e82a66889b6							2020-10-01												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							8c02dd436eb9c0c273f218cdf0ca75c6		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/039/SRR27477639/SRR27477639_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/039/SRR27477639/SRR27477639_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/039/SRR27477639/SRR27477639.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/039/SRR27477639/SRR27477639_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/039/SRR27477639/SRR27477639_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK092		2020-09-30			JK092_S81_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A85, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477639												PRJNA1063201					esophagus																																													
SRR27477640	SRX23149083	SAMN39328822	PRJNA1063201	SRS20099717	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK091	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK091	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A84, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	21930928	4383672677	Homo sapiens	2020-09-24	2024-01-11	2024-01-11		SRA1782421					PolyA												1168239973.0							JK091	871200605;848757299	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/040/SRR27477640/SRR27477640.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/040/SRR27477640/SRR27477640_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/040/SRR27477640/SRR27477640_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/040/SRR27477640/SRR27477640.lite		2ada519583db1f43ef652fb1107fe98a;7f2079fa5b586e28e1e887ef3ff8ce26							2020-09-24												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							740a28e843f548c95c847db31afb0065		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/040/SRR27477640/SRR27477640_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/040/SRR27477640/SRR27477640_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/040/SRR27477640/SRR27477640.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/040/SRR27477640/SRR27477640_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/040/SRR27477640/SRR27477640_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK091		2020-09-23			JK091_S80_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A84, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477640												PRJNA1063201					esophagus																																													
SRR27477641	SRX23149082	SAMN39328821	PRJNA1063201	SRS20099715	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK090	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK090	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A83, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	20340132	4068180300	Homo sapiens	2020-09-11	2024-01-11	2024-01-11		SRA1782421					PolyA												1083822736.0							JK090	848187824;808925822	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/041/SRR27477641/SRR27477641.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/041/SRR27477641/SRR27477641_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/041/SRR27477641/SRR27477641_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/041/SRR27477641/SRR27477641.lite		97f56ed80e6ef7af7e75a7bd82160fe2;d591c6eb3ae67cbf1bc43d0972f8f0a9							2020-09-11												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							a17f558dc7b59de0955b38f65a2ca989		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/041/SRR27477641/SRR27477641_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/041/SRR27477641/SRR27477641_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/041/SRR27477641/SRR27477641.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/041/SRR27477641/SRR27477641_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/041/SRR27477641/SRR27477641_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK090		2020-09-10			JK090_S79_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A83, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477641												PRJNA1063201					esophagus																																													
SRR27477642	SRX23149081	SAMN39328820	PRJNA1063201	SRS20099716	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK089	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK089	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A82, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	21425362	4282450802	Homo sapiens	2020-09-02	2024-01-11	2024-01-11		SRA1782421					PolyA												1141546229.0							JK089	878285427;834857680	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/042/SRR27477642/SRR27477642.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/042/SRR27477642/SRR27477642_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/042/SRR27477642/SRR27477642_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/042/SRR27477642/SRR27477642.lite		ac8cf6a9504ad07dfe0de1c68cd686fa;1c5d473f7d959eec38985cbe340fadc2							2020-09-02												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							814051156b8c11440a39684b27883b20		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/042/SRR27477642/SRR27477642_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/042/SRR27477642/SRR27477642_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/042/SRR27477642/SRR27477642.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/042/SRR27477642/SRR27477642_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/042/SRR27477642/SRR27477642_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK089		2020-09-01			JK089_S78_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A82, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477642												PRJNA1063201					esophagus																																													
SRR27477643	SRX23149080	SAMN39328748	PRJNA1063201	SRS20099714	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK009	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK009	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A10, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	15491849	3092979216	Homo sapiens	2018-06-06	2024-01-11	2024-01-11		SRA1782421					PolyA												826678651.0							JK009	627828114;584429203	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/043/SRR27477643/SRR27477643.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/043/SRR27477643/SRR27477643_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/043/SRR27477643/SRR27477643_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/043/SRR27477643/SRR27477643.lite		cc9794c6d04c404da5561f198b61475d;49bf2a4f5fe3f7ccb83e0cf8c5db8320							2018-06-06												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							8958883518e0cd6e462447d04ffb5c4e		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/043/SRR27477643/SRR27477643_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/043/SRR27477643/SRR27477643_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/043/SRR27477643/SRR27477643.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/043/SRR27477643/SRR27477643_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/043/SRR27477643/SRR27477643_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK009		2018-06-05			JK009_S9_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A10, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477643												PRJNA1063201					esophagus																																													
SRR27477644	SRX23149079	SAMN39328819	PRJNA1063201	SRS20099712	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK088	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK088	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A81, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	23750300	4741242344	Homo sapiens	2020-08-19	2024-01-11	2024-01-11		SRA1782421					PolyA												1264455834.0							JK088	970017859;934753145	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/044/SRR27477644/SRR27477644.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/044/SRR27477644/SRR27477644_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/044/SRR27477644/SRR27477644_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/044/SRR27477644/SRR27477644.lite		24415188bbb1507ae12f586e5298f260;693ddbeeab895e459129cfd606a6a2d1							2020-08-19												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							6fe389bbe433d9f1bfb9479fac12a8e9		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/044/SRR27477644/SRR27477644_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/044/SRR27477644/SRR27477644_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/044/SRR27477644/SRR27477644.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/044/SRR27477644/SRR27477644_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/044/SRR27477644/SRR27477644_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK088		2020-08-18			JK088_S77_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A81, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477644												PRJNA1063201					esophagus																																													
SRR27477645	SRX23149078	SAMN39328818	PRJNA1063201	SRS20099713	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK087	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK087	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A80, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	2606915	520134618	Homo sapiens	2020-07-20	2024-01-11	2024-01-11		SRA1782421					PolyA												139802874.0							JK087	88541076;89165099	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/045/SRR27477645/SRR27477645.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/045/SRR27477645/SRR27477645_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/045/SRR27477645/SRR27477645_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/045/SRR27477645/SRR27477645.lite		259a6acd6849006244e5f926c78352ed;5bfb0c7e1598141f348f33fae20057ea							2020-07-20												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							4ee4555e6f61c442a1f19d178f65f401		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/045/SRR27477645/SRR27477645_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/045/SRR27477645/SRR27477645_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/045/SRR27477645/SRR27477645.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/045/SRR27477645/SRR27477645_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/045/SRR27477645/SRR27477645_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK087		2020-07-19			JK087_S76_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A80, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477645												PRJNA1063201					esophagus																																													
SRR27477646	SRX23149077	SAMN39328817	PRJNA1063201	SRS20099711	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK086	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK086	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A79, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	16758923	3348437310	Homo sapiens	2020-07-15	2024-01-11	2024-01-11		SRA1782421					PolyA												894151344.0							JK086	686144747;643921186	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/046/SRR27477646/SRR27477646.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/046/SRR27477646/SRR27477646_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/046/SRR27477646/SRR27477646_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/046/SRR27477646/SRR27477646.lite		1cdd5b42f071cc05906a84f1850d6c9b;5a00580979844b27f346def01d964c67							2020-07-15												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							52e2e3439e2b2949b7470849ded0a93b		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/046/SRR27477646/SRR27477646_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/046/SRR27477646/SRR27477646_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/046/SRR27477646/SRR27477646.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/046/SRR27477646/SRR27477646_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/046/SRR27477646/SRR27477646_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK086		2020-07-14			JK086_S75_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A79, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477646												PRJNA1063201					esophagus																																													
SRR27477647	SRX23149076	SAMN39328758	PRJNA1063201	SRS20099710	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK019	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK019	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A20, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	22302430	4455793476	Homo sapiens	2018-08-16	2024-01-11	2024-01-11		SRA1782421					PolyA												1187782044.0							JK019	920352979;826364970	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/047/SRR27477647/SRR27477647.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/047/SRR27477647/SRR27477647_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/047/SRR27477647/SRR27477647_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/047/SRR27477647/SRR27477647.lite		2ff0d097242c89a71915d6bf11db1cd0;42807cb71f8feb9ac08afc2a5570319c							2018-08-16												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							c37b93ee943c05042e0465673860e19b		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/047/SRR27477647/SRR27477647_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/047/SRR27477647/SRR27477647_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/047/SRR27477647/SRR27477647.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/047/SRR27477647/SRR27477647_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/047/SRR27477647/SRR27477647_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK019		2018-08-15			JK019_S19_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A20, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477647												PRJNA1063201					esophagus																																													
SRR27477648	SRX23149075	SAMN39328757	PRJNA1063201	SRS20099709	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK018	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK018	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A19, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	23573067	4707766541	Homo sapiens	2018-08-14	2024-01-11	2024-01-11		SRA1782421					PolyA												1254811020.0							JK018	961877152;877260812	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/048/SRR27477648/SRR27477648.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/048/SRR27477648/SRR27477648_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/048/SRR27477648/SRR27477648_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/048/SRR27477648/SRR27477648.lite		85431753ec8452c3ce946314e37f93d6;d16ea6b40dd5b5493ce517e23e3a4bb9							2018-08-14												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							23b4accc4bb416e2f74b5e4d2950ed3a		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/048/SRR27477648/SRR27477648_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/048/SRR27477648/SRR27477648_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/048/SRR27477648/SRR27477648.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/048/SRR27477648/SRR27477648_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/048/SRR27477648/SRR27477648_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK018		2018-08-13			JK018_S18_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A19, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477648												PRJNA1063201					esophagus																																													
SRR27477649	SRX23149074	SAMN39328756	PRJNA1063201	SRS20099708	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK017	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK017	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A18, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	19990982	3990078701	Homo sapiens	2018-07-10	2024-01-11	2024-01-11		SRA1782421					PolyA												1065169937.0							JK017	815203204;753339968	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/049/SRR27477649/SRR27477649.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/049/SRR27477649/SRR27477649_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/049/SRR27477649/SRR27477649_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/049/SRR27477649/SRR27477649.lite		5f57acf0b4e873b59b4e239a013a6c8a;4fc59a7594a512426cf0143ec6e6d4a5							2018-07-10												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							60ed76defd6c14480de3c4133924f23a		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/049/SRR27477649/SRR27477649_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/049/SRR27477649/SRR27477649_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/049/SRR27477649/SRR27477649.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/049/SRR27477649/SRR27477649_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/049/SRR27477649/SRR27477649_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK017		2018-07-09			JK017_S17_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A18, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477649												PRJNA1063201					esophagus																																													
SRR27477650	SRX23149073	SAMN39328755	PRJNA1063201	SRS20099707	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK016	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK016	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A17, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	25625657	5116105597	Homo sapiens	2018-07-10	2024-01-11	2024-01-11		SRA1782421					PolyA												1363605314.0							JK016	1035767146;969726688	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/050/SRR27477650/SRR27477650.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/050/SRR27477650/SRR27477650_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/050/SRR27477650/SRR27477650_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/050/SRR27477650/SRR27477650.lite		64e494ba3c8b29b6b97d7bbc2586d11d;6aef0e142620d4aac5ebc94e80273645							2018-07-10												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							f32e4452b6195cba3c30ffddf1ab69ef		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/050/SRR27477650/SRR27477650_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/050/SRR27477650/SRR27477650_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/050/SRR27477650/SRR27477650.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/050/SRR27477650/SRR27477650_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/050/SRR27477650/SRR27477650_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK016		2018-07-09			JK016_S16_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A17, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477650												PRJNA1063201					esophagus																																													
SRR27477651	SRX23149072	SAMN39328754	PRJNA1063201	SRS20099706	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK015	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK015	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A16, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	18954331	3784904525	Homo sapiens	2018-07-09	2024-01-11	2024-01-11		SRA1782421					PolyA												1010083528.0							JK015	711815505;677625111	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/051/SRR27477651/SRR27477651.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/051/SRR27477651/SRR27477651_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/051/SRR27477651/SRR27477651_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/051/SRR27477651/SRR27477651.lite		087abb5b34ba9518b33199b3fad850fd;c2fd4a0a97a6c1738f5a80e18bb309e3							2018-07-09												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							632ab356fd844fc54e1af60af9e4fef7		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/051/SRR27477651/SRR27477651_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/051/SRR27477651/SRR27477651_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/051/SRR27477651/SRR27477651.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/051/SRR27477651/SRR27477651_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/051/SRR27477651/SRR27477651_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK015		2018-07-08			JK015_S15_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A16, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477651												PRJNA1063201					esophagus																																													
SRR27477652	SRX23149071	SAMN39328876	PRJNA1063201	SRS20099705	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK148	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK148	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A138, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	23322733	4639892762	Homo sapiens	2019-07-22	2024-01-11	2024-01-11		SRA1782421					PolyA												1240340542.0							JK148	958862035;945893788	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/052/SRR27477652/SRR27477652.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/052/SRR27477652/SRR27477652_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/052/SRR27477652/SRR27477652_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/052/SRR27477652/SRR27477652.lite		964f26cc7c0727df75b0845af100e5cf;7b4238a0983f611eb3e4666403afce5b							2019-07-22												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							51a649f0af4be7b8329c7fd8ea48b9fb		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/052/SRR27477652/SRR27477652_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/052/SRR27477652/SRR27477652_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/052/SRR27477652/SRR27477652.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/052/SRR27477652/SRR27477652_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/052/SRR27477652/SRR27477652_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK148		2019-07-21			JK148_S214_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A138, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477652												PRJNA1063201					esophagus																																													
SRR27477653	SRX23149070	SAMN39328875	PRJNA1063201	SRS20099704	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK147	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK147	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A137, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	23033516	4569317017	Homo sapiens	2020-01-21	2024-01-11	2024-01-11		SRA1782421					PolyA												1223419677.0							JK147	937066952;915037627	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/053/SRR27477653/SRR27477653.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/053/SRR27477653/SRR27477653_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/053/SRR27477653/SRR27477653_2.fastq.gz							USA: New York, NY	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/053/SRR27477653/SRR27477653.lite		2308d96b79a4089d7e8457d2a931e3a2;f06b7ebe979a1dc09c4c301c6390f228							2020-01-21												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							fdb8f152b07828e26b19afd1795a40af		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/053/SRR27477653/SRR27477653_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/053/SRR27477653/SRR27477653_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/053/SRR27477653/SRR27477653.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/053/SRR27477653/SRR27477653_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/053/SRR27477653/SRR27477653_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK147		2020-01-21			JK147_S213_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A137, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477653												PRJNA1063201					esophagus																																													
SRR27477654	SRX23149069	SAMN39328874	PRJNA1063201	SRS20099703	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK146	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK146	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A136, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	23208307	4552219212	Homo sapiens	2020-01-14	2024-01-11	2024-01-11		SRA1782421					PolyA												1225005451.0							JK146	928999842;911133401	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/054/SRR27477654/SRR27477654.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/054/SRR27477654/SRR27477654_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/054/SRR27477654/SRR27477654_2.fastq.gz							USA: New York, NY	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/054/SRR27477654/SRR27477654.lite		1cfebd9596dfe373d3c20a2c19488a9e;25212faa21fbeb95e09f7dbbdbf2f4b6							2020-01-14												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							ac916f70e14acf534260901bdc0ab150		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/054/SRR27477654/SRR27477654_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/054/SRR27477654/SRR27477654_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/054/SRR27477654/SRR27477654.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/054/SRR27477654/SRR27477654_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/054/SRR27477654/SRR27477654_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK146		2020-01-14			JK146_S212_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A136, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477654												PRJNA1063201					esophagus																																													
SRR27477655	SRX23149068	SAMN39328873	PRJNA1063201	SRS20099702	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK145	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK145	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A135, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	25402381	5021773573	Homo sapiens	2019-06-11	2024-01-11	2024-01-11		SRA1782421					PolyA												1345993563.0							JK145	1026616804;1002622726	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/055/SRR27477655/SRR27477655.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/055/SRR27477655/SRR27477655_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/055/SRR27477655/SRR27477655_2.fastq.gz							USA: New York, NY	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/055/SRR27477655/SRR27477655.lite		0cbb3e264ff3c81dc54d5896db909bf1;d65741fd7784775506fc7812ad21988d							2019-06-11												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							fdd5b9ff0f5f204cccae07aacfa1636a		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/055/SRR27477655/SRR27477655_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/055/SRR27477655/SRR27477655_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/055/SRR27477655/SRR27477655.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/055/SRR27477655/SRR27477655_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/055/SRR27477655/SRR27477655_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK145		2019-06-10			JK145_S211_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A135, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477655												PRJNA1063201					esophagus																																													
SRR27477656	SRX23149067	SAMN39328872	PRJNA1063201	SRS20099700	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK144	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK144	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A134, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	22977428	4573252073	Homo sapiens	2019-05-14	2024-01-11	2024-01-11		SRA1782421					PolyA												1222618317.0							JK144	919860753;897434652	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/056/SRR27477656/SRR27477656.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/056/SRR27477656/SRR27477656_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/056/SRR27477656/SRR27477656_2.fastq.gz							USA: New York, NY	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/056/SRR27477656/SRR27477656.lite		8febcbc16b1b2beb4aa683067af05210;d81be70e3d46ebde7ebadd8ee28a424b							2019-05-14												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							1a01efc07e4bd04add63f618499240fb		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/056/SRR27477656/SRR27477656_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/056/SRR27477656/SRR27477656_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/056/SRR27477656/SRR27477656.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/056/SRR27477656/SRR27477656_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/056/SRR27477656/SRR27477656_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK144		2019-05-13			JK144_S210_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A134, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477656												PRJNA1063201					esophagus																																													
SRR27477657	SRX23149066	SAMN39328871	PRJNA1063201	SRS20099701	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK143	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK143	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A133, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	18134616	3589257823	Homo sapiens	2019-04-23	2024-01-11	2024-01-11		SRA1782421					PolyA												963874253.0							JK143	564473651;584497551	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/057/SRR27477657/SRR27477657.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/057/SRR27477657/SRR27477657_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/057/SRR27477657/SRR27477657_2.fastq.gz							USA: New York, NY	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/057/SRR27477657/SRR27477657.lite		9a80dc4fe4d67f1b24ec2273242a985b;f445278b125372fd38bd878f71cff8ed							2019-04-23												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							91749cf808024230d9ff8f66ce81a8e6		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/057/SRR27477657/SRR27477657_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/057/SRR27477657/SRR27477657_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/057/SRR27477657/SRR27477657.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/057/SRR27477657/SRR27477657_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/057/SRR27477657/SRR27477657_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK143		2019-04-22			JK143_S209_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A133, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477657												PRJNA1063201					esophagus																																													
SRR27477658	SRX23149065	SAMN39328870	PRJNA1063201	SRS20099699	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK142	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK142	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A132, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	21319838	4243408786	Homo sapiens	2019-03-12	2024-01-11	2024-01-11		SRA1782421					PolyA												1134863555.0							JK142	875051389;837902745	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/058/SRR27477658/SRR27477658.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/058/SRR27477658/SRR27477658_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/058/SRR27477658/SRR27477658_2.fastq.gz							USA: New York, NY	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/058/SRR27477658/SRR27477658.lite		1edea29dcf245d6a4ed0ab67413d1cd3;b2c8610b72652a397d2f8e67e871e9c9							2019-03-12												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							1a8c948d19f64c37cc98ab76c2e700a2		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/058/SRR27477658/SRR27477658_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/058/SRR27477658/SRR27477658_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/058/SRR27477658/SRR27477658.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/058/SRR27477658/SRR27477658_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/058/SRR27477658/SRR27477658_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK142		2019-03-12			JK142_S208_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A132, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477658												PRJNA1063201					esophagus																																													
SRR27477659	SRX23149064	SAMN39328753	PRJNA1063201	SRS20099698	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK014	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK014	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A15, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	27666139	5527314491	Homo sapiens	2018-07-06	2024-01-11	2024-01-11		SRA1782421					PolyA												1471621742.0							JK014	1140949945;1085076281	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/059/SRR27477659/SRR27477659.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/059/SRR27477659/SRR27477659_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/059/SRR27477659/SRR27477659_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/059/SRR27477659/SRR27477659.lite		80213dced4ec53125b3cc6d5c623a8e7;d3c71bc710417e3f7868bb9bbdc613bd							2018-07-06												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							672a2a43427f03803bb5a4da423d342a		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/059/SRR27477659/SRR27477659_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/059/SRR27477659/SRR27477659_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/059/SRR27477659/SRR27477659.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/059/SRR27477659/SRR27477659_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/059/SRR27477659/SRR27477659_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK014		2018-07-05			JK014_S14_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A15, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477659												PRJNA1063201					esophagus																																													
SRR27477660	SRX23149063	SAMN39328869	PRJNA1063201	SRS20099697	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK141	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK141	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A131, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	30219357	6015640750	Homo sapiens	2019-02-26	2024-01-11	2024-01-11		SRA1782421					PolyA												1605397540.0							JK141	1259586116;1217406446	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/060/SRR27477660/SRR27477660.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/060/SRR27477660/SRR27477660_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/060/SRR27477660/SRR27477660_2.fastq.gz							USA: New York, NY	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/060/SRR27477660/SRR27477660.lite		83679494ab0352499160b3a65b70b2d6;28076c7f25caa8c5430b5f7eac76090f							2019-02-26												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							7b6d432a3e4dc07f54c5546e6cb416dd		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/060/SRR27477660/SRR27477660_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/060/SRR27477660/SRR27477660_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/060/SRR27477660/SRR27477660.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/060/SRR27477660/SRR27477660_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/060/SRR27477660/SRR27477660_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK141		2019-02-26			JK141_S207_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A131, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477660												PRJNA1063201					esophagus																																													
SRR27477661	SRX23149062	SAMN39328868	PRJNA1063201	SRS20099696	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK140	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK140	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A130, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	25806651	5116427615	Homo sapiens	2019-01-29	2024-01-11	2024-01-11		SRA1782421					PolyA												1369344399.0							JK140	1040903939;1015774826	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/061/SRR27477661/SRR27477661.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/061/SRR27477661/SRR27477661_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/061/SRR27477661/SRR27477661_2.fastq.gz							USA: New York, NY	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/061/SRR27477661/SRR27477661.lite		590f0f7070519a863f4aa0f95a4e4bcf;431b2884ed6651b3f36a442f6cec8593							2019-01-29												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							614c3fde2282b8e25c2e649867297a99		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/061/SRR27477661/SRR27477661_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/061/SRR27477661/SRR27477661_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/061/SRR27477661/SRR27477661.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/061/SRR27477661/SRR27477661_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/061/SRR27477661/SRR27477661_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK140		2019-01-29			JK140_S206_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A130, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477661												PRJNA1063201					esophagus																																													
SRR27477662	SRX23149061	SAMN39328867	PRJNA1063201	SRS20099695	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK139	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK139	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A129, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	26650035	5304894961	Homo sapiens	2018-12-18	2024-01-11	2024-01-11		SRA1782421					PolyA												1416805942.0							JK139	1079682994;1055670714	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/062/SRR27477662/SRR27477662.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/062/SRR27477662/SRR27477662_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/062/SRR27477662/SRR27477662_2.fastq.gz							USA: New York, NY	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/062/SRR27477662/SRR27477662.lite		8c63019dac439bf8e4e26eedb95cd7ba;3c0ddf986080bbf1e3c03f1f1883f5c0							2018-12-18												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							fc6c121c192314cad2c3b1658704ef70		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/062/SRR27477662/SRR27477662_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/062/SRR27477662/SRR27477662_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/062/SRR27477662/SRR27477662.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/062/SRR27477662/SRR27477662_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/062/SRR27477662/SRR27477662_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK139		2018-12-18			JK139_S205_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A129, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477662												PRJNA1063201					esophagus																																													
SRR27477663	SRX23149060	SAMN39328839	PRJNA1063201	SRS20099694	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK111	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK111	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A101, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	22111687	4367879416	Homo sapiens	2018-10-10	2024-01-11	2024-01-11		SRA1782421					PolyA												1171811328.0							JK111	912264358;879674528	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/063/SRR27477663/SRR27477663.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/063/SRR27477663/SRR27477663_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/063/SRR27477663/SRR27477663_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/063/SRR27477663/SRR27477663.lite		133fdbd348f4b3af6d3533846cba0cd8;4f7a1a4023bf2e38d788618ec173e600							2018-10-10												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							a17ebafa966b9ff413ca820115fc1383		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/063/SRR27477663/SRR27477663_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/063/SRR27477663/SRR27477663_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/063/SRR27477663/SRR27477663.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/063/SRR27477663/SRR27477663_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/063/SRR27477663/SRR27477663_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK111		2018-10-09			JK111_S177_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A101, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477663												PRJNA1063201					esophagus																																													
SRR27477664	SRX23149059	SAMN39328838	PRJNA1063201	SRS20099693	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK110	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK110	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A100, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	17029985	3388808371	Homo sapiens	2018-09-12	2024-01-11	2024-01-11		SRA1782421					PolyA												907353105.0							JK110	670199599;627274567	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/064/SRR27477664/SRR27477664.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/064/SRR27477664/SRR27477664_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/064/SRR27477664/SRR27477664_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/064/SRR27477664/SRR27477664.lite		4fbeeab1d9e99e748a43c2040850f548;f241e00a6b2373273644489d5636967b							2018-09-12												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							f2c92a4d60e81f290e97ac488e448979		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/064/SRR27477664/SRR27477664_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/064/SRR27477664/SRR27477664_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/064/SRR27477664/SRR27477664.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/064/SRR27477664/SRR27477664_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/064/SRR27477664/SRR27477664_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK110		2018-09-11			JK110_S176_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A100, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477664												PRJNA1063201					esophagus																																													
SRR27477665	SRX23149058	SAMN39328837	PRJNA1063201	SRS20099692	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK109	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK109	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A99, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	15214453	3034778127	Homo sapiens	2018-09-05	2024-01-11	2024-01-11		SRA1782421					PolyA												811707316.0							JK109	623008485;578212464	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/065/SRR27477665/SRR27477665.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/065/SRR27477665/SRR27477665_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/065/SRR27477665/SRR27477665_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/065/SRR27477665/SRR27477665.lite		d8d0a922d641399f819a18face0a3fa1;61301c4357590a5e09390242efabfd7f							2018-09-05												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							d8b765562206a8d828b9144af8483390		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/065/SRR27477665/SRR27477665_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/065/SRR27477665/SRR27477665_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/065/SRR27477665/SRR27477665.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/065/SRR27477665/SRR27477665_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/065/SRR27477665/SRR27477665_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK109		2018-09-04			JK109_S175_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A99, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477665												PRJNA1063201					esophagus																																													
SRR27477666	SRX23149057	SAMN39328836	PRJNA1063201	SRS20099691	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK108	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK108	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A98, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	17276174	3445380451	Homo sapiens	2018-08-20	2024-01-11	2024-01-11		SRA1782421					PolyA												921058232.0							JK108	691875632;650370297	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/066/SRR27477666/SRR27477666.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/066/SRR27477666/SRR27477666_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/066/SRR27477666/SRR27477666_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/066/SRR27477666/SRR27477666.lite		db5c6bb8e8045f36fc40bea3d83d59ee;04dfe088d513410aff52dff6201db3ae							2018-08-20												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							9f2f7356df0a4d8e0795d737a12adcbf		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/066/SRR27477666/SRR27477666_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/066/SRR27477666/SRR27477666_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/066/SRR27477666/SRR27477666.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/066/SRR27477666/SRR27477666_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/066/SRR27477666/SRR27477666_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK108		2018-08-19			JK108_S174_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A98, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477666												PRJNA1063201					esophagus																																													
SRR27477667	SRX23149056	SAMN39328835	PRJNA1063201	SRS20099690	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK107	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK107	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A97, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	17609378	3507528538	Homo sapiens	2018-08-06	2024-01-11	2024-01-11		SRA1782421					PolyA												938265274.0							JK107	698773749;664807884	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/067/SRR27477667/SRR27477667.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/067/SRR27477667/SRR27477667_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/067/SRR27477667/SRR27477667_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/067/SRR27477667/SRR27477667.lite		81232ceadcc5a8fbc9e892782e25bd44;98239b209c3d65f443c719390fd446ea							2018-08-06												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							5ee6e3ad6666cd8f3102a5b5b629cf2e		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/067/SRR27477667/SRR27477667_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/067/SRR27477667/SRR27477667_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/067/SRR27477667/SRR27477667.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/067/SRR27477667/SRR27477667_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/067/SRR27477667/SRR27477667_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK107		2018-08-05			JK107_S173_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A97, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477667												PRJNA1063201					esophagus																																													
SRR27477668	SRX23149055	SAMN39328834	PRJNA1063201	SRS20099689	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK106	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK106	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A96, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	17224984	3436893332	Homo sapiens	2018-06-27	2024-01-11	2024-01-11		SRA1782421					PolyA												918438545.0							JK106	719617648;676987766	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/068/SRR27477668/SRR27477668.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/068/SRR27477668/SRR27477668_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/068/SRR27477668/SRR27477668_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/068/SRR27477668/SRR27477668.lite		108d1c063dcf315fdce2fe53fc14e7f2;7c6301095b85bf78f66518338161ae25							2018-06-27												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							06ee397079bd0b9eb26b1c313b614907		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/068/SRR27477668/SRR27477668_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/068/SRR27477668/SRR27477668_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/068/SRR27477668/SRR27477668.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/068/SRR27477668/SRR27477668_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/068/SRR27477668/SRR27477668_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK106		2018-06-26			JK106_S172_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A96, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477668												PRJNA1063201					esophagus																																													
SRR27477669	SRX23149054	SAMN39328833	PRJNA1063201	SRS20099688	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK105	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK105	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A95, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	20253301	4035581699	Homo sapiens	2018-06-26	2024-01-11	2024-01-11		SRA1782421					PolyA												1078296684.0							JK105	845136046;806618538	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/069/SRR27477669/SRR27477669.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/069/SRR27477669/SRR27477669_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/069/SRR27477669/SRR27477669_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/069/SRR27477669/SRR27477669.lite		d69eb81819aadb434d113ce8b57ff3f3;c93970748ab06fc95a9b23cd8e6d87b5							2018-06-26												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							9a6eb9d50fd5431b0b6e73284532a916		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/069/SRR27477669/SRR27477669_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/069/SRR27477669/SRR27477669_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/069/SRR27477669/SRR27477669.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/069/SRR27477669/SRR27477669_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/069/SRR27477669/SRR27477669_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK105		2018-06-25			JK105_S171_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A95, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477669												PRJNA1063201					esophagus																																													
SRR27477670	SRX23149053	SAMN39328832	PRJNA1063201	SRS20099687	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK104	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK104	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A94, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	18443696	3660211053	Homo sapiens	2018-04-30	2024-01-11	2024-01-11		SRA1782421					PolyA												980742224.0							JK104	768227088;730945690	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/070/SRR27477670/SRR27477670.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/070/SRR27477670/SRR27477670_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/070/SRR27477670/SRR27477670_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/070/SRR27477670/SRR27477670.lite		05c19723e4ada235d39806511edb5676;25a6e4fb322b7332e6364c2ed35be4a5							2018-04-30												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							3c669c146fb5220fe5ee391279777372		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/070/SRR27477670/SRR27477670_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/070/SRR27477670/SRR27477670_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/070/SRR27477670/SRR27477670.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/070/SRR27477670/SRR27477670_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/070/SRR27477670/SRR27477670_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK104		2018-04-29			JK104_S170_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A94, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477670												PRJNA1063201					esophagus																																													
SRR27477671	SRX23149052	SAMN39328831	PRJNA1063201	SRS20099684	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK103	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK103	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A93, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	16753426	3337711085	Homo sapiens	2018-04-13	2024-01-11	2024-01-11		SRA1782421					PolyA												892935484.0							JK103	692506161;658161109	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/071/SRR27477671/SRR27477671.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/071/SRR27477671/SRR27477671_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/071/SRR27477671/SRR27477671_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/071/SRR27477671/SRR27477671.lite		8afbed0df82cbe121955f009c5363918;ca65e980c41bae7ac37dbad982980b54							2018-04-13												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							a759096f6351cedbbf23577ffa3b7832		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/071/SRR27477671/SRR27477671_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/071/SRR27477671/SRR27477671_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/071/SRR27477671/SRR27477671.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/071/SRR27477671/SRR27477671_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/071/SRR27477671/SRR27477671_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK103		2018-04-12			JK103_S169_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A93, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477671												PRJNA1063201					esophagus																																													
SRR27477672	SRX23149051	SAMN39328801	PRJNA1063201	SRS20099685	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK067	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK067	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A63, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	14212664	2827284735	Homo sapiens	2019-06-20	2024-01-11	2024-01-11		SRA1782421					PolyA												757697181.0							JK067	534085644;513392621	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/072/SRR27477672/SRR27477672.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/072/SRR27477672/SRR27477672_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/072/SRR27477672/SRR27477672_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/072/SRR27477672/SRR27477672.lite		cba0da3636c090610cf280d296e3b99f;08a838fddb774d9ec49fbeddc64daf38							2019-06-20												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							1217cdc9fdc61e2da7aec8b90575d408		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/072/SRR27477672/SRR27477672_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/072/SRR27477672/SRR27477672_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/072/SRR27477672/SRR27477672.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/072/SRR27477672/SRR27477672_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/072/SRR27477672/SRR27477672_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK067		2019-06-19			JK067_S59_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A63, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477672												PRJNA1063201					esophagus																																													
SRR27477673	SRX23149050	SAMN39328800	PRJNA1063201	SRS20099686	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK066	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK066	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A62, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	22320241	4453871738	Homo sapiens	2019-06-17	2024-01-11	2024-01-11		SRA1782421					PolyA												1188214427.0							JK066	897431971;856581844	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/073/SRR27477673/SRR27477673.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/073/SRR27477673/SRR27477673_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/073/SRR27477673/SRR27477673_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/073/SRR27477673/SRR27477673.lite		93238ead5ebe9bf469e3eccf7d466c69;922191b9317b28b3207c1ce987abfd71							2019-06-17												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							09c07a932a46e2df7ded506f77d6c585		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/073/SRR27477673/SRR27477673_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/073/SRR27477673/SRR27477673_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/073/SRR27477673/SRR27477673.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/073/SRR27477673/SRR27477673_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/073/SRR27477673/SRR27477673_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK066		2019-06-16			JK066_S58_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A62, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477673												PRJNA1063201					esophagus																																													
SRR27477674	SRX23149049	SAMN39328746	PRJNA1063201	SRS20099683	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK007	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK007	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A8, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	12845052	2561021832	Homo sapiens	2018-05-29	2024-01-11	2024-01-11		SRA1782421					PolyA												685682562.0							JK007	389578001;405261057	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/074/SRR27477674/SRR27477674.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/074/SRR27477674/SRR27477674_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/074/SRR27477674/SRR27477674_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/074/SRR27477674/SRR27477674.lite		d7fa19e0161901cc17c5ddafb08da1ac;183403325cd1f442025b9e454d802f10							2018-05-29												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							9597e7f5e4552a5bc0f267f8912b4600		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/074/SRR27477674/SRR27477674_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/074/SRR27477674/SRR27477674_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/074/SRR27477674/SRR27477674.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/074/SRR27477674/SRR27477674_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/074/SRR27477674/SRR27477674_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK007		2018-05-28			JK007_S7_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A8, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477674												PRJNA1063201					esophagus																																													
SRR27477675	SRX23149048	SAMN39328799	PRJNA1063201	SRS20099682	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK064	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK064	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A61, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	18256859	3637541447	Homo sapiens	2019-05-28	2024-01-11	2024-01-11		SRA1782421					PolyA												972595860.0							JK064	679423001;664313995	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/075/SRR27477675/SRR27477675.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/075/SRR27477675/SRR27477675_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/075/SRR27477675/SRR27477675_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/075/SRR27477675/SRR27477675.lite		4907b75edc9651db4698e57b8267fbcb;4dc8af6ac888702b53a35eaeca8ae6d9							2019-05-28												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							f64b5fc5de72dc74b7f3831393f71a13		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/075/SRR27477675/SRR27477675_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/075/SRR27477675/SRR27477675_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/075/SRR27477675/SRR27477675.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/075/SRR27477675/SRR27477675_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/075/SRR27477675/SRR27477675_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK064		2019-05-27			JK064_S57_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A61, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477675												PRJNA1063201					esophagus																																													
SRR27477676	SRX23149047	SAMN39328798	PRJNA1063201	SRS20099681	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK063	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK063	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A60, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	1916880	379664075	Homo sapiens	2019-05-21	2024-01-11	2024-01-11		SRA1782421					PolyA												102502261.0							JK063	63581911;64205156	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/076/SRR27477676/SRR27477676.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/076/SRR27477676/SRR27477676_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/076/SRR27477676/SRR27477676_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/076/SRR27477676/SRR27477676.lite		02bc06f97f6a0eea42a682fd8c2f0154;e0502cbbbf014ad441498ff5dadc0568							2019-05-21												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							7d469e97cc9192a1c126006e169d6aba		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/076/SRR27477676/SRR27477676_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/076/SRR27477676/SRR27477676_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/076/SRR27477676/SRR27477676.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/076/SRR27477676/SRR27477676_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/076/SRR27477676/SRR27477676_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK063		2019-05-20			JK063_S56_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A60, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477676												PRJNA1063201					esophagus																																													
SRR27477677	SRX23149046	SAMN39328797	PRJNA1063201	SRS20099680	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK061	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK061	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A59, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	18256050	3647653810	Homo sapiens	2019-05-02	2024-01-11	2024-01-11		SRA1782421					PolyA												973575563.0							JK061	555926585;575370804	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/077/SRR27477677/SRR27477677.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/077/SRR27477677/SRR27477677_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/077/SRR27477677/SRR27477677_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/077/SRR27477677/SRR27477677.lite		fec3fd5ec82f8c3fd3b520921b36fc76;bfb00bd767624c1dd866d1eafc96b3d3							2019-05-02												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							edd44372baa84d537891ff7e929a878c		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/077/SRR27477677/SRR27477677_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/077/SRR27477677/SRR27477677_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/077/SRR27477677/SRR27477677.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/077/SRR27477677/SRR27477677_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/077/SRR27477677/SRR27477677_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK061		2019-05-01			JK061_S55_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A59, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477677												PRJNA1063201					esophagus																																													
SRR27477678	SRX23149045	SAMN39328796	PRJNA1063201	SRS20099679	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK060	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK060	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A58, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	15088382	3012315843	Homo sapiens	2019-04-30	2024-01-11	2024-01-11		SRA1782421					PolyA												805366681.0							JK060	590862471;562596622	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/078/SRR27477678/SRR27477678.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/078/SRR27477678/SRR27477678_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/078/SRR27477678/SRR27477678_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/078/SRR27477678/SRR27477678.lite		cb7fcd0fc1b66fc41b982354a56d1ed7;fde70d6955deb6f2d3afd55523764bce							2019-04-30												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							9ecf03d148afdbf7f0e18293eb0d7a5d		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/078/SRR27477678/SRR27477678_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/078/SRR27477678/SRR27477678_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/078/SRR27477678/SRR27477678.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/078/SRR27477678/SRR27477678_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/078/SRR27477678/SRR27477678_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK060		2019-04-29			JK060_S54_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A58, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477678												PRJNA1063201					esophagus																																													
SRR27477679	SRX23149044	SAMN39328795	PRJNA1063201	SRS20099678	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK058	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK058	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A57, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	21262616	4239145339	Homo sapiens	2019-04-25	2024-01-11	2024-01-11		SRA1782421					PolyA												1132378139.0							JK058	640934910;665750416	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/079/SRR27477679/SRR27477679.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/079/SRR27477679/SRR27477679_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/079/SRR27477679/SRR27477679_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/079/SRR27477679/SRR27477679.lite		282bc344f74230995bf4957b16adbd77;41c56b4100e66df84002a009f0390ee8							2019-04-25												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							edb00f6244435b8ebbeb0b66a6fa1658		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/079/SRR27477679/SRR27477679_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/079/SRR27477679/SRR27477679_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/079/SRR27477679/SRR27477679.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/079/SRR27477679/SRR27477679_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/079/SRR27477679/SRR27477679_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK058		2019-04-24			JK058_S53_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A57, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477679												PRJNA1063201					esophagus																																													
SRR27477680	SRX23149043	SAMN39328794	PRJNA1063201	SRS20099677	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK057	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK057	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A56, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	18247605	3643825241	Homo sapiens	2019-04-23	2024-01-11	2024-01-11		SRA1782421					PolyA												972906620.0							JK057	731157720;688641774	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/080/SRR27477680/SRR27477680.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/080/SRR27477680/SRR27477680_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/080/SRR27477680/SRR27477680_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/080/SRR27477680/SRR27477680.lite		f0eb0979208ae72e319427a25d5bd4cf;affe6790bb4b3f5ccc9e452511962a89							2019-04-23												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							f475b0ce3c3e0906aad27f15517122d2		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/080/SRR27477680/SRR27477680_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/080/SRR27477680/SRR27477680_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/080/SRR27477680/SRR27477680.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/080/SRR27477680/SRR27477680_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/080/SRR27477680/SRR27477680_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK057		2019-04-22			JK057_S52_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A56, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477680												PRJNA1063201					esophagus																																													
SRR27477681	SRX23149042	SAMN39328793	PRJNA1063201	SRS20099674	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK056	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK056	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A55, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	17471173	3487239133	Homo sapiens	2019-04-23	2024-01-11	2024-01-11		SRA1782421					PolyA												931688283.0							JK056	454975912;494084632	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/081/SRR27477681/SRR27477681.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/081/SRR27477681/SRR27477681_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/081/SRR27477681/SRR27477681_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/081/SRR27477681/SRR27477681.lite		120aae80289e0a66df9cc06f23853d07;19c7707d32475169bb25390e4a3ff394							2019-04-23												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							63da5412438a2bb00e5ade6cfd757653		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/081/SRR27477681/SRR27477681_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/081/SRR27477681/SRR27477681_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/081/SRR27477681/SRR27477681.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/081/SRR27477681/SRR27477681_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/081/SRR27477681/SRR27477681_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK056		2019-04-22			JK056_S51_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A55, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477681												PRJNA1063201					esophagus																																													
SRR27477682	SRX23149041	SAMN39328792	PRJNA1063201	SRS20099675	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK055	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK055	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A54, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	20754542	4144495946	Homo sapiens	2019-04-18	2024-01-11	2024-01-11		SRA1782421					PolyA												1105837083.0							JK055	763831656;760709937	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/082/SRR27477682/SRR27477682.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/082/SRR27477682/SRR27477682_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/082/SRR27477682/SRR27477682_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/082/SRR27477682/SRR27477682.lite		e8779f514e7fa24c844a1416b5bac9e0;abd458699ee0f0de1533c384c1a70562							2019-04-18												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							83e8b2356e2cd572e7243bf7cabb7f03		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/082/SRR27477682/SRR27477682_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/082/SRR27477682/SRR27477682_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/082/SRR27477682/SRR27477682.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/082/SRR27477682/SRR27477682_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/082/SRR27477682/SRR27477682_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK055		2019-04-17			JK055_S50_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A54, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477682												PRJNA1063201					esophagus																																													
SRR27477683	SRX23149040	SAMN39328791	PRJNA1063201	SRS20099676	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK054	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK054	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A53, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	10791017	2152111187	Homo sapiens	2019-04-16	2024-01-11	2024-01-11		SRA1782421					PolyA												576891040.0							JK054	449997050;419861375	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/083/SRR27477683/SRR27477683.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/083/SRR27477683/SRR27477683_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/083/SRR27477683/SRR27477683_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/083/SRR27477683/SRR27477683.lite		2d292b6a587a42e35881146e8c28d6b4;67a46398ad5a3311e2484287de3e146d							2019-04-16												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							4de07fc222351d82858ead1ac2806e1a		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/083/SRR27477683/SRR27477683_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/083/SRR27477683/SRR27477683_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/083/SRR27477683/SRR27477683.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/083/SRR27477683/SRR27477683_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/083/SRR27477683/SRR27477683_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK054		2019-04-15			JK054_S49_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A53, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477683												PRJNA1063201					esophagus																																													
SRR27477684	SRX23149039	SAMN39328790	PRJNA1063201	SRS20099673	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK053	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK053	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A52, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	20788864	4144535472	Homo sapiens	2019-03-18	2024-01-11	2024-01-11		SRA1782421					PolyA												1107008209.0							JK053	618768214;641617451	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/084/SRR27477684/SRR27477684.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/084/SRR27477684/SRR27477684_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/084/SRR27477684/SRR27477684_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/084/SRR27477684/SRR27477684.lite		e8742b6966ffecd5565f1a87111784a9;6a089d1a1cfff44c501d83e2dd68c4ad							2019-03-18												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							4db394f8154ee002cf9bcccc3be7b3b5		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/084/SRR27477684/SRR27477684_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/084/SRR27477684/SRR27477684_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/084/SRR27477684/SRR27477684.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/084/SRR27477684/SRR27477684_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/084/SRR27477684/SRR27477684_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK053		2019-03-18			JK053_S48_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A52, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477684												PRJNA1063201					esophagus																																													
SRR27477685	SRX23149038	SAMN39328745	PRJNA1063201	SRS20099672	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK006	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK006	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A7, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	18849640	3766282860	Homo sapiens	2018-05-24	2024-01-11	2024-01-11		SRA1782421					PolyA												1004659658.0							JK006	650645276;644340054	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/085/SRR27477685/SRR27477685.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/085/SRR27477685/SRR27477685_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/085/SRR27477685/SRR27477685_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/085/SRR27477685/SRR27477685.lite		536beddf2b143497f6e4ab8884682940;92e8a8dcf91e0c8b0effccaf18c521a8							2018-05-24												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							dc00068e1cf23957618922655682bde8		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/085/SRR27477685/SRR27477685_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/085/SRR27477685/SRR27477685_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/085/SRR27477685/SRR27477685.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/085/SRR27477685/SRR27477685_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/085/SRR27477685/SRR27477685_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK006		2018-05-23			JK006_S6_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A7, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477685												PRJNA1063201					esophagus																																													
SRR27477686	SRX23149037	SAMN39328789	PRJNA1063201	SRS20099671	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK052	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK052	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A51, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	20906715	4168032783	Homo sapiens	2019-03-14	2024-01-11	2024-01-11		SRA1782421					PolyA												1113332087.0							JK052	839730336;815234011	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/086/SRR27477686/SRR27477686.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/086/SRR27477686/SRR27477686_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/086/SRR27477686/SRR27477686_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/086/SRR27477686/SRR27477686.lite		dfc5879a05870212118902b11c1f886f;6e09b7461442cff7624662824f70aac5							2019-03-14												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							905d00798d1d8799831d825b7c67b9c9		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/086/SRR27477686/SRR27477686_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/086/SRR27477686/SRR27477686_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/086/SRR27477686/SRR27477686.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/086/SRR27477686/SRR27477686_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/086/SRR27477686/SRR27477686_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK052		2019-03-14			JK052_S47_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A51, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477686												PRJNA1063201					esophagus																																													
SRR27477687	SRX23149036	SAMN39328788	PRJNA1063201	SRS20099669	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK051	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK051	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A50, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	18013951	3595774732	Homo sapiens	2019-02-21	2024-01-11	2024-01-11		SRA1782421					PolyA												960478853.0							JK051	491729494;525232070	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/087/SRR27477687/SRR27477687.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/087/SRR27477687/SRR27477687_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/087/SRR27477687/SRR27477687_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/087/SRR27477687/SRR27477687.lite		b76f2b27401843dd72e19fd840f8a567;590d3ad75d953328b2329fc3d2a595af							2019-02-21												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							b65f2abdc103bea76dab92e394803cde		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/087/SRR27477687/SRR27477687_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/087/SRR27477687/SRR27477687_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/087/SRR27477687/SRR27477687.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/087/SRR27477687/SRR27477687_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/087/SRR27477687/SRR27477687_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK051		2019-02-21			JK051_S46_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A50, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477687												PRJNA1063201					esophagus																																													
SRR27477688	SRX23149035	SAMN39328772	PRJNA1063201	SRS20099670	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK034	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK034	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A34, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	22269877	4441520396	Homo sapiens	2018-10-02	2024-01-11	2024-01-11		SRA1782421					PolyA												1185576804.0							JK034	731342426;743899150	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/088/SRR27477688/SRR27477688.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/088/SRR27477688/SRR27477688_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/088/SRR27477688/SRR27477688_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/088/SRR27477688/SRR27477688.lite		ae925fa27c35eccf1df44f27fc829aa4;62ec5f9dc153434daeb9e68112209307							2018-10-02												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							47e128b76eef19ea7b3879d86be87215		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/088/SRR27477688/SRR27477688_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/088/SRR27477688/SRR27477688_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/088/SRR27477688/SRR27477688.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/088/SRR27477688/SRR27477688_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/088/SRR27477688/SRR27477688_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK034		2018-10-01			JK034_S33_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A34, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477688												PRJNA1063201					esophagus																																													
SRR27477689	SRX23149034	SAMN39328771	PRJNA1063201	SRS20099668	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK033	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK033	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A33, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	15810817	3150922850	Homo sapiens	2018-09-27	2024-01-11	2024-01-11		SRA1782421					PolyA												843230537.0							JK033	630513219;600144436	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/089/SRR27477689/SRR27477689.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/089/SRR27477689/SRR27477689_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/089/SRR27477689/SRR27477689_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/089/SRR27477689/SRR27477689.lite		c82ae6f70ccffe898e87f6c553b0d068;1bfcfba84cbd1ae93003d0476bc25bc1							2018-09-27												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							db1abd859d2329fb6ad96535c684ee90		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/089/SRR27477689/SRR27477689_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/089/SRR27477689/SRR27477689_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/089/SRR27477689/SRR27477689.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/089/SRR27477689/SRR27477689_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/089/SRR27477689/SRR27477689_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK033		2018-09-26			JK033_S32_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A33, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477689												PRJNA1063201					esophagus																																													
SRR27477690	SRX23149033	SAMN39328770	PRJNA1063201	SRS20099667	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK032	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK032	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A32, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	21853323	4358903413	Homo sapiens	2018-09-27	2024-01-11	2024-01-11		SRA1782421					PolyA												1163567778.0							JK032	883831201;832945915	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/090/SRR27477690/SRR27477690.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/090/SRR27477690/SRR27477690_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/090/SRR27477690/SRR27477690_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/090/SRR27477690/SRR27477690.lite		6dd47242c43eb3e9213c3abc0249b41d;3d2bcec74441d96fedf3954093f52b44							2018-09-27												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							4c4edaae960569e7274017faf53d7989		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/090/SRR27477690/SRR27477690_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/090/SRR27477690/SRR27477690_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/090/SRR27477690/SRR27477690.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/090/SRR27477690/SRR27477690_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/090/SRR27477690/SRR27477690_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK032		2018-09-26			JK032_S31_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A32, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477690												PRJNA1063201					esophagus																																													
SRR27477691	SRX23149032	SAMN39328743	PRJNA1063201	SRS20099666	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK004	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK004	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A5, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	18183608	3626733826	Homo sapiens	2018-05-14	2024-01-11	2024-01-11		SRA1782421					PolyA												969119484.0							JK004	706862208;669148327	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/091/SRR27477691/SRR27477691.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/091/SRR27477691/SRR27477691_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/091/SRR27477691/SRR27477691_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/091/SRR27477691/SRR27477691.lite		11a2a4e3740b60cdf84c547f6a8d8543;5b247385f10e2c4312c83cccbbcb824b							2018-05-14												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							7ce8a30534d7d66950d17661443d2aed		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/091/SRR27477691/SRR27477691_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/091/SRR27477691/SRR27477691_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/091/SRR27477691/SRR27477691.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/091/SRR27477691/SRR27477691_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/091/SRR27477691/SRR27477691_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK004		2018-05-13			JK004_S4_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A5, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477691												PRJNA1063201					esophagus																																													
SRR27477692	SRX23149031	SAMN39328769	PRJNA1063201	SRS20099665	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK031	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK031	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A31, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	21120584	4211800430	Homo sapiens	2018-09-26	2024-01-11	2024-01-11		SRA1782421					PolyA												1124736677.0							JK031	826227310;782605107	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/092/SRR27477692/SRR27477692.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/092/SRR27477692/SRR27477692_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/092/SRR27477692/SRR27477692_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/092/SRR27477692/SRR27477692.lite		cb63817aef2ae26fe88fa5a4ef2eb317;aea264ba1a9018f870cefaea4e051ebc							2018-09-26												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							b7ee7dc5ab9da270e021db49ac621bb5		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/092/SRR27477692/SRR27477692_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/092/SRR27477692/SRR27477692_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/092/SRR27477692/SRR27477692.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/092/SRR27477692/SRR27477692_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/092/SRR27477692/SRR27477692_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK031		2018-09-25			JK031_S30_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A31, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477692												PRJNA1063201					esophagus																																													
SRR27477693	SRX23149030	SAMN39328768	PRJNA1063201	SRS20099664	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK030	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK030	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A30, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	17405458	3471169565	Homo sapiens	2018-09-24	2024-01-11	2024-01-11		SRA1782421					PolyA												927865620.0							JK030	660609441;630989548	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/093/SRR27477693/SRR27477693.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/093/SRR27477693/SRR27477693_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/093/SRR27477693/SRR27477693_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/093/SRR27477693/SRR27477693.lite		6ea4e98a3c786935e57a2be3de6479e2;a592b411a141b9b1654e19a243b5427f							2018-09-24												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							e3400305963817355d0ef36aa571a4af		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/093/SRR27477693/SRR27477693_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/093/SRR27477693/SRR27477693_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/093/SRR27477693/SRR27477693.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/093/SRR27477693/SRR27477693_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/093/SRR27477693/SRR27477693_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK030		2018-09-23			JK030_S29_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A30, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477693												PRJNA1063201					esophagus																																													
SRR27477694	SRX23149029	SAMN39328767	PRJNA1063201	SRS20099663	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK029	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK029	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A29, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	16879439	3365039850	Homo sapiens	2018-09-20	2024-01-11	2024-01-11		SRA1782421					PolyA												899966991.0							JK029	566793670;567314020	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/094/SRR27477694/SRR27477694.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/094/SRR27477694/SRR27477694_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/094/SRR27477694/SRR27477694_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/094/SRR27477694/SRR27477694.lite		4345db81b51f1fae1b543d8e224a41f7;fd794a660e85965ad16ef5096ffdabf3							2018-09-20												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							8abe4f6b74d78027c3a36b4eb065eea6		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/094/SRR27477694/SRR27477694_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/094/SRR27477694/SRR27477694_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/094/SRR27477694/SRR27477694.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/094/SRR27477694/SRR27477694_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/094/SRR27477694/SRR27477694_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK029		2018-09-19			JK029_S28_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A29, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477694												PRJNA1063201					esophagus																																													
SRR27477695	SRX23149028	SAMN39328766	PRJNA1063201	SRS20099662	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK028	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK028	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A28, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	18012821	3596139086	Homo sapiens	2018-09-19	2024-01-11	2024-01-11		SRA1782421					PolyA												960319736.0							JK028	712955136;671572573	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/095/SRR27477695/SRR27477695.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/095/SRR27477695/SRR27477695_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/095/SRR27477695/SRR27477695_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/095/SRR27477695/SRR27477695.lite		4f6561947cdb9467bbf6f7335bd8d564;432742687bff24ac4f4c53381f62c0c4							2018-09-19												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							1010b0aeeac6f83f386638ce45358228		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/095/SRR27477695/SRR27477695_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/095/SRR27477695/SRR27477695_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/095/SRR27477695/SRR27477695.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/095/SRR27477695/SRR27477695_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/095/SRR27477695/SRR27477695_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK028		2018-09-18			JK028_S27_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A28, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477695												PRJNA1063201					esophagus																																													
SRR27477696	SRX23149027	SAMN39328765	PRJNA1063201	SRS20099661	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK027	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK027	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A27, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	19633065	3918004141	Homo sapiens	2018-09-11	2024-01-11	2024-01-11		SRA1782421					PolyA												1046195195.0							JK027	817201182;763843963	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/096/SRR27477696/SRR27477696.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/096/SRR27477696/SRR27477696_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/096/SRR27477696/SRR27477696_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/096/SRR27477696/SRR27477696.lite		3bf1172c73ffc615b6a275348f990dc6;edfad3232de1baec082e03fd84f916f0							2018-09-11												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							f64a894eb819e7820311e30260054003		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/096/SRR27477696/SRR27477696_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/096/SRR27477696/SRR27477696_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/096/SRR27477696/SRR27477696.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/096/SRR27477696/SRR27477696_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/096/SRR27477696/SRR27477696_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK027		2018-09-10			JK027_S26_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A27, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477696												PRJNA1063201					esophagus																																													
SRR27477697	SRX23149026	SAMN39328764	PRJNA1063201	SRS20099660	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK026	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK026	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A26, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	15964509	3180738113	Homo sapiens	2018-09-06	2024-01-11	2024-01-11		SRA1782421					PolyA												851389927.0							JK026	513066796;520778920	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/097/SRR27477697/SRR27477697.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/097/SRR27477697/SRR27477697_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/097/SRR27477697/SRR27477697_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/097/SRR27477697/SRR27477697.lite		8570595de993b05c30a5df51c3462d61;5179a117471e5c8812343d5a1df4a6de							2018-09-06												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							2e9aca44b94f3aa8d6a6da912bafbc4f		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/097/SRR27477697/SRR27477697_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/097/SRR27477697/SRR27477697_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/097/SRR27477697/SRR27477697.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/097/SRR27477697/SRR27477697_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/097/SRR27477697/SRR27477697_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK026		2018-09-05			JK026_S25_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A26, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477697												PRJNA1063201					esophagus																																													
SRR27477698	SRX23149025	SAMN39328763	PRJNA1063201	SRS20099659	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK025	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK025	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A25, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	25249526	5046406952	Homo sapiens	2018-09-05	2024-01-11	2024-01-11		SRA1782421					PolyA												1343652409.0							JK025	814473416;838667019	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/098/SRR27477698/SRR27477698.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/098/SRR27477698/SRR27477698_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/098/SRR27477698/SRR27477698_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/098/SRR27477698/SRR27477698.lite		7e9924bbee3c5f82690dad28f436a9ca;02b4bdecd6c2dd545ebd76e4bbb0e58c							2018-09-05												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							12a20f28b3f24db4a42a32e1b77c4b54		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/098/SRR27477698/SRR27477698_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/098/SRR27477698/SRR27477698_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/098/SRR27477698/SRR27477698.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/098/SRR27477698/SRR27477698_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/098/SRR27477698/SRR27477698_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK025		2018-09-04			JK025_S24_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A25, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477698												PRJNA1063201					esophagus																																													
SRR27477699	SRX23149024	SAMN39328762	PRJNA1063201	SRS20099657	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK024	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK024	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A24, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	26293981	5255995994	Homo sapiens	2018-09-05	2024-01-11	2024-01-11		SRA1782421					PolyA												1399262641.0							JK024	1037968943;1021083101	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/099/SRR27477699/SRR27477699.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/099/SRR27477699/SRR27477699_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/099/SRR27477699/SRR27477699_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/099/SRR27477699/SRR27477699.lite		7fe0b2107b0f6861bbf90f1bdf933fab;8d61dc7dd0643b39d7aa9d7ff994e088							2018-09-05												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							7d76a4c3a6021bc05906ed3006575f3f		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/099/SRR27477699/SRR27477699_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/099/SRR27477699/SRR27477699_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/099/SRR27477699/SRR27477699.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/099/SRR27477699/SRR27477699_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/099/SRR27477699/SRR27477699_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK024		2018-09-04			JK024_S23_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A24, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477699												PRJNA1063201					esophagus																																													
SRR27477700	SRX23149023	SAMN39328761	PRJNA1063201	SRS20099658	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK023	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK023	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A23, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	23110273	4616228544	Homo sapiens	2018-09-24	2024-01-11	2024-01-11		SRA1782421					PolyA												1230479771.0							JK023	679278995;710391693	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/000/SRR27477700/SRR27477700.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/000/SRR27477700/SRR27477700_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/000/SRR27477700/SRR27477700_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/000/SRR27477700/SRR27477700.lite		5ffe06369012e70691c4b0fade63e9e2;6ed3cf0599e4b25bf6f0de42637dc950							2018-09-24												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							26c8d86546b2f2abe2514bb4ffc8576d		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/000/SRR27477700/SRR27477700_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/000/SRR27477700/SRR27477700_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/000/SRR27477700/SRR27477700.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/000/SRR27477700/SRR27477700_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/000/SRR27477700/SRR27477700_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK023		2018-09-23			JK023_S22_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A23, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477700												PRJNA1063201					esophagus																																													
SRR27477701	SRX23149022	SAMN39328760	PRJNA1063201	SRS20099656	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK022	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK022	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A22, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	22586054	4514176774	Homo sapiens	2018-08-31	2024-01-11	2024-01-11		SRA1782421					PolyA												1202828542.0							JK022	745084890;748711238	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/001/SRR27477701/SRR27477701.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/001/SRR27477701/SRR27477701_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/001/SRR27477701/SRR27477701_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/001/SRR27477701/SRR27477701.lite		e3d82ee3b20fe1cd4629b7237f3f396b;6c829d50a2fb197c22785a83f9f1da7d							2018-08-31												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							ed2b5030f4c6cdfa78d60662b62dadae		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/001/SRR27477701/SRR27477701_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/001/SRR27477701/SRR27477701_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/001/SRR27477701/SRR27477701.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/001/SRR27477701/SRR27477701_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/001/SRR27477701/SRR27477701_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK022		2018-08-30			JK022_S21_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A22, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477701												PRJNA1063201					esophagus																																													
SRR27477702	SRX23149021	SAMN39328742	PRJNA1063201	SRS20099655	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK003	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK003	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A4, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	19415008	3867550706	Homo sapiens	2018-04-26	2024-01-11	2024-01-11		SRA1782421					PolyA												1033669591.0							JK003	769661689;723680165	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/002/SRR27477702/SRR27477702.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/002/SRR27477702/SRR27477702_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/002/SRR27477702/SRR27477702_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/002/SRR27477702/SRR27477702.lite		5f9f3c732d2f35368dcb75a70ba729b4;678995a32891ae426c405128fcffcfd9							2018-04-26												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							0cec2b0d54c5572310b9fedcae4c3960		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/002/SRR27477702/SRR27477702_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/002/SRR27477702/SRR27477702_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/002/SRR27477702/SRR27477702.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/002/SRR27477702/SRR27477702_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/002/SRR27477702/SRR27477702_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK003		2018-04-25			JK003_S3_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A4, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477702												PRJNA1063201					esophagus																																													
SRR27477703	SRX23149020	SAMN39328759	PRJNA1063201	SRS20099654	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK021	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK021	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A21, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	20652789	4125850892	Homo sapiens	2018-08-28	2024-01-11	2024-01-11		SRA1782421					PolyA												1100452514.0							JK021	812593857;762079178	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/003/SRR27477703/SRR27477703.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/003/SRR27477703/SRR27477703_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/003/SRR27477703/SRR27477703_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/003/SRR27477703/SRR27477703.lite		a4025d3c91de1f199ad52785d8a4b252;b96f79d2ea54f7e989aefb6e5a2427f9							2018-08-28												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							f13f45756c440a21e48605230d1fb9fa		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/003/SRR27477703/SRR27477703_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/003/SRR27477703/SRR27477703_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/003/SRR27477703/SRR27477703.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/003/SRR27477703/SRR27477703_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/003/SRR27477703/SRR27477703_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK021		2018-08-27			JK021_S20_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A21, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477703												PRJNA1063201					esophagus																																													
SRR27477704	SRX23149019	SAMN39328866	PRJNA1063201	SRS20099653	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK138	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK138	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A128, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	30763829	6124974692	Homo sapiens	2018-12-11	2024-01-11	2024-01-11		SRA1782421					PolyA												1634215100.0							JK138	1262373892;1230305281	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/004/SRR27477704/SRR27477704.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/004/SRR27477704/SRR27477704_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/004/SRR27477704/SRR27477704_2.fastq.gz							USA: New York, NY	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/004/SRR27477704/SRR27477704.lite		a3f245c2e6261c50fc1fd317f39ff0c9;1c7c0acd992108ea020d4e56d686fa04							2018-12-11												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							2b5d7d764ed0df99b792ac2d206265ca		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/004/SRR27477704/SRR27477704_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/004/SRR27477704/SRR27477704_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/004/SRR27477704/SRR27477704.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/004/SRR27477704/SRR27477704_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/004/SRR27477704/SRR27477704_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK138		2018-12-11			JK138_S204_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A128, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477704												PRJNA1063201					esophagus																																													
SRR27477705	SRX23149018	SAMN39328865	PRJNA1063201	SRS20099652	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK137	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK137	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A127, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	26076670	5194681125	Homo sapiens	2018-12-05	2024-01-11	2024-01-11		SRA1782421					PolyA												1386777894.0							JK137	1078071072;1049743374	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/005/SRR27477705/SRR27477705.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/005/SRR27477705/SRR27477705_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/005/SRR27477705/SRR27477705_2.fastq.gz							USA: New York, NY	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/005/SRR27477705/SRR27477705.lite		928789d91b925c006bd64591426f69c7;6183e59ed60d1b96146634803f5cd1f6							2018-12-05												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							bb5aa73f806ff6a0affeb04d3126b404		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/005/SRR27477705/SRR27477705_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/005/SRR27477705/SRR27477705_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/005/SRR27477705/SRR27477705.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/005/SRR27477705/SRR27477705_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/005/SRR27477705/SRR27477705_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK137		2018-12-05			JK137_S203_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A127, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477705												PRJNA1063201					esophagus																																													
SRR27477706	SRX23149017	SAMN39328864	PRJNA1063201	SRS20099651	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK136	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK136	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A126, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	28117663	5599188251	Homo sapiens	2018-10-02	2024-01-11	2024-01-11		SRA1782421					PolyA												1494627036.0							JK136	1098245338;1087879905	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/006/SRR27477706/SRR27477706.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/006/SRR27477706/SRR27477706_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/006/SRR27477706/SRR27477706_2.fastq.gz							USA: New York, NY	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/006/SRR27477706/SRR27477706.lite		e8d326558ea84549551dc2a1b7b5b850;e6a6e2d0bd4fcc2b1b4a29ea8e834363							2018-10-02												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							53f1bad227143c85af6ce01c109ca8f8		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/006/SRR27477706/SRR27477706_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/006/SRR27477706/SRR27477706_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/006/SRR27477706/SRR27477706.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/006/SRR27477706/SRR27477706_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/006/SRR27477706/SRR27477706_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK136		2018-10-01			JK136_S202_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A126, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477706												PRJNA1063201					esophagus																																													
SRR27477707	SRX23149016	SAMN39328863	PRJNA1063201	SRS20099650	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK135	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK135	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A125, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	25468792	5077012548	Homo sapiens	2018-08-07	2024-01-11	2024-01-11		SRA1782421					PolyA												1354987824.0							JK135	1051589178;1023222727	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/007/SRR27477707/SRR27477707.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/007/SRR27477707/SRR27477707_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/007/SRR27477707/SRR27477707_2.fastq.gz							USA: New York, NY	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/007/SRR27477707/SRR27477707.lite		b9f3510a1166228447eb8637a543d496;c84144a0b7e80d83bedebc4d209823cb							2018-08-07												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							52cc1de7394674b7988e77d6e1b3ec4a		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/007/SRR27477707/SRR27477707_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/007/SRR27477707/SRR27477707_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/007/SRR27477707/SRR27477707.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/007/SRR27477707/SRR27477707_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/007/SRR27477707/SRR27477707_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK135		2018-08-06			JK135_S201_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A125, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477707												PRJNA1063201					esophagus																																													
SRR27477708	SRX23149015	SAMN39328862	PRJNA1063201	SRS20099649	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK134	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK134	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A124, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	18265779	3626695425	Homo sapiens	2018-07-10	2024-01-11	2024-01-11		SRA1782421					PolyA												971993607.0							JK134	690618995;684494733	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/008/SRR27477708/SRR27477708.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/008/SRR27477708/SRR27477708_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/008/SRR27477708/SRR27477708_2.fastq.gz							USA: New York, NY	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/008/SRR27477708/SRR27477708.lite		bc34c6c1e4f7c73f1cc966d324cfee77;c666eb6a9a670cd62a2668364b24f9a8							2018-07-10												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							017110db9c9f15af5fb44d54d763bf2b		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/008/SRR27477708/SRR27477708_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/008/SRR27477708/SRR27477708_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/008/SRR27477708/SRR27477708.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/008/SRR27477708/SRR27477708_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/008/SRR27477708/SRR27477708_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK134		2018-07-09			JK134_S200_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A124, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477708												PRJNA1063201					esophagus																																													
SRR27477709	SRX23149014	SAMN39328861	PRJNA1063201	SRS20099648	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK133	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK133	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A123, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	18831788	3726420343	Homo sapiens	2018-05-29	2024-01-11	2024-01-11		SRA1782421					PolyA												999599625.0							JK133	763938115;749064657	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/009/SRR27477709/SRR27477709.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/009/SRR27477709/SRR27477709_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/009/SRR27477709/SRR27477709_2.fastq.gz							USA: New York, NY	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/009/SRR27477709/SRR27477709.lite		8339bb1bbd78982fff326edd8fca02d2;1b217f52a890b00def3e1fdc18a8013d							2018-05-29												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							00a85d32070f175f26ff95896b42a50c		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/009/SRR27477709/SRR27477709_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/009/SRR27477709/SRR27477709_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/009/SRR27477709/SRR27477709.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/009/SRR27477709/SRR27477709_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/009/SRR27477709/SRR27477709_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK133		2018-05-28			JK133_S199_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A123, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477709												PRJNA1063201					esophagus																																													
SRR27477710	SRX23149013	SAMN39328860	PRJNA1063201	SRS20099647	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK132	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK132	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A122, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	21544066	4278442371	Homo sapiens	2018-05-22	2024-01-11	2024-01-11		SRA1782421					PolyA												1144971822.0							JK132	871027193;848385214	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/010/SRR27477710/SRR27477710.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/010/SRR27477710/SRR27477710_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/010/SRR27477710/SRR27477710_2.fastq.gz							USA: New York, NY	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/010/SRR27477710/SRR27477710.lite		71afea430004f9a9d84cc96e03753551;79709a2d404831d3549dc05485e63ff9							2018-05-22												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							f66553fc88c3582a15787d3bed4bb39e		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/010/SRR27477710/SRR27477710_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/010/SRR27477710/SRR27477710_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/010/SRR27477710/SRR27477710.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/010/SRR27477710/SRR27477710_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/010/SRR27477710/SRR27477710_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK132		2018-05-21			JK132_S198_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A122, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477710												PRJNA1063201					esophagus																																													
SRR27477711	SRX23149012	SAMN39328752	PRJNA1063201	SRS20099646	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK013	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK013	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A14, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	18334745	3654733814	Homo sapiens	2018-06-21	2024-01-11	2024-01-11		SRA1782421					PolyA												976726154.0							JK013	681380058;656996806	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/011/SRR27477711/SRR27477711.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/011/SRR27477711/SRR27477711_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/011/SRR27477711/SRR27477711_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/011/SRR27477711/SRR27477711.lite		c6915cff955d12a82ef10fdad384c20a;51ecd2684080b66aba8b127a4a9f5731							2018-06-21												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							7edbc5023d69bea5192735ce4f46b445		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/011/SRR27477711/SRR27477711_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/011/SRR27477711/SRR27477711_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/011/SRR27477711/SRR27477711.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/011/SRR27477711/SRR27477711_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/011/SRR27477711/SRR27477711_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK013		2018-06-20			JK013_S13_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A14, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477711												PRJNA1063201					esophagus																																													
SRR27477712	SRX23149011	SAMN39328859	PRJNA1063201	SRS20099645	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK131	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK131	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A121, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	17259966	3387130267	Homo sapiens	2018-05-08	2024-01-11	2024-01-11		SRA1782421					PolyA												912223149.0							JK131	694001442;670230992	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/012/SRR27477712/SRR27477712.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/012/SRR27477712/SRR27477712_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/012/SRR27477712/SRR27477712_2.fastq.gz							USA: New York, NY	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/012/SRR27477712/SRR27477712.lite		e86816b2612cd2c91a569049ec794c2f;f8834ee9849bd91e697eb3443a147e95							2018-05-08												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							537a3748014368b3550d01e154b6c3d7		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/012/SRR27477712/SRR27477712_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/012/SRR27477712/SRR27477712_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/012/SRR27477712/SRR27477712.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/012/SRR27477712/SRR27477712_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/012/SRR27477712/SRR27477712_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK131		2018-05-07			JK131_S197_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A121, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477712												PRJNA1063201					esophagus																																													
SRR27477713	SRX23149010	SAMN39328858	PRJNA1063201	SRS20099644	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK130	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK130	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A120, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	21858571	4306591901	Homo sapiens	2018-03-06	2024-01-11	2024-01-11		SRA1782421					PolyA												1156520923.0							JK130	906035938;868456895	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/013/SRR27477713/SRR27477713.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/013/SRR27477713/SRR27477713_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/013/SRR27477713/SRR27477713_2.fastq.gz							USA: New York, NY	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/013/SRR27477713/SRR27477713.lite		bf1c555554213697aee084b0dcc087ec;6924278bf1e2fbf181a40893441f19ea							2018-03-06												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							81f24d1bc233f8ef2842b700fd05a9d9		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/013/SRR27477713/SRR27477713_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/013/SRR27477713/SRR27477713_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/013/SRR27477713/SRR27477713.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/013/SRR27477713/SRR27477713_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/013/SRR27477713/SRR27477713_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK130		2018-03-06			JK130_S196_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A120, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477713												PRJNA1063201					esophagus																																													
SRR27477714	SRX23149009	SAMN39328857	PRJNA1063201	SRS20099643	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK129	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK129	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A119, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	19925395	3934101570	Homo sapiens	2021-01-20	2024-01-11	2024-01-11		SRA1782421					PolyA												1056024071.0							JK129	825606607;798568258	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/014/SRR27477714/SRR27477714.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/014/SRR27477714/SRR27477714_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/014/SRR27477714/SRR27477714_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/014/SRR27477714/SRR27477714.lite		4a802b86759def65585e16c55dbea7b2;ce920896580a32300a61fc6a3397b147							2021-01-20												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							736db508ea0ed72b0c623e2bad24ad64		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/014/SRR27477714/SRR27477714_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/014/SRR27477714/SRR27477714_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/014/SRR27477714/SRR27477714.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/014/SRR27477714/SRR27477714_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/014/SRR27477714/SRR27477714_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK129		2021-01-20			JK129_S195_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A119, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477714												PRJNA1063201					esophagus																																													
SRR27477715	SRX23149008	SAMN39328856	PRJNA1063201	SRS20099642	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK128	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK128	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A118, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	19701495	3885695094	Homo sapiens	2020-12-07	2024-01-11	2024-01-11		SRA1782421					PolyA												1043552210.0							JK128	798995528;778931586	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/015/SRR27477715/SRR27477715.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/015/SRR27477715/SRR27477715_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/015/SRR27477715/SRR27477715_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/015/SRR27477715/SRR27477715.lite		cb3a3ea8654226f0b17b1deebc962f67;ec4d8071647ba48af32e4f0e8166856b							2020-12-07												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							9beb706c08c530c482a9a826a10489b4		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/015/SRR27477715/SRR27477715_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/015/SRR27477715/SRR27477715_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/015/SRR27477715/SRR27477715.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/015/SRR27477715/SRR27477715_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/015/SRR27477715/SRR27477715_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK128		2020-12-07			JK128_S194_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A118, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477715												PRJNA1063201					esophagus																																													
SRR27477716	SRX23149007	SAMN39328855	PRJNA1063201	SRS20099641	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK127	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK127	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A117, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	17858461	3496790589	Homo sapiens	2020-11-11	2024-01-11	2024-01-11		SRA1782421					PolyA												942081002.0							JK127	732135331;712895570	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/016/SRR27477716/SRR27477716.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/016/SRR27477716/SRR27477716_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/016/SRR27477716/SRR27477716_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/016/SRR27477716/SRR27477716.lite		8d7b1a7c0ea370e48e459ec39c781084;b0b91a7acc69579988454169a81e1895							2020-11-11												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							9c2359e486f87f8eba522b1f271be339		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/016/SRR27477716/SRR27477716_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/016/SRR27477716/SRR27477716_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/016/SRR27477716/SRR27477716.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/016/SRR27477716/SRR27477716_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/016/SRR27477716/SRR27477716_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK127		2020-11-11			JK127_S193_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A117, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477716												PRJNA1063201					esophagus																																													
SRR27477717	SRX23149006	SAMN39328854	PRJNA1063201	SRS20099640	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK126	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK126	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A116, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	12456138	2455684061	Homo sapiens	2020-09-16	2024-01-11	2024-01-11		SRA1782421					PolyA												661590271.0							JK126	416944836;417970217	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/017/SRR27477717/SRR27477717.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/017/SRR27477717/SRR27477717_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/017/SRR27477717/SRR27477717_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/017/SRR27477717/SRR27477717.lite		8c4edf783a2c8d39a3c8875c0a27ef4e;2745322a4c8ce3eaf604d6690466a8f6							2020-09-16												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							049a7c81a068dc9d20ecf5664ebc2028		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/017/SRR27477717/SRR27477717_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/017/SRR27477717/SRR27477717_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/017/SRR27477717/SRR27477717.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/017/SRR27477717/SRR27477717_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/017/SRR27477717/SRR27477717_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK126		2020-09-15			JK126_S192_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A116, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477717												PRJNA1063201					esophagus																																													
SRR27477718	SRX23149005	SAMN39328853	PRJNA1063201	SRS20099639	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK125	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK125	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A115, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	9927470	1875155490	Homo sapiens	2020-07-01	2024-01-11	2024-01-11		SRA1782421					PolyA												515089923.0							JK125	307663483;314165490	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/018/SRR27477718/SRR27477718.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/018/SRR27477718/SRR27477718_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/018/SRR27477718/SRR27477718_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/018/SRR27477718/SRR27477718.lite		adbb6ec160bfe4ca26a1e3a363df5c98;2ed1548489f120893949ec58bd984bc1							2020-07-01												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							83ff1bd050780d70298b7fed9e1bbdde		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/018/SRR27477718/SRR27477718_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/018/SRR27477718/SRR27477718_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/018/SRR27477718/SRR27477718.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/018/SRR27477718/SRR27477718_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/018/SRR27477718/SRR27477718_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK125		2020-06-30			JK125_S191_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A115, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477718												PRJNA1063201					esophagus																																													
SRR27477719	SRX23149004	SAMN39328852	PRJNA1063201	SRS20099637	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK124	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK124	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A114, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	23445628	4643819637	Homo sapiens	2020-03-11	2024-01-11	2024-01-11		SRA1782421					PolyA												1243871870.0							JK124	962754273;936096961	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/019/SRR27477719/SRR27477719.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/019/SRR27477719/SRR27477719_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/019/SRR27477719/SRR27477719_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/019/SRR27477719/SRR27477719.lite		52d787f47379b1aa0979a64f0f32425a;fcad2293002bb1af88b3c06b4a1dca8b							2020-03-11												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							d06a5db2f1b1469291fc74793661faa6		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/019/SRR27477719/SRR27477719_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/019/SRR27477719/SRR27477719_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/019/SRR27477719/SRR27477719.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/019/SRR27477719/SRR27477719_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/019/SRR27477719/SRR27477719_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK124		2020-03-11			JK124_S190_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A114, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477719												PRJNA1063201					esophagus																																													
SRR27477720	SRX23149003	SAMN39328816	PRJNA1063201	SRS20099638	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK085	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK085	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A78, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	22135395	4418630353	Homo sapiens	2020-07-13	2024-01-11	2024-01-11		SRA1782421					PolyA												1178853090.0							JK085	912267537;857893583	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/020/SRR27477720/SRR27477720.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/020/SRR27477720/SRR27477720_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/020/SRR27477720/SRR27477720_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/020/SRR27477720/SRR27477720.lite		fd3229412205db46e2311debfcb5b559;f1c712493c8e34bc1c6e1d70e8e042f9							2020-07-13												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							d1d6bdf39e73ae2dec830f67ca354007		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/020/SRR27477720/SRR27477720_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/020/SRR27477720/SRR27477720_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/020/SRR27477720/SRR27477720.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/020/SRR27477720/SRR27477720_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/020/SRR27477720/SRR27477720_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK085		2020-07-12			JK085_S74_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A78, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477720												PRJNA1063201					esophagus																																													
SRR27477721	SRX23149002	SAMN39328815	PRJNA1063201	SRS20099636	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK084	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK084	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A77, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	19896708	3965843324	Homo sapiens	2020-06-11	2024-01-11	2024-01-11		SRA1782421					PolyA												1059645522.0							JK084	827322635;784743348	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/021/SRR27477721/SRR27477721.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/021/SRR27477721/SRR27477721_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/021/SRR27477721/SRR27477721_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/021/SRR27477721/SRR27477721.lite		202f5636203bb8ea8972f623a570d504;f45c11a3dff402a339f00defc52a830c							2020-06-11												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							2a32d4ec0402143d124c3ea7cb66dbca		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/021/SRR27477721/SRR27477721_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/021/SRR27477721/SRR27477721_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/021/SRR27477721/SRR27477721.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/021/SRR27477721/SRR27477721_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/021/SRR27477721/SRR27477721_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK084		2020-06-10			JK084_S73_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A77, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477721												PRJNA1063201					esophagus																																													
SRR27477722	SRX23149001	SAMN39328814	PRJNA1063201	SRS20099635	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK083	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK083	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A76, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	21067808	4203873787	Homo sapiens	2020-06-11	2024-01-11	2024-01-11		SRA1782421					PolyA												1122083404.0							JK083	808651666;791244134	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/022/SRR27477722/SRR27477722.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/022/SRR27477722/SRR27477722_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/022/SRR27477722/SRR27477722_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/022/SRR27477722/SRR27477722.lite		7a6cd6138cc86a94093815351572f412;e4d7bbe63f74ca372a802fab0b5782d2							2020-06-11												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							1c47582ffd708acdb3a55263f782fdaa		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/022/SRR27477722/SRR27477722_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/022/SRR27477722/SRR27477722_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/022/SRR27477722/SRR27477722.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/022/SRR27477722/SRR27477722_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/022/SRR27477722/SRR27477722_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK083		2020-06-10			JK083_S72_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A76, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477722												PRJNA1063201					esophagus																																													
SRR27477723	SRX23149000	SAMN39328813	PRJNA1063201	SRS20099634	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK082	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK082	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A75, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	23876779	4764567993	Homo sapiens	2020-06-05	2024-01-11	2024-01-11		SRA1782421					PolyA												1270806700.0							JK082	968604176;936967862	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/023/SRR27477723/SRR27477723.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/023/SRR27477723/SRR27477723_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/023/SRR27477723/SRR27477723_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/023/SRR27477723/SRR27477723.lite		6f982932bfeb536e3aea0d8d539d07f7;d09de86cd358a52ddb879a6177d35f76							2020-06-05												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							11ec0a3b42f27166da76f83fdd000afc		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/023/SRR27477723/SRR27477723_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/023/SRR27477723/SRR27477723_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/023/SRR27477723/SRR27477723.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/023/SRR27477723/SRR27477723_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/023/SRR27477723/SRR27477723_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK082		2020-06-04			JK082_S71_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A75, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477723												PRJNA1063201					esophagus																																													
SRR27477724	SRX23148999	SAMN39328812	PRJNA1063201	SRS20099632	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK081	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK081	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A74, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	24995010	4988302879	Homo sapiens	2020-05-19	2024-01-11	2024-01-11		SRA1782421					PolyA												1330130102.0							JK081	1041104244;1004547277	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/024/SRR27477724/SRR27477724.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/024/SRR27477724/SRR27477724_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/024/SRR27477724/SRR27477724_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/024/SRR27477724/SRR27477724.lite		3ff677c4c60a08ef14c25c496e5bfc62;f5f4ca4d6a3dfab6e95aee2e67e7782c							2020-05-19												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							cddaf19bf9ad33921958fe76bbffa75f		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/024/SRR27477724/SRR27477724_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/024/SRR27477724/SRR27477724_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/024/SRR27477724/SRR27477724.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/024/SRR27477724/SRR27477724_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/024/SRR27477724/SRR27477724_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK081		2020-05-18			JK081_S70_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A74, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477724												PRJNA1063201					esophagus																																													
SRR27477725	SRX23148998	SAMN39328811	PRJNA1063201	SRS20099631	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK080	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK080	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A73, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	10272543	2045521871	Homo sapiens	2020-03-17	2024-01-11	2024-01-11		SRA1782421					PolyA												549040267.0							JK080	429750715;407609254	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/025/SRR27477725/SRR27477725.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/025/SRR27477725/SRR27477725_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/025/SRR27477725/SRR27477725_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/025/SRR27477725/SRR27477725.lite		8a1a136fceb19a04a338836226b0cf93;8ca23a5a367b450338a231bcaebac21e							2020-03-17												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							30e5b0c8fb725dfb119b1300a7a52c4c		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/025/SRR27477725/SRR27477725_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/025/SRR27477725/SRR27477725_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/025/SRR27477725/SRR27477725.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/025/SRR27477725/SRR27477725_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/025/SRR27477725/SRR27477725_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK080		2020-03-17			JK080_S69_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A73, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477725												PRJNA1063201					esophagus																																													
SRR27477726	SRX23148997	SAMN39328810	PRJNA1063201	SRS20099633	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK079	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK079	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A72, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	23062810	4600077157	Homo sapiens	2020-03-06	2024-01-11	2024-01-11		SRA1782421					PolyA												1227791604.0							JK079	949839896;913745246	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/026/SRR27477726/SRR27477726.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/026/SRR27477726/SRR27477726_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/026/SRR27477726/SRR27477726_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/026/SRR27477726/SRR27477726.lite		0bd1e56b7ba3cc666ce838189a56052a;d88c6895bd9d04320e99d9bcc2bae484							2020-03-06												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							4e71fad846615b1bbf21b05138a88c0f		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/026/SRR27477726/SRR27477726_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/026/SRR27477726/SRR27477726_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/026/SRR27477726/SRR27477726.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/026/SRR27477726/SRR27477726_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/026/SRR27477726/SRR27477726_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK079		2020-03-06			JK079_S68_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A72, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477726												PRJNA1063201					esophagus																																													
SRR27477727	SRX23148996	SAMN39328747	PRJNA1063201	SRS20099630	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK008	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK008	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A9, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	17737447	3543701516	Homo sapiens	2018-05-31	2024-01-11	2024-01-11		SRA1782421					PolyA												945814402.0							JK008	681184392;641156731	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/027/SRR27477727/SRR27477727.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/027/SRR27477727/SRR27477727_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/027/SRR27477727/SRR27477727_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/027/SRR27477727/SRR27477727.lite		a5c9fc351c29442dcd507d9e6d08e199;2683dfa3b418b94d98c92fc66abe76f8							2018-05-31												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							50b7068e2212d24bfc9c1bea15340036		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/027/SRR27477727/SRR27477727_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/027/SRR27477727/SRR27477727_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/027/SRR27477727/SRR27477727.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/027/SRR27477727/SRR27477727_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/027/SRR27477727/SRR27477727_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK008		2018-05-30			JK008_S8_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A9, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477727												PRJNA1063201					esophagus																																													
SRR27477728	SRX23148995	SAMN39328809	PRJNA1063201	SRS20099629	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK078	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK078	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A71, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	28128097	5611246975	Homo sapiens	2020-02-18	2024-01-11	2024-01-11		SRA1782421					PolyA												1495485821.0							JK078	1144640971;1098976901	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/028/SRR27477728/SRR27477728.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/028/SRR27477728/SRR27477728_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/028/SRR27477728/SRR27477728_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/028/SRR27477728/SRR27477728.lite		baf219d7105fe02d269847ebd0275e67;87bcb090ff024a8abe629d729d549d4b							2020-02-18												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							ca759f876311547088b9773636e5da8c		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/028/SRR27477728/SRR27477728_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/028/SRR27477728/SRR27477728_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/028/SRR27477728/SRR27477728.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/028/SRR27477728/SRR27477728_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/028/SRR27477728/SRR27477728_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK078		2020-02-18			JK078_S67_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A71, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477728												PRJNA1063201					esophagus																																													
SRR27477729	SRX23148994	SAMN39328808	PRJNA1063201	SRS20099628	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK077	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK077	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A70, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	17563099	3498283422	Homo sapiens	2020-02-17	2024-01-11	2024-01-11		SRA1782421					PolyA												935872544.0							JK077	624921803;616955176	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/029/SRR27477729/SRR27477729.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/029/SRR27477729/SRR27477729_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/029/SRR27477729/SRR27477729_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/029/SRR27477729/SRR27477729.lite		73835b54fdb245459c07b3ab8d998099;415e8a9c84538b908d7c52238578d986							2020-02-17												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							9612f834e5cf889621dcc71e8ce3d5e2		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/029/SRR27477729/SRR27477729_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/029/SRR27477729/SRR27477729_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/029/SRR27477729/SRR27477729.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/029/SRR27477729/SRR27477729_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/029/SRR27477729/SRR27477729_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK077		2020-02-17			JK077_S66_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A70, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477729												PRJNA1063201					esophagus																																													
SRR27477730	SRX23148993	SAMN39328807	PRJNA1063201	SRS20099627	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK076	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK076	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A69, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	9506553	1893970131	Homo sapiens	2020-01-30	2024-01-11	2024-01-11		SRA1782421					PolyA												508135403.0							JK076	402160643;369745192	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/030/SRR27477730/SRR27477730.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/030/SRR27477730/SRR27477730_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/030/SRR27477730/SRR27477730_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/030/SRR27477730/SRR27477730.lite		908ec28d200f2200049076910a8174ad;a2f45d5de0a0d730c033e3b5d15684bc							2020-01-30												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							63f2bfd661a1bcfe3a6f36a01196646d		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/030/SRR27477730/SRR27477730_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/030/SRR27477730/SRR27477730_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/030/SRR27477730/SRR27477730.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/030/SRR27477730/SRR27477730_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/030/SRR27477730/SRR27477730_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK076		2020-01-30			JK076_S65_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A69, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477730												PRJNA1063201					esophagus																																													
SRR27477731	SRX23148992	SAMN39328806	PRJNA1063201	SRS20099626	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK075	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK075	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A68, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	19112379	3820391722	Homo sapiens	2020-01-28	2024-01-11	2024-01-11		SRA1782421					PolyA												1018857671.0							JK075	694871306;697211042	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/031/SRR27477731/SRR27477731.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/031/SRR27477731/SRR27477731_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/031/SRR27477731/SRR27477731_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/031/SRR27477731/SRR27477731.lite		4365ae64bee0907707d6140f0667ec7c;5f61b84309e23d5f2a9b1c89d409e592							2020-01-28												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							b1e310359bc2acdefa2ae753a57da0e9		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/031/SRR27477731/SRR27477731_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/031/SRR27477731/SRR27477731_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/031/SRR27477731/SRR27477731.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/031/SRR27477731/SRR27477731_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/031/SRR27477731/SRR27477731_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK075		2020-01-28			JK075_S64_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A68, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477731												PRJNA1063201					esophagus																																													
SRR27477732	SRX23148991	SAMN39328805	PRJNA1063201	SRS20099625	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK074	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK074	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A67, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	20378295	4074088300	Homo sapiens	2020-01-17	2024-01-11	2024-01-11		SRA1782421					PolyA												1086068388.0							JK074	827294481;793328249	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/032/SRR27477732/SRR27477732.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/032/SRR27477732/SRR27477732_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/032/SRR27477732/SRR27477732_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/032/SRR27477732/SRR27477732.lite		a3966b2ce5e1e478791c2348b81fd026;4e03b19c434fd02765643594f012171b							2020-01-17												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							55f954670a291ff620bc2949f55c28c1		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/032/SRR27477732/SRR27477732_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/032/SRR27477732/SRR27477732_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/032/SRR27477732/SRR27477732.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/032/SRR27477732/SRR27477732_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/032/SRR27477732/SRR27477732_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK074		2020-01-17			JK074_S63_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A67, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477732												PRJNA1063201					esophagus																																													
SRR27477733	SRX23148990	SAMN39328804	PRJNA1063201	SRS20099623	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK072	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK072	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A66, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	17745432	3542181396	Homo sapiens	2019-10-23	2024-01-11	2024-01-11		SRA1782421					PolyA												946085719.0							JK072	712539142;669336000	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/033/SRR27477733/SRR27477733.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/033/SRR27477733/SRR27477733_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/033/SRR27477733/SRR27477733_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/033/SRR27477733/SRR27477733.lite		58369883df69de0ceef8986c1decb786;5547348d0ccd2bed5604e95897355736							2019-10-23												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							b49771f75e437b069bc13729bd74d26e		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/033/SRR27477733/SRR27477733_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/033/SRR27477733/SRR27477733_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/033/SRR27477733/SRR27477733.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/033/SRR27477733/SRR27477733_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/033/SRR27477733/SRR27477733_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK072		2019-10-22			JK072_S62_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A66, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477733												PRJNA1063201					esophagus																																													
SRR27477734	SRX23148989	SAMN39328803	PRJNA1063201	SRS20099624	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK071	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK071	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A65, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	16280726	3251756857	Homo sapiens	2019-10-18	2024-01-11	2024-01-11		SRA1782421					PolyA												868703438.0							JK071	671412421;628178505	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/034/SRR27477734/SRR27477734.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/034/SRR27477734/SRR27477734_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/034/SRR27477734/SRR27477734_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/034/SRR27477734/SRR27477734.lite		cc81da3fd09b8bb1969bdff2c238d9a0;38107470061e0665b3f7f3e2b9466af8							2019-10-18												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							f1510596480917d7b0662b251c258a6c		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/034/SRR27477734/SRR27477734_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/034/SRR27477734/SRR27477734_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/034/SRR27477734/SRR27477734.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/034/SRR27477734/SRR27477734_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/034/SRR27477734/SRR27477734_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK071		2019-10-17			JK071_S61_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A65, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477734												PRJNA1063201					esophagus																																													
SRR27477735	SRX23148988	SAMN39328802	PRJNA1063201	SRS20099622	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK068	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK068	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A64, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	20516899	4095440284	Homo sapiens	2019-09-16	2024-01-11	2024-01-11		SRA1782421					PolyA												1092923837.0							JK068	720658727;724779735	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/035/SRR27477735/SRR27477735.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/035/SRR27477735/SRR27477735_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/035/SRR27477735/SRR27477735_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/035/SRR27477735/SRR27477735.lite		0b100f0f4436b87ab897bf2ccc33c909;ef264fbc562ae62980cfebd1e56f9480							2019-09-16												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							a5bf15c6a1f3138316309cbc9308260d		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/035/SRR27477735/SRR27477735_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/035/SRR27477735/SRR27477735_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/035/SRR27477735/SRR27477735.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/035/SRR27477735/SRR27477735_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/035/SRR27477735/SRR27477735_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK068		2019-09-15			JK068_S60_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A64, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477735												PRJNA1063201					esophagus																																													
SRR27477736	SRX23148987	SAMN39328851	PRJNA1063201	SRS20099621	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK123	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK123	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A113, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	17645395	3490917916	Homo sapiens	2020-02-19	2024-01-11	2024-01-11		SRA1782421					PolyA												937021402.0							JK123	731583265;710781477	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/036/SRR27477736/SRR27477736.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/036/SRR27477736/SRR27477736_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/036/SRR27477736/SRR27477736_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/036/SRR27477736/SRR27477736.lite		33ebe9cb6c1243134199e795f48528a4;db7a3964ae88b3495c05c4579455ab81							2020-02-19												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							1806862f3e65f6a8bb324ee3e997ce30		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/036/SRR27477736/SRR27477736_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/036/SRR27477736/SRR27477736_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/036/SRR27477736/SRR27477736.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/036/SRR27477736/SRR27477736_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/036/SRR27477736/SRR27477736_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK123		2020-02-19			JK123_S189_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A113, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477736												PRJNA1063201					esophagus																																													
SRR27477737	SRX23148986	SAMN39328850	PRJNA1063201	SRS20099620	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK122	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK122	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A112, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	20964187	4162888088	Homo sapiens	2019-11-18	2024-01-11	2024-01-11		SRA1782421					PolyA												1114759639.0							JK122	844930586;824945916	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/037/SRR27477737/SRR27477737.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/037/SRR27477737/SRR27477737_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/037/SRR27477737/SRR27477737_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/037/SRR27477737/SRR27477737.lite		238dbae25f59a6e12c0bf992afbd1559;fcce0cb740d098685960046cb0b26628							2019-11-18												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							98064c767afaa1efa7321a68ec193ee2		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/037/SRR27477737/SRR27477737_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/037/SRR27477737/SRR27477737_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/037/SRR27477737/SRR27477737.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/037/SRR27477737/SRR27477737_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/037/SRR27477737/SRR27477737_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK122		2019-11-18			JK122_S188_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A112, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477737												PRJNA1063201					esophagus																																													
SRR27477738	SRX23148985	SAMN39328751	PRJNA1063201	SRS20099619	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK012	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK012	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A13, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	19564379	3906547343	Homo sapiens	2018-06-19	2024-01-11	2024-01-11		SRA1782421					PolyA												1042671333.0							JK012	797368699;754753706	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/038/SRR27477738/SRR27477738.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/038/SRR27477738/SRR27477738_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/038/SRR27477738/SRR27477738_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/038/SRR27477738/SRR27477738.lite		4ad9a9abd34305f34922d608f3bcdb3b;091f350d0e930cc0bc0bb6be25b89d38							2018-06-19												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							495469c00faf5d7aeb3436d1a2026e42		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/038/SRR27477738/SRR27477738_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/038/SRR27477738/SRR27477738_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/038/SRR27477738/SRR27477738.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/038/SRR27477738/SRR27477738_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/038/SRR27477738/SRR27477738_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK012		2018-06-18			JK012_S12_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A13, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477738												PRJNA1063201					esophagus																																													
SRR27477739	SRX23148984	SAMN39328849	PRJNA1063201	SRS20099618	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK121	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK121	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A111, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	23492686	4667718418	Homo sapiens	2019-10-23	2024-01-11	2024-01-11		SRA1782421					PolyA												1248753572.0							JK121	924801278;910681228	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/039/SRR27477739/SRR27477739.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/039/SRR27477739/SRR27477739_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/039/SRR27477739/SRR27477739_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/039/SRR27477739/SRR27477739.lite		0d2e288a21efb0e2776839a55d52e4c5;0a026506deb98c38ddd67ca463f0b926							2019-10-23												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							da0f7e4dbe0b41e4d32325786cc8f6a1		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/039/SRR27477739/SRR27477739_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/039/SRR27477739/SRR27477739_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/039/SRR27477739/SRR27477739.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/039/SRR27477739/SRR27477739_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/039/SRR27477739/SRR27477739_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK121		2019-10-22			JK121_S187_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A111, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477739												PRJNA1063201					esophagus																																													
SRR27477740	SRX23148983	SAMN39328848	PRJNA1063201	SRS20099617	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK120	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK120	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A110, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	19576053	3880878334	Homo sapiens	2019-09-23	2024-01-11	2024-01-11		SRA1782421					PolyA												1040578235.0							JK120	792084342;754672942	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/040/SRR27477740/SRR27477740.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/040/SRR27477740/SRR27477740_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/040/SRR27477740/SRR27477740_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/040/SRR27477740/SRR27477740.lite		8dff2f75ec917b55fdd6d4c33063baf7;7701a6ae4b77fc30c3f3d393d3d5640f							2019-09-23												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							1780a090e0ebd11f4f220d10476c51d1		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/040/SRR27477740/SRR27477740_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/040/SRR27477740/SRR27477740_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/040/SRR27477740/SRR27477740.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/040/SRR27477740/SRR27477740_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/040/SRR27477740/SRR27477740_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK120		2019-09-22			JK120_S186_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A110, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477740												PRJNA1063201					esophagus																																													
SRR27477741	SRX23148982	SAMN39328847	PRJNA1063201	SRS20099616	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK119	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK119	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A109, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	11063565	2152307672	Homo sapiens	2019-06-24	2024-01-11	2024-01-11		SRA1782421					PolyA												583388182.0							JK119	412137031;402949632	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/041/SRR27477741/SRR27477741.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/041/SRR27477741/SRR27477741_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/041/SRR27477741/SRR27477741_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/041/SRR27477741/SRR27477741.lite		93b7c86ef4afcb5bb35bc0cce5026a14;369270c6608b10679fedb6d88ebfbde7							2019-06-24												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							57a011fe77ddc9aff17743f274f4cb1f		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/041/SRR27477741/SRR27477741_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/041/SRR27477741/SRR27477741_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/041/SRR27477741/SRR27477741.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/041/SRR27477741/SRR27477741_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/041/SRR27477741/SRR27477741_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK119		2019-06-23			JK119_S185_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A109, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477741												PRJNA1063201					esophagus																																													
SRR27477742	SRX23148981	SAMN39328846	PRJNA1063201	SRS20099615	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK118	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK118	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A108, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	22799621	4521556921	Homo sapiens	2019-04-24	2024-01-11	2024-01-11		SRA1782421					PolyA												1210944673.0							JK118	944339216;906597342	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/042/SRR27477742/SRR27477742.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/042/SRR27477742/SRR27477742_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/042/SRR27477742/SRR27477742_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/042/SRR27477742/SRR27477742.lite		83ad4835ddbfd67619be1cb321d42ee6;f8386fccf00f96123b8cdb96d557523a							2019-04-24												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							8265c7c6a77a4e4ca2d1c69aeb760e59		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/042/SRR27477742/SRR27477742_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/042/SRR27477742/SRR27477742_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/042/SRR27477742/SRR27477742.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/042/SRR27477742/SRR27477742_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/042/SRR27477742/SRR27477742_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK118		2019-04-23			JK118_S184_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A108, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477742												PRJNA1063201					esophagus																																													
SRR27477743	SRX23148980	SAMN39328845	PRJNA1063201	SRS20099614	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK117	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK117	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A107, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	21696244	4302298694	Homo sapiens	2019-02-26	2024-01-11	2024-01-11		SRA1782421					PolyA												1152597379.0							JK117	899712194;864267299	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/043/SRR27477743/SRR27477743.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/043/SRR27477743/SRR27477743_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/043/SRR27477743/SRR27477743_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/043/SRR27477743/SRR27477743.lite		073c51f95dbcc4eafee57bb9d4bb93d4;8286d4c6320838793e8b8767ad18ac6b							2019-02-26												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							ebbf30f5e9905f8f1526a121a4ec4d9b		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/043/SRR27477743/SRR27477743_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/043/SRR27477743/SRR27477743_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/043/SRR27477743/SRR27477743.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/043/SRR27477743/SRR27477743_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/043/SRR27477743/SRR27477743_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK117		2019-02-26			JK117_S183_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A107, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477743												PRJNA1063201					esophagus																																													
SRR27477744	SRX23148979	SAMN39328844	PRJNA1063201	SRS20099613	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK116	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK116	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A106, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	25071807	4968505458	Homo sapiens	2018-12-17	2024-01-11	2024-01-11		SRA1782421					PolyA												1330059899.0							JK116	1044296654;1005701049	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/044/SRR27477744/SRR27477744.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/044/SRR27477744/SRR27477744_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/044/SRR27477744/SRR27477744_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/044/SRR27477744/SRR27477744.lite		c791c1c09128ba48d5a3fb9c791e219e;44b5c8b0acf3cf269f69916445aa9ed2							2018-12-17												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							87f938e97a8483b1a8bbdec052914e68		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/044/SRR27477744/SRR27477744_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/044/SRR27477744/SRR27477744_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/044/SRR27477744/SRR27477744.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/044/SRR27477744/SRR27477744_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/044/SRR27477744/SRR27477744_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK116		2018-12-17			JK116_S182_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A106, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477744												PRJNA1063201					esophagus																																													
SRR27477745	SRX23148978	SAMN39328843	PRJNA1063201	SRS20099612	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK115	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK115	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A105, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	19668959	3889700768	Homo sapiens	2018-12-17	2024-01-11	2024-01-11		SRA1782421					PolyA												1043978558.0							JK115	824045745;789861914	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/045/SRR27477745/SRR27477745.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/045/SRR27477745/SRR27477745_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/045/SRR27477745/SRR27477745_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/045/SRR27477745/SRR27477745.lite		a27735a370b89494ae198bab3afd532f;e4ab109c08b98c43a77f15cf3267e0d5							2018-12-17												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							65bdc1e67d099a18ee0b32c849e34f3c		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/045/SRR27477745/SRR27477745_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/045/SRR27477745/SRR27477745_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/045/SRR27477745/SRR27477745.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/045/SRR27477745/SRR27477745_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/045/SRR27477745/SRR27477745_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK115		2018-12-17			JK115_S181_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A105, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477745												PRJNA1063201					esophagus																																													
SRR27477746	SRX23148977	SAMN39328842	PRJNA1063201	SRS20099611	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK114	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK114	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A104, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	22115566	4382373711	Homo sapiens	2018-11-26	2024-01-11	2024-01-11		SRA1782421					PolyA												1174168333.0							JK114	919479763;884106399	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/046/SRR27477746/SRR27477746.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/046/SRR27477746/SRR27477746_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/046/SRR27477746/SRR27477746_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/046/SRR27477746/SRR27477746.lite		d2d151aa2a451fbb95ca7dfb8e948889;9a00b5cf75b18bff733b8127061d9abb							2018-11-26												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							5b3eca65451a9197ac4297bc3b30b991		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/046/SRR27477746/SRR27477746_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/046/SRR27477746/SRR27477746_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/046/SRR27477746/SRR27477746.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/046/SRR27477746/SRR27477746_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/046/SRR27477746/SRR27477746_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK114		2018-11-26			JK114_S180_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A104, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477746												PRJNA1063201					esophagus																																													
SRR27477747	SRX23148976	SAMN39328841	PRJNA1063201	SRS20099610	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK113	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK113	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A103, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	18884482	3718420098	Homo sapiens	2018-11-20	2024-01-11	2024-01-11		SRA1782421					PolyA												999986013.0							JK113	782310641;756253499	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/047/SRR27477747/SRR27477747.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/047/SRR27477747/SRR27477747_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/047/SRR27477747/SRR27477747_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/047/SRR27477747/SRR27477747.lite		94294d2cd88384936b4495d40dc67594;86b3e33c5e127970ca96826ae51627bf							2018-11-20												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							81ef830364e6c07953e49c39babbda85		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/047/SRR27477747/SRR27477747_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/047/SRR27477747/SRR27477747_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/047/SRR27477747/SRR27477747.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/047/SRR27477747/SRR27477747_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/047/SRR27477747/SRR27477747_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK113		2018-11-20			JK113_S179_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A103, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477747												PRJNA1063201					esophagus																																													
SRR27477748	SRX23148975	SAMN39328840	PRJNA1063201	SRS20099609	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK112	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK112	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A102, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	25175300	4977845902	Homo sapiens	2018-10-16	2024-01-11	2024-01-11		SRA1782421					PolyA												1334089625.0							JK112	1049423720;1010876895	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/048/SRR27477748/SRR27477748.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/048/SRR27477748/SRR27477748_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/048/SRR27477748/SRR27477748_2.fastq.gz							USA: Philadelphia, PA	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/048/SRR27477748/SRR27477748.lite		0a3830489cd379368e4e501ab07d58da;ee76c0dc7e277b2abfb02312fc91054d							2018-10-16												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							a7b5705fb9cb3ec7ffadf338454b19ca		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/048/SRR27477748/SRR27477748_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/048/SRR27477748/SRR27477748_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/048/SRR27477748/SRR27477748.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/048/SRR27477748/SRR27477748_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/048/SRR27477748/SRR27477748_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK112		2018-10-15			JK112_S178_L002_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A102, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477748												PRJNA1063201					esophagus																																													
SRR27477749	SRX23148974	SAMN39328750	PRJNA1063201	SRS20099608	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK011	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK011	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A12, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	20279808	4049431430	Homo sapiens	2018-06-18	2024-01-11	2024-01-11		SRA1782421					PolyA												1080459976.0							JK011	714292613;698276237	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/049/SRR27477749/SRR27477749.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/049/SRR27477749/SRR27477749_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/049/SRR27477749/SRR27477749_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/049/SRR27477749/SRR27477749.lite		65d35e29b16fc41c230be29c092ab749;bb825f8d3268f5fe7c9bb44ecba81b14							2018-06-18												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							a2c6151d882fed432b61c43075fa3d35		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/049/SRR27477749/SRR27477749_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/049/SRR27477749/SRR27477749_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/049/SRR27477749/SRR27477749.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/049/SRR27477749/SRR27477749_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/049/SRR27477749/SRR27477749_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK011		2018-06-17			JK011_S11_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A12, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477749												PRJNA1063201					esophagus																																													
SRR27477750	SRX23148973	SAMN39328741	PRJNA1063201	SRS20099606	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK002	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK002	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A3, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	23193180	4635426503	Homo sapiens	2018-04-09	2024-01-11	2024-01-11		SRA1782421					PolyA												1234922995.0							JK002	946565729;907881815	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/050/SRR27477750/SRR27477750.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/050/SRR27477750/SRR27477750_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/050/SRR27477750/SRR27477750_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/050/SRR27477750/SRR27477750.lite		363ae2fbc961f771c27d5b4fa3d21a64;bbf986f7f7ead66aeabcff115ed43925							2018-04-09												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							703a82c47c2072c8722e5fe72bd1005c		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/050/SRR27477750/SRR27477750_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/050/SRR27477750/SRR27477750_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/050/SRR27477750/SRR27477750.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/050/SRR27477750/SRR27477750_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/050/SRR27477750/SRR27477750_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK002		2018-04-08			JK002_S2_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A3, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477750												PRJNA1063201					esophagus																																													
SRR27477751	SRX23148972	SAMN39328740	PRJNA1063201	SRS20099607	SRP482838			Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus	JK001	Shifts in Serum Bile Acid Profiles Associated with Barretts Esophagus and Stages of Progression to Esophageal Adenocarcinoma	JK001	"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A2, 5))"	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	19117691	3821016652	Homo sapiens	2018-03-19	2024-01-11	2024-01-11		SRA1782421					PolyA												1019149212.0							JK001	800513979;758926064	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR274/051/SRR27477751/SRR27477751.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/051/SRR27477751/SRR27477751_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/051/SRR27477751/SRR27477751_2.fastq.gz							USA: Rochester, MN	Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR274/051/SRR27477751/SRR27477751.lite		b716013d589dea6fd717016f482c6e63;6d69eb86ddda63f948b513be5cb50a5e							2018-03-19												Illumina NovaSeq 6000 sequencing: RNA-Seq of Homo sapiens: esophagus							30fbf6d2f0abcce1580b6a0010c500b1		ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/051/SRR27477751/SRR27477751_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR274/051/SRR27477751/SRR27477751_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR274/051/SRR27477751/SRR27477751.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/051/SRR27477751/SRR27477751_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR274/051/SRR27477751/SRR27477751_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			RNASeq_Human_JK001		2018-03-19			JK001_S1_L001_R1_001.fastq.gz						"=CONCATENATE(""211104_JULIAN_JULIAN_144_HUMAN_RNA_STRDPOLYA_20M_PE100_NOVASEQ_"", RIGHT(A2, 5))"		SUB14144474					env_tax;env_tax:terrestrial	2024-01-11				9606									SRR27477751												PRJNA1063201					esophagus																																													
SRR17303511	SRX13480689	SAMN24254405	PRJNA776531	SRS11376932	SRP352058			Illumina NovaSeq 6000 sequencing: RNAseq fastq file1 of early Barrett's esophagus patient1	RNAseq fastq file1 of early Barrett's esophagus patient1	Stem Cell Transitions in Oncogenesis Highlight Lineage Vulnerabilities	RNAseq fastq file1 of early Barrett's esophagus patient1	Early BE of Pt1 A01	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	50025762	15007728600	Homo sapiens		2024-02-25	2024-02-26	Homo sapiens	SRA1347291					cDNA												3762091983.0							esophageal adenocarcinoma patient	2717549062;2717629245	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR173/011/SRR17303511/SRR17303511.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/011/SRR17303511/SRR17303511_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/011/SRR17303511/SRR17303511_2.fastq.gz								Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR173/011/SRR17303511/SRR17303511.lite		4359f1bf4c64f31685b90e90b8223890;2e4c9fd5ec398390a07f3a34e85b652c																			Illumina NovaSeq 6000 sequencing: RNAseq fastq file1 of early Barrett's esophagus patient1							d5dcc905cac1cab923d60437e9a31e55	stem cell pool 5	ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/011/SRR17303511/SRR17303511_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/011/SRR17303511/SRR17303511_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR173/011/SRR17303511/SRR17303511.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR173/011/SRR17303511/SRR17303511_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR173/011/SRR17303511/SRR17303511_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			Early BE of Pt1 A01					case1_BE2_dup2_1.fq.gz						Early BE of Pt1 A01		SUB10829594					env_tax;env_tax:terrestrial	2024-02-25				9606									SRR17303511												PRJNA776531					Esophagus																																													
SRR17303512	SRX13480688	SAMN24254406	PRJNA776531	SRS11376931	SRP352058			Illumina NovaSeq 6000 sequencing: RNAseq fastq file2 of early Barrett's esophagus patient1	RNAseq fastq file2 of early Barrett's esophagus patient1	Stem Cell Transitions in Oncogenesis Highlight Lineage Vulnerabilities	RNAseq fastq file2 of early Barrett's esophagus patient1	Early BE of Pt1 B02	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	36206084	10861825200	Homo sapiens		2024-02-25	2024-02-26	Homo sapiens	SRA1347291					cDNA												2722376880.0							esophageal adenocarcinoma patient	1963169786;1963483363	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR173/012/SRR17303512/SRR17303512.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/012/SRR17303512/SRR17303512_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/012/SRR17303512/SRR17303512_2.fastq.gz								Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR173/012/SRR17303512/SRR17303512.lite		6c82297b9c08fbd80a6b90b92b0c85af;ecbdccbbd5b42a1c46017580c499f1d4																			Illumina NovaSeq 6000 sequencing: RNAseq fastq file2 of early Barrett's esophagus patient1							a73475e4271048464d63afeadfcd602d	stem cell pool 6	ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/012/SRR17303512/SRR17303512_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/012/SRR17303512/SRR17303512_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR173/012/SRR17303512/SRR17303512.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR173/012/SRR17303512/SRR17303512_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR173/012/SRR17303512/SRR17303512_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			Early BE of Pt1 B02					case1_BE2_dup1_1.fq.gz						Early BE of Pt1 B02		SUB10829594					env_tax;env_tax:terrestrial	2024-02-25				9606									SRR17303512												PRJNA776531					Esophagus																																													
SRR17303513	SRX13480687	SAMN24254407	PRJNA776531	SRS11376930	SRP352058			Illumina NovaSeq 6000 sequencing: RNAseq fastq file1 of advanced Barrett's esophagus patient1	RNAseq fastq file1 of advanced Barrett's esophagus patient1	Stem Cell Transitions in Oncogenesis Highlight Lineage Vulnerabilities	RNAseq fastq file1 of advanced Barrett's esophagus patient1	Advanced BE of Pt1 A03	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	46830527	14049158100	Homo sapiens		2024-02-25	2024-02-26	Homo sapiens	SRA1347291					cDNA												3522233350.0							esophageal adenocarcinoma patient	2536259609;2535842596	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR173/013/SRR17303513/SRR17303513.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/013/SRR17303513/SRR17303513_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/013/SRR17303513/SRR17303513_2.fastq.gz								Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR173/013/SRR17303513/SRR17303513.lite		6c51fdf241980a9c3af09092cfa75e4c;c0d57478980fcabc35c9970c1eddb123																			Illumina NovaSeq 6000 sequencing: RNAseq fastq file1 of advanced Barrett's esophagus patient1							f7519c7129512d3c5e59054c57045ddd	stem cell pool 7	ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/013/SRR17303513/SRR17303513_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/013/SRR17303513/SRR17303513_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR173/013/SRR17303513/SRR17303513.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR173/013/SRR17303513/SRR17303513_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR173/013/SRR17303513/SRR17303513_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			Advanced BE of Pt1 A03					case1_BE1_dup2_1.fq.gz						Advanced BE of Pt1 A03		SUB10829594					env_tax;env_tax:terrestrial	2024-02-25				9606									SRR17303513												PRJNA776531					Esophagus																																													
SRR17303514	SRX13480686	SAMN24254408	PRJNA776531	SRS11376929	SRP352058			Illumina NovaSeq 6000 sequencing: RNAseq fastq file2 of advanced Barrett's esophagus patient1	RNAseq fastq file2 of advanced Barrett's esophagus patient1	Stem Cell Transitions in Oncogenesis Highlight Lineage Vulnerabilities	RNAseq fastq file2 of advanced Barrett's esophagus patient1	Advanced BE of Pt1 B04	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	40583181	12174954300	Homo sapiens		2024-02-25	2024-02-26	Homo sapiens	SRA1347291					cDNA												3051405312.0							esophageal adenocarcinoma patient	2192591410;2192599486	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR173/014/SRR17303514/SRR17303514.lite								female			ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/014/SRR17303514/SRR17303514_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/014/SRR17303514/SRR17303514_2.fastq.gz								Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR173/014/SRR17303514/SRR17303514.lite		3203a4238bb7b97e090e7be242160016;f5b9e8515cc072db1fe7e0794c8bfa97																			Illumina NovaSeq 6000 sequencing: RNAseq fastq file2 of advanced Barrett's esophagus patient1							7871a7e4c098f737c38959475fe73706	stem cell pool 8	ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/014/SRR17303514/SRR17303514_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/014/SRR17303514/SRR17303514_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR173/014/SRR17303514/SRR17303514.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR173/014/SRR17303514/SRR17303514_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR173/014/SRR17303514/SRR17303514_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			Advanced BE of Pt1 B04					case1_BE1_dup1_1.fq.gz						Advanced BE of Pt1 B04		SUB10829594					env_tax;env_tax:terrestrial	2024-02-25				9606									SRR17303514												PRJNA776531					Esophagus																																													
SRR17303515	SRX13480685	SAMN24254404	PRJNA776531	SRS11376928	SRP352058			Illumina NovaSeq 6000 sequencing: RNAseq fastq file2 of advanced Barrett's esophagus patient2	RNAseq fastq file2 of advanced Barrett's esophagus patient2	Stem Cell Transitions in Oncogenesis Highlight Lineage Vulnerabilities	RNAseq fastq file2 of advanced Barrett's esophagus patient2	Advanced BE of Pt2 B04	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	45833813	13750143900	Homo sapiens		2024-02-25	2024-02-25	Homo sapiens	SRA1347291					cDNA												3442440888.0							esophageal adenocarcinoma patient	2459879356;2461417467	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR173/015/SRR17303515/SRR17303515.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/015/SRR17303515/SRR17303515_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/015/SRR17303515/SRR17303515_2.fastq.gz								Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR173/015/SRR17303515/SRR17303515.lite		342dfe5d291e57c226527fd237152fac;3fff5a5dcb6fe85337265024be87b4e0																			Illumina NovaSeq 6000 sequencing: RNAseq fastq file2 of advanced Barrett's esophagus patient2							9dd09cd3e1fbd4ac7040afd7f57afd67	stem cell pool 4	ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/015/SRR17303515/SRR17303515_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/015/SRR17303515/SRR17303515_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR173/015/SRR17303515/SRR17303515.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR173/015/SRR17303515/SRR17303515_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR173/015/SRR17303515/SRR17303515_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			Advanced BE of Pt2 B04					case2_BE1_dup2_1.fq.gz						Advanced BE of Pt2 B04		SUB10829594					env_tax;env_tax:terrestrial	2024-02-25				9606									SRR17303515												PRJNA776531					Esophagus																																													
SRR17303516	SRX13480684	SAMN24254403	PRJNA776531	SRS11376927	SRP352058			Illumina NovaSeq 6000 sequencing: RNAseq fastq file1 of advanced Barrett's esophagus patient2	RNAseq fastq file1 of advanced Barrett's esophagus patient2	Stem Cell Transitions in Oncogenesis Highlight Lineage Vulnerabilities	RNAseq fastq file1 of advanced Barrett's esophagus patient2	Advanced BE of Pt2 A03	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	36720626	11016187800	Homo sapiens		2024-02-02	2024-02-05	Homo sapiens	SRA1347291					cDNA												2759024619.0							esophageal adenocarcinoma patient	1976854841;1977733835	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR173/016/SRR17303516/SRR17303516.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/016/SRR17303516/SRR17303516_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/016/SRR17303516/SRR17303516_2.fastq.gz								Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR173/016/SRR17303516/SRR17303516.lite		702d697861a901bb661998f0c7b568f7;521f7ba35df0a2d6f93afb2e8cbb8342																			Illumina NovaSeq 6000 sequencing: RNAseq fastq file1 of advanced Barrett's esophagus patient2							3d709d4ef233246a70221e7c5d82c103	stem cell pool 3	ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/016/SRR17303516/SRR17303516_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/016/SRR17303516/SRR17303516_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR173/016/SRR17303516/SRR17303516.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR173/016/SRR17303516/SRR17303516_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR173/016/SRR17303516/SRR17303516_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			Advanced BE of Pt2 A03					case2_BE2_dup1_1.fq.gz						Advanced BE of Pt2 A03		SUB10829594					env_tax;env_tax:terrestrial	2024-02-02				9606									SRR17303516												PRJNA776531					Esophagus																																													
SRR17303517	SRX13480683	SAMN24254402	PRJNA776531	SRS11376926	SRP352058			Illumina NovaSeq 6000 sequencing: RNAseq fastq file2 of early Barrett's esophagus patient2	RNAseq fastq file2 of early Barrett's esophagus patient2	Stem Cell Transitions in Oncogenesis Highlight Lineage Vulnerabilities	RNAseq fastq file2 of early Barrett's esophagus patient2	Early BE of Pt2 B02	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	31671725	9501517500	Homo sapiens		2024-02-25	2024-02-26	Homo sapiens	SRA1347291					cDNA												2379684721.0							esophageal adenocarcinoma patient	1702600499;1703520469	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR173/017/SRR17303517/SRR17303517.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/017/SRR17303517/SRR17303517_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/017/SRR17303517/SRR17303517_2.fastq.gz								Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR173/017/SRR17303517/SRR17303517.lite		85f83ce23766986d3c08091b77ac0443;03c676cc7c37385f4d1d76ec480df7d9																			Illumina NovaSeq 6000 sequencing: RNAseq fastq file2 of early Barrett's esophagus patient2							af85b87846adda7a79a5a76da0e2de1f	stem cell pool 2	ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/017/SRR17303517/SRR17303517_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/017/SRR17303517/SRR17303517_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR173/017/SRR17303517/SRR17303517.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR173/017/SRR17303517/SRR17303517_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR173/017/SRR17303517/SRR17303517_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			Early BE of Pt2 B02					case2_BE2_dup2_1.fq.gz						Early BE of Pt2 B02		SUB10829594					env_tax;env_tax:terrestrial	2024-02-25				9606									SRR17303517												PRJNA776531					Esophagus																																													
SRR17303518	SRX13480682	SAMN24254401	PRJNA776531	SRS11376925	SRP352058			Illumina NovaSeq 6000 sequencing: RNAseq fastq file1 of early Barrett's esophagus patient2	RNAseq fastq file1 of early Barrett's esophagus patient2	Stem Cell Transitions in Oncogenesis Highlight Lineage Vulnerabilities	RNAseq fastq file1 of early Barrett's esophagus patient2	Early BE of Pt2 A01	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina NovaSeq 6000	39198140	11759442000	Homo sapiens		2024-02-25	2024-02-25	Homo sapiens	SRA1347291					cDNA												2943608565.0							esophageal adenocarcinoma patient	2099779722;2100784894	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR173/018/SRR17303518/SRR17303518.lite								male			ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/018/SRR17303518/SRR17303518_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/018/SRR17303518/SRR17303518_2.fastq.gz								Human	ftp.sra.ebi.ac.uk/vol1/srr/SRR173/018/SRR17303518/SRR17303518.lite		5049787651b6b4b1fab85024d32ec555;f266de4160a46a3b1252fe45205f89ad																			Illumina NovaSeq 6000 sequencing: RNAseq fastq file1 of early Barrett's esophagus patient2							f8d664f24b932bc7b03d947bcd04403b	stem cell pool 1	ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/018/SRR17303518/SRR17303518_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR173/018/SRR17303518/SRR17303518_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR173/018/SRR17303518/SRR17303518.lite																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR173/018/SRR17303518/SRR17303518_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR173/018/SRR17303518/SRR17303518_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			Early BE of Pt2 A01					case2_BE1_dup1_1.fq.gz						Early BE of Pt2 A01		SUB10829594					env_tax;env_tax:terrestrial	2024-02-25				9606									SRR17303518												PRJNA776531					Esophagus																																													
SRR17658172	SRX13826244	SAMN25078456	PRJNA798444	SRS11705469	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824055: Esophagus Sample 46 Homo sapiens RNA-Seq	Esophagus Sample 46	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 46	GSM5824055	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	50731680	10247799360	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												6543680887.0								4101137291;4032614162	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/072/SRR17658172											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/072/SRR17658172/SRR17658172_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/072/SRR17658172/SRR17658172_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/072/SRR17658172		1e97e42cd34cb9d89754e17e7317a9e9;edb1bae32597d57c6c2e4c757c7fd075																			Illumina HiSeq 2000 sequencing: GSM5824055: Esophagus Sample 46 Homo sapiens RNA-Seq							0095462a85a071b96515d6f42312bfda		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/072/SRR17658172/SRR17658172_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/072/SRR17658172/SRR17658172_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/072/SRR17658172																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/072/SRR17658172/SRR17658172_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/072/SRR17658172/SRR17658172_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824055					GSM5824055_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824055_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658172												GSE193946					Esophagus																																													
SRR17658173	SRX13826243	SAMN25078457	PRJNA798444	SRS11705468	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824054: Esophagus Sample 45 Homo sapiens RNA-Seq	Esophagus Sample 45	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 45	GSM5824054	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	55562358	11223596316	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												7206788291.0								4497127440;4469712442	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/073/SRR17658173											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/073/SRR17658173/SRR17658173_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/073/SRR17658173/SRR17658173_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/073/SRR17658173		d32abc2bbf670cde77a9fe33aa03b26e;b152100d08a0e0a90df1c5210f142bab																			Illumina HiSeq 2000 sequencing: GSM5824054: Esophagus Sample 45 Homo sapiens RNA-Seq							c674586bbe5b263fea79558886b03664		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/073/SRR17658173/SRR17658173_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/073/SRR17658173/SRR17658173_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/073/SRR17658173																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/073/SRR17658173/SRR17658173_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/073/SRR17658173/SRR17658173_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824054					GSM5824054_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824054_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658173												GSE193946					Esophagus																																													
SRR17658174	SRX13826242	SAMN25078458	PRJNA798444	SRS11705467	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824053: Esophagus Sample 44 Homo sapiens RNA-Seq	Esophagus Sample 44	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 44	GSM5824053	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	59132532	11944771464	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												7657363515.0								4792713552;4726056457	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/074/SRR17658174											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/074/SRR17658174/SRR17658174_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/074/SRR17658174/SRR17658174_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/074/SRR17658174		fac648890232e3365915730f0cd86fc4;6ae3cbc4115d968c934adb0f50370666																			Illumina HiSeq 2000 sequencing: GSM5824053: Esophagus Sample 44 Homo sapiens RNA-Seq							f8bff4721ff426835381a6ab69edf8e5		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/074/SRR17658174/SRR17658174_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/074/SRR17658174/SRR17658174_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/074/SRR17658174																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/074/SRR17658174/SRR17658174_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/074/SRR17658174/SRR17658174_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824053					GSM5824053_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824053_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658174												GSE193946					Esophagus																																													
SRR17658175	SRX13826241	SAMN25078459	PRJNA798444	SRS11705466	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824052: Esophagus Sample 43 Homo sapiens RNA-Seq	Esophagus Sample 43	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 43	GSM5824052	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	47925162	9680882724	Homo sapiens	missing	2022-08-19	2022-10-27	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												6149430213.0								3839919843;3802113116	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/075/SRR17658175											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/075/SRR17658175/SRR17658175_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/075/SRR17658175/SRR17658175_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/075/SRR17658175		aee30aa642a855bd2e14d47d105737d3;1fa52e0dbf6a850e52778af11d85a4f6																			Illumina HiSeq 2000 sequencing: GSM5824052: Esophagus Sample 43 Homo sapiens RNA-Seq							4a6e66b5fe06ffa0207562bbe3af823c		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/075/SRR17658175/SRR17658175_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/075/SRR17658175/SRR17658175_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/075/SRR17658175																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/075/SRR17658175/SRR17658175_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/075/SRR17658175/SRR17658175_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824052					GSM5824052_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824052_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658175												GSE193946					Esophagus																																													
SRR17658176	SRX13826240	SAMN25078460	PRJNA798444	SRS11705465	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824051: Esophagus Sample 42 Homo sapiens RNA-Seq	Esophagus Sample 42	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 42	GSM5824051	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	51337761	10370227722	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												6654988362.0								4174016236;4104609624	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/076/SRR17658176											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/076/SRR17658176/SRR17658176_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/076/SRR17658176/SRR17658176_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/076/SRR17658176		a35f07ac8a400c24df42f3e61e791325;c17fa55d71cd265ddb3492a981cd5c82																			Illumina HiSeq 2000 sequencing: GSM5824051: Esophagus Sample 42 Homo sapiens RNA-Seq							bc96744b205ba07144717d944d5869bf		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/076/SRR17658176/SRR17658176_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/076/SRR17658176/SRR17658176_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/076/SRR17658176																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/076/SRR17658176/SRR17658176_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/076/SRR17658176/SRR17658176_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824051					GSM5824051_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824051_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658176												GSE193946					Esophagus																																													
SRR17658177	SRX13826239	SAMN25078461	PRJNA798444	SRS11705464	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824050: Esophagus Sample 41 Homo sapiens RNA-Seq	Esophagus Sample 41	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 41	GSM5824050	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	52114557	10527140514	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												6775367066.0								4226534658;4202949788	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/077/SRR17658177											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/077/SRR17658177/SRR17658177_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/077/SRR17658177/SRR17658177_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/077/SRR17658177		ea5b2ba5e7bc294a30f0559fea672dca;a28a61142c512e50c455cebd757b8245																			Illumina HiSeq 2000 sequencing: GSM5824050: Esophagus Sample 41 Homo sapiens RNA-Seq							165c839eecdcf981b7f649364445f93c		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/077/SRR17658177/SRR17658177_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/077/SRR17658177/SRR17658177_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/077/SRR17658177																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/077/SRR17658177/SRR17658177_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/077/SRR17658177/SRR17658177_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824050					GSM5824050_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824050_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658177												GSE193946					Esophagus																																													
SRR17658178	SRX13826238	SAMN25078462	PRJNA798444	SRS11705463	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824049: Esophagus Sample 40 Homo sapiens RNA-Seq	Esophagus Sample 40	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 40	GSM5824049	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	55617831	11234801862	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												7204590459.0								4502587326;4452120978	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/078/SRR17658178											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/078/SRR17658178/SRR17658178_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/078/SRR17658178/SRR17658178_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/078/SRR17658178		5be981c33176a8213b5b6b5f41231fbd;dff4626608d7b6d752feffb2605cbb05																			Illumina HiSeq 2000 sequencing: GSM5824049: Esophagus Sample 40 Homo sapiens RNA-Seq							b027a0a125a92fec2510728ed25cc2c3		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/078/SRR17658178/SRR17658178_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/078/SRR17658178/SRR17658178_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/078/SRR17658178																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/078/SRR17658178/SRR17658178_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/078/SRR17658178/SRR17658178_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824049					GSM5824049_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824049_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658178												GSE193946					Esophagus																																													
SRR17658179	SRX13826237	SAMN25078463	PRJNA798444	SRS11705462	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824048: Esophagus Sample 39 Homo sapiens RNA-Seq	Esophagus Sample 39	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 39	GSM5824048	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	46924646	9478778492	Homo sapiens	missing	2022-08-19	2022-10-27	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												6154424437.0								3856791711;3808774508	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/079/SRR17658179											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/079/SRR17658179/SRR17658179_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/079/SRR17658179/SRR17658179_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/079/SRR17658179		adc124029db2802bd5df44d8f8dccbb3;d7710bbf3a00b09d401a392369c25ed0																			Illumina HiSeq 2000 sequencing: GSM5824048: Esophagus Sample 39 Homo sapiens RNA-Seq							38c4186d964c2b87fb1af992dcd2ec8d		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/079/SRR17658179/SRR17658179_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/079/SRR17658179/SRR17658179_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/079/SRR17658179																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/079/SRR17658179/SRR17658179_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/079/SRR17658179/SRR17658179_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824048					GSM5824048_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824048_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658179												GSE193946					Esophagus																																													
SRR17658180	SRX13826236	SAMN25078464	PRJNA798444	SRS11705461	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824047: Esophagus Sample 38 Homo sapiens RNA-Seq	Esophagus Sample 38	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 38	GSM5824047	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	69176899	13973733598	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												9129373585.0								5709189544;5649352409	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/080/SRR17658180											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/080/SRR17658180/SRR17658180_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/080/SRR17658180/SRR17658180_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/080/SRR17658180		f5edaa9e3d01bcc49060515f7b612e76;4358fc73b96be565b260c033e8423270																			Illumina HiSeq 2000 sequencing: GSM5824047: Esophagus Sample 38 Homo sapiens RNA-Seq							419712dafe91dbbedf56368694628ca2		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/080/SRR17658180/SRR17658180_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/080/SRR17658180/SRR17658180_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/080/SRR17658180																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/080/SRR17658180/SRR17658180_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/080/SRR17658180/SRR17658180_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824047					GSM5824047_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824047_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658180												GSE193946					Esophagus																																													
SRR17658181	SRX13826235	SAMN25078465	PRJNA798444	SRS11705460	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824046: Esophagus Sample 37 Homo sapiens RNA-Seq	Esophagus Sample 37	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 37	GSM5824046	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	43244060	8735300120	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												5591775591.0								3509501565;3445331454	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/081/SRR17658181											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/081/SRR17658181/SRR17658181_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/081/SRR17658181/SRR17658181_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/081/SRR17658181		6ac466df37077e1aed683786f4177734;9ec914c730c29610133a131430a1f79d																			Illumina HiSeq 2000 sequencing: GSM5824046: Esophagus Sample 37 Homo sapiens RNA-Seq							db435be208283a5cb83237899bd8d058		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/081/SRR17658181/SRR17658181_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/081/SRR17658181/SRR17658181_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/081/SRR17658181																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/081/SRR17658181/SRR17658181_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/081/SRR17658181/SRR17658181_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824046					GSM5824046_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824046_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658181												GSE193946					Esophagus																																													
SRR17658182	SRX13826234	SAMN25078466	PRJNA798444	SRS11705459	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824045: Esophagus Sample 36 Homo sapiens RNA-Seq	Esophagus Sample 36	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 36	GSM5824045	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	55147034	11139700868	Homo sapiens	missing	2022-08-19	2022-10-27	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												7039942013.0								4429541255;4326279564	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/082/SRR17658182											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/082/SRR17658182/SRR17658182_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/082/SRR17658182/SRR17658182_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/082/SRR17658182		af09a929afe5b188f9d76e22f6e58446;a23d5ec5a9e63d4aaee8d1184a9d03a8																			Illumina HiSeq 2000 sequencing: GSM5824045: Esophagus Sample 36 Homo sapiens RNA-Seq							2d29d1db48c388fc921e6809d697673c		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/082/SRR17658182/SRR17658182_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/082/SRR17658182/SRR17658182_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/082/SRR17658182																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/082/SRR17658182/SRR17658182_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/082/SRR17658182/SRR17658182_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824045					GSM5824045_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824045_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658182												GSE193946					Esophagus																																													
SRR17658183	SRX13826233	SAMN25078467	PRJNA798444	SRS11705458	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824044: Esophagus Sample 35 Homo sapiens RNA-Seq	Esophagus Sample 35	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 35	GSM5824044	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	52583274	10621821348	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												6791011963.0								4242541633;4181439711	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/083/SRR17658183											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/083/SRR17658183/SRR17658183_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/083/SRR17658183/SRR17658183_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/083/SRR17658183		72bef0724ab2c808badb6074acea000b;3e180315dfd378c214ba9672602b1535																			Illumina HiSeq 2000 sequencing: GSM5824044: Esophagus Sample 35 Homo sapiens RNA-Seq							c01b5248cbd4535362ae32165389229f		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/083/SRR17658183/SRR17658183_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/083/SRR17658183/SRR17658183_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/083/SRR17658183																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/083/SRR17658183/SRR17658183_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/083/SRR17658183/SRR17658183_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824044					GSM5824044_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824044_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658183												GSE193946					Esophagus																																													
SRR17658184	SRX13826232	SAMN25078468	PRJNA798444	SRS11705457	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824043: Esophagus Sample 34 Homo sapiens RNA-Seq	Esophagus Sample 34	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 34	GSM5824043	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	62634745	12652218490	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												8179711875.0								5116902724;5066544251	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/084/SRR17658184											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/084/SRR17658184/SRR17658184_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/084/SRR17658184/SRR17658184_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/084/SRR17658184		787bd29186148c1115e211e55bedff78;8a7c542b2b710588d5433349480836b1																			Illumina HiSeq 2000 sequencing: GSM5824043: Esophagus Sample 34 Homo sapiens RNA-Seq							56c50be855bb85bf804a832299aef8f1		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/084/SRR17658184/SRR17658184_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/084/SRR17658184/SRR17658184_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/084/SRR17658184																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/084/SRR17658184/SRR17658184_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/084/SRR17658184/SRR17658184_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824043					GSM5824043_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824043_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658184												GSE193946					Esophagus																																													
SRR17658185	SRX13826231	SAMN25078469	PRJNA798444	SRS11705456	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824042: Esophagus Sample 33 Homo sapiens RNA-Seq	Esophagus Sample 33	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 33	GSM5824042	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	71056116	14353335432	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												9197284576.0								5749828619;5656984513	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/085/SRR17658185											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/085/SRR17658185/SRR17658185_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/085/SRR17658185/SRR17658185_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/085/SRR17658185		467cb0e0b0568a90cc45c37fe79879f4;ae22188be49c22cd62afb8dbfc6e5060																			Illumina HiSeq 2000 sequencing: GSM5824042: Esophagus Sample 33 Homo sapiens RNA-Seq							ba83093d1f16057cbaf222af1584f5ae		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/085/SRR17658185/SRR17658185_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/085/SRR17658185/SRR17658185_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/085/SRR17658185																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/085/SRR17658185/SRR17658185_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/085/SRR17658185/SRR17658185_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824042					GSM5824042_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824042_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658185												GSE193946					Esophagus																																													
SRR17658186	SRX13826230	SAMN25078470	PRJNA798444	SRS11705455	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824041: Esophagus Sample 32 Homo sapiens RNA-Seq	Esophagus Sample 32	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 32	GSM5824041	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	44615568	9012344736	Homo sapiens	missing	2022-08-19	2022-10-27	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												5767815674.0								3608645316;3570998952	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/086/SRR17658186											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/086/SRR17658186/SRR17658186_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/086/SRR17658186/SRR17658186_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/086/SRR17658186		9b043314ad8b5fd83a670ba9b1dfcdcb;45de0ea1dcded4b3e595159d54cd55bd																			Illumina HiSeq 2000 sequencing: GSM5824041: Esophagus Sample 32 Homo sapiens RNA-Seq							2162929d2035356c2d55fd1d9a408afb		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/086/SRR17658186/SRR17658186_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/086/SRR17658186/SRR17658186_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/086/SRR17658186																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/086/SRR17658186/SRR17658186_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/086/SRR17658186/SRR17658186_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824041					GSM5824041_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824041_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658186												GSE193946					Esophagus																																													
SRR17658187	SRX13826229	SAMN25078471	PRJNA798444	SRS11705454	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824040: Esophagus Sample 31 Homo sapiens RNA-Seq	Esophagus Sample 31	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 31	GSM5824040	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	62000001	12524000202	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												7963845106.0								4989389173;4935652658	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/087/SRR17658187											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/087/SRR17658187/SRR17658187_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/087/SRR17658187/SRR17658187_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/087/SRR17658187		0cb5dc3624491520c56257c63411e6b2;d440088c8e90d73579697732c9cc30ce																			Illumina HiSeq 2000 sequencing: GSM5824040: Esophagus Sample 31 Homo sapiens RNA-Seq							43dabf81efc6f3bf2a80220ae2a6ff1c		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/087/SRR17658187/SRR17658187_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/087/SRR17658187/SRR17658187_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/087/SRR17658187																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/087/SRR17658187/SRR17658187_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/087/SRR17658187/SRR17658187_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824040					GSM5824040_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824040_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658187												GSE193946					Esophagus																																													
SRR17658188	SRX13826228	SAMN25078472	PRJNA798444	SRS11705453	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824039: Esophagus Sample 30 Homo sapiens RNA-Seq	Esophagus Sample 30	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 30	GSM5824039	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	51135626	10329396452	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												6595587482.0								4123140134;4066089291	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/088/SRR17658188											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/088/SRR17658188/SRR17658188_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/088/SRR17658188/SRR17658188_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/088/SRR17658188		33236d7674f8d2dfd8f8ccfe16a95b86;d162d826c396ef3d811d31a208d128c8																			Illumina HiSeq 2000 sequencing: GSM5824039: Esophagus Sample 30 Homo sapiens RNA-Seq							0d582c1cecc0444641857674649e1fb5		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/088/SRR17658188/SRR17658188_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/088/SRR17658188/SRR17658188_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/088/SRR17658188																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/088/SRR17658188/SRR17658188_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/088/SRR17658188/SRR17658188_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824039					GSM5824039_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824039_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658188												GSE193946					Esophagus																																													
SRR17658189	SRX13826227	SAMN25078473	PRJNA798444	SRS11705452	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824038: Esophagus Sample 29 Homo sapiens RNA-Seq	Esophagus Sample 29	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 29	GSM5824038	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	75451445	15241191890	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												9945375298.0								6209207702;6181650943	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/089/SRR17658189											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/089/SRR17658189/SRR17658189_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/089/SRR17658189/SRR17658189_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/089/SRR17658189		4dccd45b532e2af7e70be49c5e56ca00;19d1f3371d50d243a5c2946ca6d191b6																			Illumina HiSeq 2000 sequencing: GSM5824038: Esophagus Sample 29 Homo sapiens RNA-Seq							874d30ea9e28789c377e92d3484af1dd		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/089/SRR17658189/SRR17658189_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/089/SRR17658189/SRR17658189_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/089/SRR17658189																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/089/SRR17658189/SRR17658189_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/089/SRR17658189/SRR17658189_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824038					GSM5824038_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824038_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658189												GSE193946					Esophagus																																													
SRR17658190	SRX13826226	SAMN25078474	PRJNA798444	SRS11705451	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824037: Esophagus Sample 28 Homo sapiens RNA-Seq	Esophagus Sample 28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 28	GSM5824037	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	47316401	9557913002	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												6192317915.0								3882741763;3830685524	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/090/SRR17658190											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/090/SRR17658190/SRR17658190_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/090/SRR17658190/SRR17658190_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/090/SRR17658190		60953dfb61d394b4b453524459e84c7f;5f47167fd40283b55a5ce52f097dde9e																			Illumina HiSeq 2000 sequencing: GSM5824037: Esophagus Sample 28 Homo sapiens RNA-Seq							ec5d347cdac6d4d27ffc9ab3dcac6656		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/090/SRR17658190/SRR17658190_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/090/SRR17658190/SRR17658190_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/090/SRR17658190																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/090/SRR17658190/SRR17658190_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/090/SRR17658190/SRR17658190_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824037					GSM5824037_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824037_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658190												GSE193946					Esophagus																																													
SRR17658191	SRX13826225	SAMN25078475	PRJNA798444	SRS11705450	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824036: Esophagus Sample 27 Homo sapiens RNA-Seq	Esophagus Sample 27	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 27	GSM5824036	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	60412419	12203308638	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												7851294742.0								4903812001;4868536917	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/091/SRR17658191											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/091/SRR17658191/SRR17658191_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/091/SRR17658191/SRR17658191_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/091/SRR17658191		bfa5c92ed48d5659ff73c5af074aaad9;5ae98d3678cccda93c0d3fa20a3318a6																			Illumina HiSeq 2000 sequencing: GSM5824036: Esophagus Sample 27 Homo sapiens RNA-Seq							ac9db3024de6eaa2ca753e7e2f0849d8		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/091/SRR17658191/SRR17658191_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/091/SRR17658191/SRR17658191_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/091/SRR17658191																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/091/SRR17658191/SRR17658191_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/091/SRR17658191/SRR17658191_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824036					GSM5824036_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824036_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658191												GSE193946					Esophagus																																													
SRR17658192	SRX13826224	SAMN25078476	PRJNA798444	SRS11705449	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824035: Esophagus Sample 26 Homo sapiens RNA-Seq	Esophagus Sample 26	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 26	GSM5824035	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	58426196	11802091592	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												7514640215.0								4713840949;4649793884	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/092/SRR17658192											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/092/SRR17658192/SRR17658192_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/092/SRR17658192/SRR17658192_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/092/SRR17658192		1317063b6052c2f5749c2c3639bcaac8;cdd2bfd0600ec70c3e161e26ead28a73																			Illumina HiSeq 2000 sequencing: GSM5824035: Esophagus Sample 26 Homo sapiens RNA-Seq							98343ad8b37d776182bdec1dc6193dc0		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/092/SRR17658192/SRR17658192_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/092/SRR17658192/SRR17658192_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/092/SRR17658192																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/092/SRR17658192/SRR17658192_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/092/SRR17658192/SRR17658192_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824035					GSM5824035_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824035_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658192												GSE193946					Esophagus																																													
SRR17658193	SRX13826223	SAMN25078477	PRJNA798444	SRS11705448	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824034: Esophagus Sample 25 Homo sapiens RNA-Seq	Esophagus Sample 25	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 25	GSM5824034	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	59966137	12113159674	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												7669171997.0								4806186903;4721814735	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/093/SRR17658193											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/093/SRR17658193/SRR17658193_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/093/SRR17658193/SRR17658193_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/093/SRR17658193		38a65eb8b4246e8bcf36db9be69d1c82;0cfcd50b4c65611a0582328c265557cb																			Illumina HiSeq 2000 sequencing: GSM5824034: Esophagus Sample 25 Homo sapiens RNA-Seq							7a9b914b02b9169be97e1776a1d5ff1d		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/093/SRR17658193/SRR17658193_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/093/SRR17658193/SRR17658193_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/093/SRR17658193																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/093/SRR17658193/SRR17658193_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/093/SRR17658193/SRR17658193_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824034					GSM5824034_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824034_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658193												GSE193946					Esophagus																																													
SRR17658194	SRX13826222	SAMN25078478	PRJNA798444	SRS11705447	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824033: Esophagus Sample 24 Homo sapiens RNA-Seq	Esophagus Sample 24	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 24	GSM5824033	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	42321512	8548945424	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												5520103967.0								3470556915;3395187664	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/094/SRR17658194											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/094/SRR17658194/SRR17658194_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/094/SRR17658194/SRR17658194_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/094/SRR17658194		49ac94b455552e1665784bd8fbc34083;49b8c191c19e7382245bc826e53a6464																			Illumina HiSeq 2000 sequencing: GSM5824033: Esophagus Sample 24 Homo sapiens RNA-Seq							f0215be8f3739c0fa8dacd312fd0187f		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/094/SRR17658194/SRR17658194_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/094/SRR17658194/SRR17658194_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/094/SRR17658194																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/094/SRR17658194/SRR17658194_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/094/SRR17658194/SRR17658194_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824033					GSM5824033_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824033_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658194												GSE193946					Esophagus																																													
SRR17658195	SRX13826221	SAMN25078479	PRJNA798444	SRS11705446	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824032: Esophagus Sample 23 Homo sapiens RNA-Seq	Esophagus Sample 23	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 23	GSM5824032	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	55331156	11176893512	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												7193785216.0								4495903825;4452470482	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/095/SRR17658195											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/095/SRR17658195/SRR17658195_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/095/SRR17658195/SRR17658195_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/095/SRR17658195		bb43165108b6ddd553329f108db8f209;45be49b468ee935e1ccd04f5c37382c0																			Illumina HiSeq 2000 sequencing: GSM5824032: Esophagus Sample 23 Homo sapiens RNA-Seq							f93c684d014349ccd7c4c76c64b417f7		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/095/SRR17658195/SRR17658195_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/095/SRR17658195/SRR17658195_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/095/SRR17658195																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/095/SRR17658195/SRR17658195_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/095/SRR17658195/SRR17658195_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824032					GSM5824032_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824032_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658195												GSE193946					Esophagus																																													
SRR17658196	SRX13826220	SAMN25078480	PRJNA798444	SRS11705445	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824031: Esophagus Sample 22 Homo sapiens RNA-Seq	Esophagus Sample 22	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 22	GSM5824031	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	53591575	10825498150	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												6884608762.0								4317049938;4241547059	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/096/SRR17658196											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/096/SRR17658196/SRR17658196_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/096/SRR17658196/SRR17658196_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/096/SRR17658196		aec0469ec5e940ecfd2692f8b9ec64f4;6f155446a58d2c2dc8378a976b802ee8																			Illumina HiSeq 2000 sequencing: GSM5824031: Esophagus Sample 22 Homo sapiens RNA-Seq							6a3431202b718eeb2aa767892e7349fb		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/096/SRR17658196/SRR17658196_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/096/SRR17658196/SRR17658196_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/096/SRR17658196																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/096/SRR17658196/SRR17658196_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/096/SRR17658196/SRR17658196_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824031					GSM5824031_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824031_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658196												GSE193946					Esophagus																																													
SRR17658197	SRX13826219	SAMN25078481	PRJNA798444	SRS11705444	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824030: Esophagus Sample 21 Homo sapiens RNA-Seq	Esophagus Sample 21	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 21	GSM5824030	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	44546572	8998407544	Homo sapiens	missing	2022-08-19	2022-10-27	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												5802138699.0								3643032337;3584278503	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/097/SRR17658197											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/097/SRR17658197/SRR17658197_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/097/SRR17658197/SRR17658197_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/097/SRR17658197		900981917c35dcd0625be93ca4423aa5;dd48a0f9c701e8291cfc8626a51bf400																			Illumina HiSeq 2000 sequencing: GSM5824030: Esophagus Sample 21 Homo sapiens RNA-Seq							050ef509f447b4ca5cb349934bb638f4		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/097/SRR17658197/SRR17658197_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/097/SRR17658197/SRR17658197_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/097/SRR17658197																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/097/SRR17658197/SRR17658197_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/097/SRR17658197/SRR17658197_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824030					GSM5824030_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824030_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658197												GSE193946					Esophagus																																													
SRR17658198	SRX13826218	SAMN25078482	PRJNA798444	SRS11705443	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824029: Esophagus Sample 20 Homo sapiens RNA-Seq	Esophagus Sample 20	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 20	GSM5824029	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	54289372	10966453144	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												6978344982.0								4373574953;4303633827	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/098/SRR17658198											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/098/SRR17658198/SRR17658198_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/098/SRR17658198/SRR17658198_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/098/SRR17658198		45a45076d37c2b914b021c983973a48e;94a480ff1c846553a31c403f4b9f785e																			Illumina HiSeq 2000 sequencing: GSM5824029: Esophagus Sample 20 Homo sapiens RNA-Seq							3f84c0bb0705dd94981e100e555ae620		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/098/SRR17658198/SRR17658198_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/098/SRR17658198/SRR17658198_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/098/SRR17658198																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/098/SRR17658198/SRR17658198_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/098/SRR17658198/SRR17658198_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824029					GSM5824029_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824029_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658198												GSE193946					Esophagus																																													
SRR17658199	SRX13826217	SAMN25078483	PRJNA798444	SRS11705442	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824028: Esophagus Sample 19 Homo sapiens RNA-Seq	Esophagus Sample 19	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 19	GSM5824028	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	50423697	10185586794	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												6632927878.0								4151756862;4116279069	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/099/SRR17658199											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/099/SRR17658199/SRR17658199_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/099/SRR17658199/SRR17658199_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/099/SRR17658199		182237f76bad40e3007bf18287f3827a;8c0251ba36b9ee65fb6c24ef31ab9276																			Illumina HiSeq 2000 sequencing: GSM5824028: Esophagus Sample 19 Homo sapiens RNA-Seq							78208a9951ee7f41fe5f370772817622		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/099/SRR17658199/SRR17658199_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/099/SRR17658199/SRR17658199_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/099/SRR17658199																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/099/SRR17658199/SRR17658199_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/099/SRR17658199/SRR17658199_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824028					GSM5824028_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824028_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658199												GSE193946					Esophagus																																													
SRR17658200	SRX13826216	SAMN25078484	PRJNA798444	SRS11705441	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824027: Esophagus Sample 18 Homo sapiens RNA-Seq	Esophagus Sample 18	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 18	GSM5824027	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	47678560	9631069120	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												6236948327.0								3906460287;3866798361	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/000/SRR17658200											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/000/SRR17658200/SRR17658200_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/000/SRR17658200/SRR17658200_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/000/SRR17658200		9c9d87f4f94830c425f53d7b603d555d;83ce5946ee9765c25fd74b3687060ea2																			Illumina HiSeq 2000 sequencing: GSM5824027: Esophagus Sample 18 Homo sapiens RNA-Seq							30b4bd6e212358cdd6804bc4c7359594		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/000/SRR17658200/SRR17658200_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/000/SRR17658200/SRR17658200_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/000/SRR17658200																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/000/SRR17658200/SRR17658200_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/000/SRR17658200/SRR17658200_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824027					GSM5824027_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824027_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658200												GSE193946					Esophagus																																													
SRR17658201	SRX13826215	SAMN25078485	PRJNA798444	SRS11705440	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824026: Esophagus Sample 17 Homo sapiens RNA-Seq	Esophagus Sample 17	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 17	GSM5824026	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	59367326	11992199852	Homo sapiens	missing	2022-08-19	2022-10-29	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												7649625914.0								4790721213;4725458010	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/001/SRR17658201											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/001/SRR17658201/SRR17658201_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/001/SRR17658201/SRR17658201_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/001/SRR17658201		fee2b10dd41c517f3cbd85e33e6519d6;7bcc5fee81c7ea882cd15b346f880d8a																			Illumina HiSeq 2000 sequencing: GSM5824026: Esophagus Sample 17 Homo sapiens RNA-Seq							a01d5aaf37f6916bbeb8df444fb9c4d1		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/001/SRR17658201/SRR17658201_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/001/SRR17658201/SRR17658201_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/001/SRR17658201																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/001/SRR17658201/SRR17658201_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/001/SRR17658201/SRR17658201_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824026					GSM5824026_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824026_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658201												GSE193946					Esophagus																																													
SRR17658202	SRX13826214	SAMN25078486	PRJNA798444	SRS11705439	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824025: Esophagus Sample 16 Homo sapiens RNA-Seq	Esophagus Sample 16	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 16	GSM5824025	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	48329661	9762591522	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												6225667612.0								3895272241;3859867792	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/002/SRR17658202											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/002/SRR17658202/SRR17658202_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/002/SRR17658202/SRR17658202_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/002/SRR17658202		a40d46bc3cc5d503f2ebf792c88fe5ad;8a1fe724fac9a7746ead5fcafde70936																			Illumina HiSeq 2000 sequencing: GSM5824025: Esophagus Sample 16 Homo sapiens RNA-Seq							9b44c0b59f67fbd5a641ef9027241f8c		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/002/SRR17658202/SRR17658202_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/002/SRR17658202/SRR17658202_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/002/SRR17658202																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/002/SRR17658202/SRR17658202_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/002/SRR17658202/SRR17658202_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824025					GSM5824025_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824025_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658202												GSE193946					Esophagus																																													
SRR17658203	SRX13826213	SAMN25078487	PRJNA798444	SRS11705438	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824024: Esophagus Sample 15 Homo sapiens RNA-Seq	Esophagus Sample 15	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 15	GSM5824024	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	55495627	11210116654	Homo sapiens	missing	2022-08-19	2022-10-29	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												7169444878.0								4485279710;4417496249	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/003/SRR17658203											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/003/SRR17658203/SRR17658203_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/003/SRR17658203/SRR17658203_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/003/SRR17658203		f2ff4f2a94643a98e9c8721372483408;6721b6653b29a22d72af5128eadc572f																			Illumina HiSeq 2000 sequencing: GSM5824024: Esophagus Sample 15 Homo sapiens RNA-Seq							4eedace0549c9734516fce0cc1f0254f		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/003/SRR17658203/SRR17658203_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/003/SRR17658203/SRR17658203_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/003/SRR17658203																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/003/SRR17658203/SRR17658203_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/003/SRR17658203/SRR17658203_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824024					GSM5824024_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824024_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658203												GSE193946					Esophagus																																													
SRR17658204	SRX13826212	SAMN25078488	PRJNA798444	SRS11705437	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824023: Esophagus Sample 14 Homo sapiens RNA-Seq	Esophagus Sample 14	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 14	GSM5824023	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	46770507	9447642414	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												6034098625.0								3776844629;3729881570	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/004/SRR17658204											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/004/SRR17658204/SRR17658204_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/004/SRR17658204/SRR17658204_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/004/SRR17658204		ad1acfc4e99518a15f4cda6a32551485;aea20ba76e0e989ab23bd2cba22c0be2																			Illumina HiSeq 2000 sequencing: GSM5824023: Esophagus Sample 14 Homo sapiens RNA-Seq							9b1773af6622087b47faa4d49de79573		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/004/SRR17658204/SRR17658204_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/004/SRR17658204/SRR17658204_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/004/SRR17658204																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/004/SRR17658204/SRR17658204_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/004/SRR17658204/SRR17658204_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824023					GSM5824023_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824023_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658204												GSE193946					Esophagus																																													
SRR17658205	SRX13826211	SAMN25078489	PRJNA798444	SRS11705436	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824022: Esophagus Sample 13 Homo sapiens RNA-Seq	Esophagus Sample 13	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 13	GSM5824022	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	48409989	9778817778	Homo sapiens	missing	2022-08-19	2022-10-29	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												6235396172.0								3916355438;3856029028	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/005/SRR17658205											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/005/SRR17658205/SRR17658205_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/005/SRR17658205/SRR17658205_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/005/SRR17658205		d4e981c5c3af5cc3b9e1120f3eb4b9d3;9121bc8afb15b55fc74c7c5d51af287a																			Illumina HiSeq 2000 sequencing: GSM5824022: Esophagus Sample 13 Homo sapiens RNA-Seq							a7553d9315fb6d2e7b7cc5046fb80959		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/005/SRR17658205/SRR17658205_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/005/SRR17658205/SRR17658205_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/005/SRR17658205																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/005/SRR17658205/SRR17658205_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/005/SRR17658205/SRR17658205_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824022					GSM5824022_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824022_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658205												GSE193946					Esophagus																																													
SRR17658206	SRX13826210	SAMN25078490	PRJNA798444	SRS11705435	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824021: Esophagus Sample 12 Homo sapiens RNA-Seq	Esophagus Sample 12	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 12	GSM5824021	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	47672280	9629800560	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												6023043647.0								3802990294;3697032321	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/006/SRR17658206											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/006/SRR17658206/SRR17658206_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/006/SRR17658206/SRR17658206_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/006/SRR17658206		b7ac7d78cf735e320faa4670afd0e13a;c43633abf0657a7da68407c793901448																			Illumina HiSeq 2000 sequencing: GSM5824021: Esophagus Sample 12 Homo sapiens RNA-Seq							82035fe6b92d5a335d43677e904c0872		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/006/SRR17658206/SRR17658206_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/006/SRR17658206/SRR17658206_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/006/SRR17658206																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/006/SRR17658206/SRR17658206_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/006/SRR17658206/SRR17658206_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824021					GSM5824021_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824021_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658206												GSE193946					Esophagus																																													
SRR17658207	SRX13826209	SAMN25078491	PRJNA798444	SRS11705434	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824020: Esophagus Sample 11 Homo sapiens RNA-Seq	Esophagus Sample 11	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 11	GSM5824020	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	52089837	10522147074	Homo sapiens	missing	2022-08-19	2022-10-29	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												6746508439.0								4205350058;4173231608	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/007/SRR17658207											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/007/SRR17658207/SRR17658207_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/007/SRR17658207/SRR17658207_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/007/SRR17658207		4b36c2e5427aed21d2f7f2e23ae41800;15078308899f347980bbb16934c9bbd3																			Illumina HiSeq 2000 sequencing: GSM5824020: Esophagus Sample 11 Homo sapiens RNA-Seq							9e932f1be02f8216e9fa5fae8faf9057		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/007/SRR17658207/SRR17658207_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/007/SRR17658207/SRR17658207_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/007/SRR17658207																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/007/SRR17658207/SRR17658207_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/007/SRR17658207/SRR17658207_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824020					GSM5824020_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824020_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658207												GSE193946					Esophagus																																													
SRR17658208	SRX13826208	SAMN25078492	PRJNA798444	SRS11705433	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824019: Esophagus Sample 10 Homo sapiens RNA-Seq	Esophagus Sample 10	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 10	GSM5824019	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	64865396	13102809992	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												8485262823.0								5290819693;5267833448	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/008/SRR17658208											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/008/SRR17658208/SRR17658208_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/008/SRR17658208/SRR17658208_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/008/SRR17658208		f4143b3867b18ad803bb5f6a7bc3daed;f0e1546f5de9c8b7272b52cfedf271d9																			Illumina HiSeq 2000 sequencing: GSM5824019: Esophagus Sample 10 Homo sapiens RNA-Seq							17a89f5b201024feabdfc2cfb31d1124		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/008/SRR17658208/SRR17658208_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/008/SRR17658208/SRR17658208_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/008/SRR17658208																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/008/SRR17658208/SRR17658208_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/008/SRR17658208/SRR17658208_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824019					GSM5824019_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824019_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658208												GSE193946					Esophagus																																													
SRR17658209	SRX13826207	SAMN25078493	PRJNA798444	SRS11705432	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824018: Esophagus Sample 9 Homo sapiens RNA-Seq	Esophagus Sample 9	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 9	GSM5824018	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	59521593	12023361786	Homo sapiens	missing	2022-08-19	2022-10-29	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												7697163594.0								4825984610;4758146227	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/009/SRR17658209											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/009/SRR17658209/SRR17658209_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/009/SRR17658209/SRR17658209_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/009/SRR17658209		cdb7f00c9d40e0ebfb362b4c3d2f44c0;e08c92776d6e065e420ce4d558b11608																			Illumina HiSeq 2000 sequencing: GSM5824018: Esophagus Sample 9 Homo sapiens RNA-Seq							b13b31963b3cdb7b4b3928053b80f4aa		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/009/SRR17658209/SRR17658209_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/009/SRR17658209/SRR17658209_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/009/SRR17658209																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/009/SRR17658209/SRR17658209_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/009/SRR17658209/SRR17658209_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824018					GSM5824018_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824018_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658209												GSE193946					Esophagus																																													
SRR17658210	SRX13826206	SAMN25078494	PRJNA798444	SRS11705431	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824017: Esophagus Sample 8 Homo sapiens RNA-Seq	Esophagus Sample 8	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 8	GSM5824017	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	47570786	9609298772	Homo sapiens	missing	2022-08-19	2022-10-27	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												6147929809.0								3848705205;3787965281	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/010/SRR17658210											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/010/SRR17658210/SRR17658210_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/010/SRR17658210/SRR17658210_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/010/SRR17658210		324c2880484e962207f1f380d5d71798;64dc0c6bbd83149c1b1507b7556df794																			Illumina HiSeq 2000 sequencing: GSM5824017: Esophagus Sample 8 Homo sapiens RNA-Seq							5d88e4c33a3439799de8455735157af3		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/010/SRR17658210/SRR17658210_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/010/SRR17658210/SRR17658210_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/010/SRR17658210																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/010/SRR17658210/SRR17658210_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/010/SRR17658210/SRR17658210_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824017					GSM5824017_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824017_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658210												GSE193946					Esophagus																																													
SRR17658211	SRX13826205	SAMN25078495	PRJNA798444	SRS11705430	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824016: Esophagus Sample 7 Homo sapiens RNA-Seq	Esophagus Sample 7	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 7	GSM5824016	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	51628897	10429037194	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												6835151283.0								4261796992;4243986188	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/011/SRR17658211											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/011/SRR17658211/SRR17658211_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/011/SRR17658211/SRR17658211_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/011/SRR17658211		d0b240b24db798d22d620d0e25ccb9b9;ab1dca2a6176a9a4bd70eb5b9921aec0																			Illumina HiSeq 2000 sequencing: GSM5824016: Esophagus Sample 7 Homo sapiens RNA-Seq							47eec7288bab37376a692fd62444b330		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/011/SRR17658211/SRR17658211_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/011/SRR17658211/SRR17658211_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/011/SRR17658211																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/011/SRR17658211/SRR17658211_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/011/SRR17658211/SRR17658211_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824016					GSM5824016_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824016_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658211												GSE193946					Esophagus																																													
SRR17658212	SRX13826204	SAMN25078496	PRJNA798444	SRS11705429	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824015: Esophagus Sample 6 Homo sapiens RNA-Seq	Esophagus Sample 6	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 6	GSM5824015	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	51446467	10392186334	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												6633788100.0								4145699429;4101633047	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/012/SRR17658212											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/012/SRR17658212/SRR17658212_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/012/SRR17658212/SRR17658212_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/012/SRR17658212		d3e547cddc6369d3bbf2ca54848b0d3b;8a63999a6298d079b6b8c70c1a81988f																			Illumina HiSeq 2000 sequencing: GSM5824015: Esophagus Sample 6 Homo sapiens RNA-Seq							2d0ba3e99ca020ed603bb0ca3769ae88		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/012/SRR17658212/SRR17658212_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/012/SRR17658212/SRR17658212_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/012/SRR17658212																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/012/SRR17658212/SRR17658212_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/012/SRR17658212/SRR17658212_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824015					GSM5824015_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824015_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658212												GSE193946					Esophagus																																													
SRR17658213	SRX13826203	SAMN25078497	PRJNA798444	SRS11705428	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824014: Esophagus Sample 5 Homo sapiens RNA-Seq	Esophagus Sample 5	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 5	GSM5824014	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	42947244	8675343288	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												5381577525.0								3418240541;3246729384	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/013/SRR17658213											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/013/SRR17658213/SRR17658213_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/013/SRR17658213/SRR17658213_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/013/SRR17658213		cb8f319bf6ecb418e9fd17170bb4af14;e794973d9365caeed150cd6328cb8ddb																			Illumina HiSeq 2000 sequencing: GSM5824014: Esophagus Sample 5 Homo sapiens RNA-Seq							67f99582f2b583febb4558b2319cbc2f		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/013/SRR17658213/SRR17658213_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/013/SRR17658213/SRR17658213_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/013/SRR17658213																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/013/SRR17658213/SRR17658213_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/013/SRR17658213/SRR17658213_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824014					GSM5824014_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824014_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658213												GSE193946					Esophagus																																													
SRR17658214	SRX13826202	SAMN25078498	PRJNA798444	SRS11705427	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824013: Esophagus Sample 4 Homo sapiens RNA-Seq	Esophagus Sample 4	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 4	GSM5824013	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	52672079	10639759958	Homo sapiens	missing	2022-08-19	2022-10-27	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												6753270987.0								4251482027;4161937925	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/014/SRR17658214											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/014/SRR17658214/SRR17658214_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/014/SRR17658214/SRR17658214_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/014/SRR17658214		9de58d8746e231864e7c84317ba379f9;31aec85b8b18c94d1665807ec34432fe																			Illumina HiSeq 2000 sequencing: GSM5824013: Esophagus Sample 4 Homo sapiens RNA-Seq							e6da7eca9fb5517f53eb157437fef3f4		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/014/SRR17658214/SRR17658214_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/014/SRR17658214/SRR17658214_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/014/SRR17658214																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/014/SRR17658214/SRR17658214_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/014/SRR17658214/SRR17658214_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824013					GSM5824013_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824013_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658214												GSE193946					Esophagus																																													
SRR17658215	SRX13826201	SAMN25078499	PRJNA798444	SRS11705426	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824012: Esophagus Sample 3 Homo sapiens RNA-Seq	Esophagus Sample 3	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 3	GSM5824012	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	64036648	12935402896	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												8259309192.0								5200187016;5094982826	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/015/SRR17658215											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/015/SRR17658215/SRR17658215_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/015/SRR17658215/SRR17658215_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/015/SRR17658215		e7907f546d89d36bf3883899c78263d0;1cdb45c7584b038b43b9ab3b617391d4																			Illumina HiSeq 2000 sequencing: GSM5824012: Esophagus Sample 3 Homo sapiens RNA-Seq							c18d464bb971962aef13ee52e1db5054		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/015/SRR17658215/SRR17658215_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/015/SRR17658215/SRR17658215_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/015/SRR17658215																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/015/SRR17658215/SRR17658215_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/015/SRR17658215/SRR17658215_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824012					GSM5824012_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824012_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658215												GSE193946					Esophagus																																													
SRR17658216	SRX13826200	SAMN25078500	PRJNA798444	SRS11705425	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824011: Esophagus Sample 2 Homo sapiens RNA-Seq	Esophagus Sample 2	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 2	GSM5824011	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	74612660	15071757320	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												9731852028.0								6080856649;6015900083	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/016/SRR17658216											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/016/SRR17658216/SRR17658216_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/016/SRR17658216/SRR17658216_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/016/SRR17658216		c4167c28dc5bae6fcca33a489bd3b806;edfc13c99b2d60eb8e3795564543060b																			Illumina HiSeq 2000 sequencing: GSM5824011: Esophagus Sample 2 Homo sapiens RNA-Seq							e776fd66753f10dda9d3cf59aaf5e0af		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/016/SRR17658216/SRR17658216_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/016/SRR17658216/SRR17658216_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/016/SRR17658216																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/016/SRR17658216/SRR17658216_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/016/SRR17658216/SRR17658216_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824011					GSM5824011_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824011_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658216												GSE193946					Esophagus																																													
SRR17658217	SRX13826199	SAMN25078501	PRJNA798444	SRS11705424	SRP355695			Illumina HiSeq 2000 sequencing: GSM5824010: Esophagus Sample 1 Homo sapiens RNA-Seq	Esophagus Sample 1	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	Esophagus Sample 1	GSM5824010	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2000	61588122	12440800644	Homo sapiens	missing	2022-08-19	2022-10-28	Isoform switching events in Barrett's Esophagus and esophageal adenocarcinoma	SRA1358588					cDNA												7920597055.0								4990911590;4881350318	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR176/017/SRR17658217											ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/017/SRR17658217/SRR17658217_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/017/SRR17658217/SRR17658217_2.fastq.gz							missing	Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR176/017/SRR17658217		23e715e10abba60cb78c3dd0b55f0f25;2037127a6eab25be8de86b0a07a20c04																			Illumina HiSeq 2000 sequencing: GSM5824010: Esophagus Sample 1 Homo sapiens RNA-Seq							10a41c1841478de0ea1c4725a2e44d8a		ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/017/SRR17658217/SRR17658217_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR176/017/SRR17658217/SRR17658217_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR176/017/SRR17658217																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/017/SRR17658217/SRR17658217_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR176/017/SRR17658217/SRR17658217_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5824010					GSM5824010_r1				RNA was isolated using Trizol reagent. RNA libraries were prepared for sequencing using standard Illumina protocols.		GSM5824010_r1							env_tax;env_tax:terrestrial	2022-08-19				9606									SRR17658217												GSE193946					Esophagus																																													
SRR8762209	SRX5553300	SAMN14328155	PRJNA223420	SRS6291160	SRP048907			Illumina HiSeq 2500 paired end sequencing	Neoplasms tumor RNA sample from Esophagus of a human female participant in the dbGaP study University of Michigan Clinical Sequencing Exploratory Research (CSER)	CSER: Exploring Precision Cancer Medicine for Sarcoma and Rare Cancers	Neoplasms tumor RNA sample from Esophagus of a human female participant in the dbGaP study University of Michigan Clinical Sequencing Exploratory Research (CSER)	SI_14457	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	0	0	Homo sapiens		2020-04-30	2020-04-30	Homo sapiens	SRA190841					Hybrid Selection						Protected file(s). Go to dbGap											Protected file(s). Go to dbGap				ILLUMINA						Protected file(s). Go to dbGap						female											Generic																						Illumina HiSeq 2500 paired end sequencing	58.0																																					263.0			public				1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			673-MCTP_SI_14457					HYGWKBCXX_0_MO_1654_MCTP_SI_14457						MO_1654_MCTP_SI_14457		UM-MCTP					env_tax;env_tax:terrestrial	2020-04-30				9606	PROTECTED								SRR8762209												phs000673																																																		
SRR9304310	SRX5552984	SAMN14327421	PRJNA223420	SRS6290887	SRP048907			Illumina HiSeq 2500 paired end sequencing	Neoplasms tumor RNA sample from Esophagus of a human male participant in the dbGaP study University of Michigan Clinical Sequencing Exploratory Research (CSER)	CSER: Exploring Precision Cancer Medicine for Sarcoma and Rare Cancers	Neoplasms tumor RNA sample from Esophagus of a human male participant in the dbGaP study University of Michigan Clinical Sequencing Exploratory Research (CSER)	SI_13334	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	0	0	Homo sapiens		2020-04-30	2020-04-30	Homo sapiens	SRA190841					Hybrid Selection						Protected file(s). Go to dbGap											Protected file(s). Go to dbGap				ILLUMINA						Protected file(s). Go to dbGap						male											Generic																						Illumina HiSeq 2500 paired end sequencing	103.0																																					228.0			public				1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			673-MCTP_SI_13334					HL5FCBCXX_0_TP_2211_MCTP_SI_13334						TP_2211_MCTP_SI_13334		UM-MCTP					env_tax;env_tax:terrestrial	2020-04-30				9606	PROTECTED								SRR9304310												phs000673																																																		
SRR4306272	SRX1909226	SAMN05338791	PRJNA223420	SRS1740197	SRP048907			Illumina HiSeq 2500 paired end sequencing	Neoplasms tumor RNA sample from ESOPHAGUS of a human male participant in the dbGaP study University of Michigan Clinical Sequencing Exploratory Research (CSER)	CSER: Exploring Precision Cancer Medicine for Sarcoma and Rare Cancers	Neoplasms tumor RNA sample from ESOPHAGUS of a human male participant in the dbGaP study University of Michigan Clinical Sequencing Exploratory Research (CSER)	SI_5218	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	0	0	Homo sapiens		2017-07-29	2017-07-29	Homo sapiens	SRA190841					Hybrid Selection						Protected file(s). Go to dbGap											Protected file(s). Go to dbGap				ILLUMINA						Protected file(s). Go to dbGap						male											Generic																						Illumina HiSeq 2500 paired end sequencing	98.0																																					233.0			public				1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			673-MCTP_SI_5218					C0VTLACXX_1_MO_1067_MCTP_SI_5218						MO_1067_MCTP_SI_5218		UM-MCTP					env_tax;env_tax:terrestrial	2017-07-29				9606	PROTECTED								SRR4306272												phs000673																																																		
ERR3728072	ERX3729252	SAMEA6379809	PRJEB35765	ERS4145897	ERP118877			Illumina HiSeq 4000 paired end sequencing: RNA-seq of human Barrett's oesophagus and oesophageal adenocarcinoma samples	B_001	RNA-seq of human Barrett's oesophagus and oesophageal adenocarcinoma samples	Protocols: Barrett's oesophagus and OAC tissue were collected from routine endoscopies and placed into RNALater (Qiagen) and stored at -80degC. Biopsies were minced with a scalpel and RNA was extracted using RNeasy kit (Qiagen). RNA-seq libraries were constructed using Illumina TruSeq Stranded mRNA kit.	B_001_p	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 4000	37322159	11240195658	Homo sapiens		2020-09-30	2019-12-11	RNA-seq of human Barrett's oesophagus and oesophageal adenocarcinoma samples	ERA2316641					Oligo-dT						ftp.sra.ebi.ac.uk/vol1/run/ERR372/ERR3728072/1_R1.fq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR372/ERR3728072/1_R2.fq.gz						4752116643.0					ftp.sra.ebi.ac.uk/vol1/run/ERR372/ERR3728072/1_R1.fq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR372/ERR3728072/1_R2.fq.gz			2939697958;3382344287	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR372/002/ERR3728072		fasp.sra.ebi.ac.uk:/vol1/run/ERR372/ERR3728072/1_R1.fq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR372/ERR3728072/1_R2.fq.gz						female	7979202ffa216752bb7830b62921c3ba;daa94baa244165e5d76124c674199e18	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR372/002/ERR3728072/ERR3728072_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR372/002/ERR3728072/ERR3728072_2.fastq.gz				3168759428;3623520268					ftp.sra.ebi.ac.uk/vol1/err/ERR372/002/ERR3728072		c6e7929e3029ce2db60ccc9c5995dead;73124c72c04f00567f51b60a5cde49c2																			Illumina HiSeq 4000 paired end sequencing: RNA-seq of human Barrett's oesophagus and oesophageal adenocarcinoma samples	25.0						57da466e37434529c93708d894761f2c		ftp.sra.ebi.ac.uk/vol1/fastq/ERR372/002/ERR3728072/ERR3728072_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR372/002/ERR3728072/ERR3728072_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR372/002/ERR3728072											dcc_arrayexpress									150.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR372/002/ERR3728072/ERR3728072_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR372/002/ERR3728072/ERR3728072_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-8584:B_001					E-MTAB-8584:1_R			PAIRED;PAIRED	Barrett's oesophagus and OAC tissue were collected from routine endoscopies and placed into RNALater (Qiagen) and stored at -80degC. Biopsies were minced with a scalpel and RNA was extracted using RNeasy kit (Qiagen). RNA-seq libraries were constructed using Illumina TruSeq Stranded mRNA kit.		E-MTAB-8584:B_001_p		European Bioinformatics Institute;UNIVERSITY OF MANCHESTER			neoplasm		env_tax;env_tax:terrestrial	2019-12-11				9606	FASTQ;FASTQ								ERR3728072												E-MTAB-8584																																																		
ERR3728073	ERX3729253	SAMEA6379810	PRJEB35765	ERS4145898	ERP118877			Illumina HiSeq 4000 paired end sequencing: RNA-seq of human Barrett's oesophagus and oesophageal adenocarcinoma samples	B_002	RNA-seq of human Barrett's oesophagus and oesophageal adenocarcinoma samples	Protocols: Barrett's oesophagus and OAC tissue were collected from routine endoscopies and placed into RNALater (Qiagen) and stored at -80degC. Biopsies were minced with a scalpel and RNA was extracted using RNeasy kit (Qiagen). RNA-seq libraries were constructed using Illumina TruSeq Stranded mRNA kit.	B_002_p	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 4000	50087223	15082891046	Homo sapiens		2020-09-30	2019-12-11	RNA-seq of human Barrett's oesophagus and oesophageal adenocarcinoma samples	ERA2316641					Oligo-dT						ftp.sra.ebi.ac.uk/vol1/run/ERR372/ERR3728073/2_R1.fq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR372/ERR3728073/2_R2.fq.gz						6397334122.0					ftp.sra.ebi.ac.uk/vol1/run/ERR372/ERR3728073/2_R1.fq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR372/ERR3728073/2_R2.fq.gz			4052673158;4619116858	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR372/003/ERR3728073		fasp.sra.ebi.ac.uk:/vol1/run/ERR372/ERR3728073/2_R1.fq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR372/ERR3728073/2_R2.fq.gz						male	477157167171ec73d54ecae11d4856d0;1a9052273d211ba614e07dcca92899a4	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR372/003/ERR3728073/ERR3728073_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR372/003/ERR3728073/ERR3728073_2.fastq.gz				4304647175;4891047252					ftp.sra.ebi.ac.uk/vol1/err/ERR372/003/ERR3728073		fda31e9f53e96840b6d966bf247d18e5;67128d340cfecea426cf38669c05cf65																			Illumina HiSeq 4000 paired end sequencing: RNA-seq of human Barrett's oesophagus and oesophageal adenocarcinoma samples	25.0						a7b5e81b5dfa51996ad11c2b5b796d3c		ftp.sra.ebi.ac.uk/vol1/fastq/ERR372/003/ERR3728073/ERR3728073_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR372/003/ERR3728073/ERR3728073_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR372/003/ERR3728073											dcc_arrayexpress									150.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR372/003/ERR3728073/ERR3728073_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR372/003/ERR3728073/ERR3728073_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-8584:B_002					E-MTAB-8584:2_R			PAIRED;PAIRED	Barrett's oesophagus and OAC tissue were collected from routine endoscopies and placed into RNALater (Qiagen) and stored at -80degC. Biopsies were minced with a scalpel and RNA was extracted using RNeasy kit (Qiagen). RNA-seq libraries were constructed using Illumina TruSeq Stranded mRNA kit.		E-MTAB-8584:B_002_p		European Bioinformatics Institute;UNIVERSITY OF MANCHESTER			neoplasm		env_tax;env_tax:terrestrial	2019-12-11				9606	FASTQ;FASTQ								ERR3728073												E-MTAB-8584																																																		
ERR3728074	ERX3729254	SAMEA6379811	PRJEB35765	ERS4145899	ERP118877			Illumina HiSeq 4000 paired end sequencing: RNA-seq of human Barrett's oesophagus and oesophageal adenocarcinoma samples	B_004	RNA-seq of human Barrett's oesophagus and oesophageal adenocarcinoma samples	Protocols: Barrett's oesophagus and OAC tissue were collected from routine endoscopies and placed into RNALater (Qiagen) and stored at -80degC. Biopsies were minced with a scalpel and RNA was extracted using RNeasy kit (Qiagen). RNA-seq libraries were constructed using Illumina TruSeq Stranded mRNA kit.	B_004_p	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 4000	42044596	12661565424	Homo sapiens		2020-09-30	2019-12-11	RNA-seq of human Barrett's oesophagus and oesophageal adenocarcinoma samples	ERA2316641					Oligo-dT						ftp.sra.ebi.ac.uk/vol1/run/ERR372/ERR3728074/4_R1.fq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR372/ERR3728074/4_R2.fq.gz						5377156848.0					ftp.sra.ebi.ac.uk/vol1/run/ERR372/ERR3728074/4_R1.fq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR372/ERR3728074/4_R2.fq.gz			3396207272;3881212426	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR372/004/ERR3728074		fasp.sra.ebi.ac.uk:/vol1/run/ERR372/ERR3728074/4_R1.fq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR372/ERR3728074/4_R2.fq.gz						female	5a709d39a6ba4a31848c8b13132f80d2;77ff78b10d94da35a9abfded8250a25f	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR372/004/ERR3728074/ERR3728074_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR372/004/ERR3728074/ERR3728074_2.fastq.gz				3615463547;4118148975					ftp.sra.ebi.ac.uk/vol1/err/ERR372/004/ERR3728074		a1651a4ca6057ec849728b156a190b0b;d8e5cdaab55a010d2b3ad8fa900176ba																			Illumina HiSeq 4000 paired end sequencing: RNA-seq of human Barrett's oesophagus and oesophageal adenocarcinoma samples	25.0						fb67c442f72c2c96d427a4463a0b034b		ftp.sra.ebi.ac.uk/vol1/fastq/ERR372/004/ERR3728074/ERR3728074_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR372/004/ERR3728074/ERR3728074_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR372/004/ERR3728074											dcc_arrayexpress									150.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR372/004/ERR3728074/ERR3728074_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR372/004/ERR3728074/ERR3728074_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-8584:B_004					E-MTAB-8584:4_R			PAIRED;PAIRED	Barrett's oesophagus and OAC tissue were collected from routine endoscopies and placed into RNALater (Qiagen) and stored at -80degC. Biopsies were minced with a scalpel and RNA was extracted using RNeasy kit (Qiagen). RNA-seq libraries were constructed using Illumina TruSeq Stranded mRNA kit.		E-MTAB-8584:B_004_p		European Bioinformatics Institute;UNIVERSITY OF MANCHESTER			neoplasm		env_tax;env_tax:terrestrial	2019-12-11				9606	FASTQ;FASTQ								ERR3728074												E-MTAB-8584																																																		
ERR3728075	ERX3729255	SAMEA6379812	PRJEB35765	ERS4145900	ERP118877			NextSeq 500 paired end sequencing: RNA-seq of human Barrett's oesophagus and oesophageal adenocarcinoma samples	T_002	RNA-seq of human Barrett's oesophagus and oesophageal adenocarcinoma samples	Protocols: Barrett's oesophagus and OAC tissue were collected from routine endoscopies and placed into RNALater (Qiagen) and stored at -80degC. Biopsies were minced with a scalpel and RNA was extracted using RNeasy kit (Qiagen). RNA-seq libraries were constructed using Illumina TruSeq Stranded mRNA kit.	T_002_p	RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	24139643	3642841435	Homo sapiens		2020-09-30	2019-12-11	RNA-seq of human Barrett's oesophagus and oesophageal adenocarcinoma samples	ERA2316641					Oligo-dT						ftp.sra.ebi.ac.uk/vol1/run/ERR372/ERR3728075/14_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR372/ERR3728075/14_R2.fastq.gz						1481113548.0					ftp.sra.ebi.ac.uk/vol1/run/ERR372/ERR3728075/14_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR372/ERR3728075/14_R2.fastq.gz			1098682485;1153307000	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR372/005/ERR3728075		fasp.sra.ebi.ac.uk:/vol1/run/ERR372/ERR3728075/14_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR372/ERR3728075/14_R2.fastq.gz						male	894f8350b8387a2338c59e33edb419df;84c75dda72e114846b46067b423f92ec	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR372/005/ERR3728075/ERR3728075_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR372/005/ERR3728075/ERR3728075_2.fastq.gz				1170725662;1220867787					ftp.sra.ebi.ac.uk/vol1/err/ERR372/005/ERR3728075		28de8a23263d7d22d123968a57b601d2;57dc69a6a5acfe998c17fbb3ab0f6dda																			NextSeq 500 paired end sequencing: RNA-seq of human Barrett's oesophagus and oesophageal adenocarcinoma samples	25.0						5d27e317daa82d43fecd4a2e9ddb64e9		ftp.sra.ebi.ac.uk/vol1/fastq/ERR372/005/ERR3728075/ERR3728075_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR372/005/ERR3728075/ERR3728075_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR372/005/ERR3728075											dcc_arrayexpress									150.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR372/005/ERR3728075/ERR3728075_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR372/005/ERR3728075/ERR3728075_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-8584:T_002					E-MTAB-8584:14_R			PAIRED;PAIRED	Barrett's oesophagus and OAC tissue were collected from routine endoscopies and placed into RNALater (Qiagen) and stored at -80degC. Biopsies were minced with a scalpel and RNA was extracted using RNeasy kit (Qiagen). RNA-seq libraries were constructed using Illumina TruSeq Stranded mRNA kit.		E-MTAB-8584:T_002_p		European Bioinformatics Institute;UNIVERSITY OF MANCHESTER			neoplasm		env_tax;env_tax:terrestrial	2019-12-11				9606	FASTQ;FASTQ								ERR3728075												E-MTAB-8584																																																		
ERR3728076	ERX3729256	SAMEA6379813	PRJEB35765	ERS4145901	ERP118877			NextSeq 500 paired end sequencing: RNA-seq of human Barrett's oesophagus and oesophageal adenocarcinoma samples	T_003	RNA-seq of human Barrett's oesophagus and oesophageal adenocarcinoma samples	Protocols: Barrett's oesophagus and OAC tissue were collected from routine endoscopies and placed into RNALater (Qiagen) and stored at -80degC. Biopsies were minced with a scalpel and RNA was extracted using RNeasy kit (Qiagen). RNA-seq libraries were constructed using Illumina TruSeq Stranded mRNA kit.	T_003_p	RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	23282226	3513820868	Homo sapiens		2020-09-30	2019-12-11	RNA-seq of human Barrett's oesophagus and oesophageal adenocarcinoma samples	ERA2316641					Oligo-dT						ftp.sra.ebi.ac.uk/vol1/run/ERR372/ERR3728076/15_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR372/ERR3728076/15_R2.fastq.gz						1396652097.0					ftp.sra.ebi.ac.uk/vol1/run/ERR372/ERR3728076/15_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR372/ERR3728076/15_R2.fastq.gz			1044428689;1099474440	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR372/006/ERR3728076		fasp.sra.ebi.ac.uk:/vol1/run/ERR372/ERR3728076/15_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR372/ERR3728076/15_R2.fastq.gz						male	e72dac9ae51f41a7713623fac78d67ed;5c849a85bb8b91b8c08027ec7382c893	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR372/006/ERR3728076/ERR3728076_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR372/006/ERR3728076/ERR3728076_2.fastq.gz				1106665414;1158922814					ftp.sra.ebi.ac.uk/vol1/err/ERR372/006/ERR3728076		5b22296ea35e357247239c29cd59af44;199f9ced46d768692bd032d272b1dca3																			NextSeq 500 paired end sequencing: RNA-seq of human Barrett's oesophagus and oesophageal adenocarcinoma samples	25.0						5aabf856ec9ab06bd5733b0cd1b76580		ftp.sra.ebi.ac.uk/vol1/fastq/ERR372/006/ERR3728076/ERR3728076_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR372/006/ERR3728076/ERR3728076_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR372/006/ERR3728076											dcc_arrayexpress									150.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR372/006/ERR3728076/ERR3728076_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR372/006/ERR3728076/ERR3728076_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-8584:T_003					E-MTAB-8584:15_R			PAIRED;PAIRED	Barrett's oesophagus and OAC tissue were collected from routine endoscopies and placed into RNALater (Qiagen) and stored at -80degC. Biopsies were minced with a scalpel and RNA was extracted using RNeasy kit (Qiagen). RNA-seq libraries were constructed using Illumina TruSeq Stranded mRNA kit.		E-MTAB-8584:T_003_p		European Bioinformatics Institute;UNIVERSITY OF MANCHESTER			neoplasm		env_tax;env_tax:terrestrial	2019-12-11				9606	FASTQ;FASTQ								ERR3728076												E-MTAB-8584																																																		
SRR22957189	SRX18913982	SAMN32543533	PRJNA917632	SRS16341796	SRP415592			NextSeq 500 sequencing: GSM6914628: s7, scRNAseq Homo sapiens RNA-Seq	s7, scRNAseq	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	s7, scRNAseq	GSM6914628	RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	18006587	1620592830	Homo sapiens		2023-03-01	2023-03-14	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	SRA1568393					cDNA												995706620.0								937594102	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR229/089/SRR22957189											ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/089/SRR22957189/SRR22957189.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR229/089/SRR22957189		5b78c5b10650f9fb23b71f955b1bf754																			NextSeq 500 sequencing: GSM6914628: s7, scRNAseq Homo sapiens RNA-Seq							23c4a388162d061bad86c5cc204ca613	Mixed	ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/089/SRR22957189/SRR22957189.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR229/089/SRR22957189																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR229/089/SRR22957189/SRR22957189.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM6914628					GSM6914628_r1				PI was added prior to sorting to exclude non-viable cells. Live CD45+ and CD45- populations were sorted and adjusted to 1 x 103/ml. Samples with >85% cell viability were processed at the Genomics Birmingham Sequencing Facility (University of Birmingham, UK) for gene expression profiling using the 10X Genomics platform. Around 1.7 x 104 cells per sample were processed using the Chromium Controller (10X Genomics) for a recovery of 1 x 104 cells per sample, and library preparation was performed using the Chromium Single Cell 3 Library & Gel Bead Kit v2 according to manufacturer's instructions. Library quantification and quality control was performed using TapeStation (Agilent). Samples were sequenced on an Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell. Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell.		GSM6914628_r1							env_tax;env_tax:terrestrial	2023-03-01				9606									SRR22957189												GSE222078					Adjacent normal Esophagus																																													
SRR22957190	SRX18913982	SAMN32543533	PRJNA917632	SRS16341796	SRP415592			NextSeq 500 sequencing: GSM6914628: s7, scRNAseq Homo sapiens RNA-Seq	s7, scRNAseq	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	s7, scRNAseq	GSM6914628	RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	19846760	1786208400	Homo sapiens		2023-03-01	2023-03-16	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	SRA1568393					cDNA												1124823791.0								1058406675	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR229/090/SRR22957190											ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/090/SRR22957190/SRR22957190.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR229/090/SRR22957190		9b2e5ce15ee9eee5854751334527c956																			NextSeq 500 sequencing: GSM6914628: s7, scRNAseq Homo sapiens RNA-Seq							b2418223fd00288f16aebe4a47351212	Mixed	ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/090/SRR22957190/SRR22957190.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR229/090/SRR22957190																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR229/090/SRR22957190/SRR22957190.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM6914628					GSM6914628_r10				PI was added prior to sorting to exclude non-viable cells. Live CD45+ and CD45- populations were sorted and adjusted to 1 x 103/ml. Samples with >85% cell viability were processed at the Genomics Birmingham Sequencing Facility (University of Birmingham, UK) for gene expression profiling using the 10X Genomics platform. Around 1.7 x 104 cells per sample were processed using the Chromium Controller (10X Genomics) for a recovery of 1 x 104 cells per sample, and library preparation was performed using the Chromium Single Cell 3 Library & Gel Bead Kit v2 according to manufacturer's instructions. Library quantification and quality control was performed using TapeStation (Agilent). Samples were sequenced on an Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell. Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell.		GSM6914628_r1							env_tax;env_tax:terrestrial	2023-03-01				9606									SRR22957190												GSE222078					Adjacent normal Esophagus																																													
SRR22957191	SRX18913982	SAMN32543533	PRJNA917632	SRS16341796	SRP415592			NextSeq 500 sequencing: GSM6914628: s7, scRNAseq Homo sapiens RNA-Seq	s7, scRNAseq	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	s7, scRNAseq	GSM6914628	RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	20259521	1823356890	Homo sapiens		2023-03-01	2023-03-14	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	SRA1568393					cDNA												1154571158.0								1087463985	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR229/091/SRR22957191											ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/091/SRR22957191/SRR22957191.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR229/091/SRR22957191		d9b8d01e5eca7fc58f4738f8661dd4f4																			NextSeq 500 sequencing: GSM6914628: s7, scRNAseq Homo sapiens RNA-Seq							e9357c3f6254e7644556b894e7c0c3ec	Mixed	ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/091/SRR22957191/SRR22957191.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR229/091/SRR22957191																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR229/091/SRR22957191/SRR22957191.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM6914628					GSM6914628_r11				PI was added prior to sorting to exclude non-viable cells. Live CD45+ and CD45- populations were sorted and adjusted to 1 x 103/ml. Samples with >85% cell viability were processed at the Genomics Birmingham Sequencing Facility (University of Birmingham, UK) for gene expression profiling using the 10X Genomics platform. Around 1.7 x 104 cells per sample were processed using the Chromium Controller (10X Genomics) for a recovery of 1 x 104 cells per sample, and library preparation was performed using the Chromium Single Cell 3 Library & Gel Bead Kit v2 according to manufacturer's instructions. Library quantification and quality control was performed using TapeStation (Agilent). Samples were sequenced on an Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell. Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell.		GSM6914628_r1							env_tax;env_tax:terrestrial	2023-03-01				9606									SRR22957191												GSE222078					Adjacent normal Esophagus																																													
SRR22957192	SRX18913982	SAMN32543533	PRJNA917632	SRS16341796	SRP415592			NextSeq 500 sequencing: GSM6914628: s7, scRNAseq Homo sapiens RNA-Seq	s7, scRNAseq	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	s7, scRNAseq	GSM6914628	RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	20134277	1812084930	Homo sapiens		2023-03-01	2023-03-14	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	SRA1568393					cDNA												1146221108.0								1078935591	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR229/092/SRR22957192											ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/092/SRR22957192/SRR22957192.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR229/092/SRR22957192		5d1df04338374926bcd2475bb47486f9																			NextSeq 500 sequencing: GSM6914628: s7, scRNAseq Homo sapiens RNA-Seq							bf9490f73931f92879b6411494b6025b	Mixed	ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/092/SRR22957192/SRR22957192.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR229/092/SRR22957192																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR229/092/SRR22957192/SRR22957192.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM6914628					GSM6914628_r12				PI was added prior to sorting to exclude non-viable cells. Live CD45+ and CD45- populations were sorted and adjusted to 1 x 103/ml. Samples with >85% cell viability were processed at the Genomics Birmingham Sequencing Facility (University of Birmingham, UK) for gene expression profiling using the 10X Genomics platform. Around 1.7 x 104 cells per sample were processed using the Chromium Controller (10X Genomics) for a recovery of 1 x 104 cells per sample, and library preparation was performed using the Chromium Single Cell 3 Library & Gel Bead Kit v2 according to manufacturer's instructions. Library quantification and quality control was performed using TapeStation (Agilent). Samples were sequenced on an Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell. Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell.		GSM6914628_r1							env_tax;env_tax:terrestrial	2023-03-01				9606									SRR22957192												GSE222078					Adjacent normal Esophagus																																													
SRR22957193	SRX18913982	SAMN32543533	PRJNA917632	SRS16341796	SRP415592			NextSeq 500 sequencing: GSM6914628: s7, scRNAseq Homo sapiens RNA-Seq	s7, scRNAseq	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	s7, scRNAseq	GSM6914628	RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	17768488	1599163920	Homo sapiens		2023-03-01	2023-03-14	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	SRA1568393					cDNA												982153606.0								924462748	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR229/093/SRR22957193											ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/093/SRR22957193/SRR22957193.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR229/093/SRR22957193		4fd329d7de625bd300a76f5b789f5efc																			NextSeq 500 sequencing: GSM6914628: s7, scRNAseq Homo sapiens RNA-Seq							59e62e2c21af9f41f222498cef18a953	Mixed	ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/093/SRR22957193/SRR22957193.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR229/093/SRR22957193																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR229/093/SRR22957193/SRR22957193.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM6914628					GSM6914628_r2				PI was added prior to sorting to exclude non-viable cells. Live CD45+ and CD45- populations were sorted and adjusted to 1 x 103/ml. Samples with >85% cell viability were processed at the Genomics Birmingham Sequencing Facility (University of Birmingham, UK) for gene expression profiling using the 10X Genomics platform. Around 1.7 x 104 cells per sample were processed using the Chromium Controller (10X Genomics) for a recovery of 1 x 104 cells per sample, and library preparation was performed using the Chromium Single Cell 3 Library & Gel Bead Kit v2 according to manufacturer's instructions. Library quantification and quality control was performed using TapeStation (Agilent). Samples were sequenced on an Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell. Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell.		GSM6914628_r1							env_tax;env_tax:terrestrial	2023-03-01				9606									SRR22957193												GSE222078					Adjacent normal Esophagus																																													
SRR22957194	SRX18913982	SAMN32543533	PRJNA917632	SRS16341796	SRP415592			NextSeq 500 sequencing: GSM6914628: s7, scRNAseq Homo sapiens RNA-Seq	s7, scRNAseq	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	s7, scRNAseq	GSM6914628	RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	18200034	1638003060	Homo sapiens		2023-03-01	2023-03-14	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	SRA1568393					cDNA												1011537462.0								953053816	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR229/094/SRR22957194											ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/094/SRR22957194/SRR22957194.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR229/094/SRR22957194		2101cedc355c28d26dbf19b35f71d729																			NextSeq 500 sequencing: GSM6914628: s7, scRNAseq Homo sapiens RNA-Seq							62a9116925f2f5c1776a136b9bc24d3b	Mixed	ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/094/SRR22957194/SRR22957194.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR229/094/SRR22957194																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR229/094/SRR22957194/SRR22957194.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM6914628					GSM6914628_r3				PI was added prior to sorting to exclude non-viable cells. Live CD45+ and CD45- populations were sorted and adjusted to 1 x 103/ml. Samples with >85% cell viability were processed at the Genomics Birmingham Sequencing Facility (University of Birmingham, UK) for gene expression profiling using the 10X Genomics platform. Around 1.7 x 104 cells per sample were processed using the Chromium Controller (10X Genomics) for a recovery of 1 x 104 cells per sample, and library preparation was performed using the Chromium Single Cell 3 Library & Gel Bead Kit v2 according to manufacturer's instructions. Library quantification and quality control was performed using TapeStation (Agilent). Samples were sequenced on an Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell. Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell.		GSM6914628_r1							env_tax;env_tax:terrestrial	2023-03-01				9606									SRR22957194												GSE222078					Adjacent normal Esophagus																																													
SRR22957195	SRX18913982	SAMN32543533	PRJNA917632	SRS16341796	SRP415592			NextSeq 500 sequencing: GSM6914628: s7, scRNAseq Homo sapiens RNA-Seq	s7, scRNAseq	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	s7, scRNAseq	GSM6914628	RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	17908448	1611760320	Homo sapiens		2023-03-01	2023-03-16	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	SRA1568393					cDNA												992565453.0								934173564	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR229/095/SRR22957195											ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/095/SRR22957195/SRR22957195.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR229/095/SRR22957195		eb92f448f9497280b045a93ce83136ef																			NextSeq 500 sequencing: GSM6914628: s7, scRNAseq Homo sapiens RNA-Seq							1bf28b78729566dd8e18ff1d0930036c	Mixed	ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/095/SRR22957195/SRR22957195.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR229/095/SRR22957195																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR229/095/SRR22957195/SRR22957195.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM6914628					GSM6914628_r4				PI was added prior to sorting to exclude non-viable cells. Live CD45+ and CD45- populations were sorted and adjusted to 1 x 103/ml. Samples with >85% cell viability were processed at the Genomics Birmingham Sequencing Facility (University of Birmingham, UK) for gene expression profiling using the 10X Genomics platform. Around 1.7 x 104 cells per sample were processed using the Chromium Controller (10X Genomics) for a recovery of 1 x 104 cells per sample, and library preparation was performed using the Chromium Single Cell 3 Library & Gel Bead Kit v2 according to manufacturer's instructions. Library quantification and quality control was performed using TapeStation (Agilent). Samples were sequenced on an Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell. Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell.		GSM6914628_r1							env_tax;env_tax:terrestrial	2023-03-01				9606									SRR22957195												GSE222078					Adjacent normal Esophagus																																													
SRR22957196	SRX18913982	SAMN32543533	PRJNA917632	SRS16341796	SRP415592			NextSeq 500 sequencing: GSM6914628: s7, scRNAseq Homo sapiens RNA-Seq	s7, scRNAseq	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	s7, scRNAseq	GSM6914628	RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	20147762	1813298580	Homo sapiens		2023-03-01	2023-03-14	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	SRA1568393					cDNA												1113981136.0								1047473216	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR229/096/SRR22957196											ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/096/SRR22957196/SRR22957196.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR229/096/SRR22957196		30ea44a912d6ca449910f62e5ad8e477																			NextSeq 500 sequencing: GSM6914628: s7, scRNAseq Homo sapiens RNA-Seq							2690a7c90cb061e34e7f0d6ca79f85db	Mixed	ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/096/SRR22957196/SRR22957196.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR229/096/SRR22957196																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR229/096/SRR22957196/SRR22957196.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM6914628					GSM6914628_r5				PI was added prior to sorting to exclude non-viable cells. Live CD45+ and CD45- populations were sorted and adjusted to 1 x 103/ml. Samples with >85% cell viability were processed at the Genomics Birmingham Sequencing Facility (University of Birmingham, UK) for gene expression profiling using the 10X Genomics platform. Around 1.7 x 104 cells per sample were processed using the Chromium Controller (10X Genomics) for a recovery of 1 x 104 cells per sample, and library preparation was performed using the Chromium Single Cell 3 Library & Gel Bead Kit v2 according to manufacturer's instructions. Library quantification and quality control was performed using TapeStation (Agilent). Samples were sequenced on an Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell. Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell.		GSM6914628_r1							env_tax;env_tax:terrestrial	2023-03-01				9606									SRR22957196												GSE222078					Adjacent normal Esophagus																																													
SRR22957197	SRX18913982	SAMN32543533	PRJNA917632	SRS16341796	SRP415592			NextSeq 500 sequencing: GSM6914628: s7, scRNAseq Homo sapiens RNA-Seq	s7, scRNAseq	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	s7, scRNAseq	GSM6914628	RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	20039588	1803562920	Homo sapiens		2023-03-01	2023-03-14	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	SRA1568393					cDNA												1110967200.0								1044234335	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR229/097/SRR22957197											ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/097/SRR22957197/SRR22957197.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR229/097/SRR22957197		c74a84f03b82f60d1018ab3f51d63b34																			NextSeq 500 sequencing: GSM6914628: s7, scRNAseq Homo sapiens RNA-Seq							ab54959b512b20f64ab95a43a24bbb7d	Mixed	ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/097/SRR22957197/SRR22957197.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR229/097/SRR22957197																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR229/097/SRR22957197/SRR22957197.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM6914628					GSM6914628_r6				PI was added prior to sorting to exclude non-viable cells. Live CD45+ and CD45- populations were sorted and adjusted to 1 x 103/ml. Samples with >85% cell viability were processed at the Genomics Birmingham Sequencing Facility (University of Birmingham, UK) for gene expression profiling using the 10X Genomics platform. Around 1.7 x 104 cells per sample were processed using the Chromium Controller (10X Genomics) for a recovery of 1 x 104 cells per sample, and library preparation was performed using the Chromium Single Cell 3 Library & Gel Bead Kit v2 according to manufacturer's instructions. Library quantification and quality control was performed using TapeStation (Agilent). Samples were sequenced on an Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell. Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell.		GSM6914628_r1							env_tax;env_tax:terrestrial	2023-03-01				9606									SRR22957197												GSE222078					Adjacent normal Esophagus																																													
SRR22957198	SRX18913982	SAMN32543533	PRJNA917632	SRS16341796	SRP415592			NextSeq 500 sequencing: GSM6914628: s7, scRNAseq Homo sapiens RNA-Seq	s7, scRNAseq	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	s7, scRNAseq	GSM6914628	RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	20352080	1831687200	Homo sapiens		2023-03-01	2023-03-16	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	SRA1568393					cDNA												1130411870.0								1062733169	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR229/098/SRR22957198											ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/098/SRR22957198/SRR22957198.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR229/098/SRR22957198		f4bffc9c77d25051688cf72668fbf3a7																			NextSeq 500 sequencing: GSM6914628: s7, scRNAseq Homo sapiens RNA-Seq							36deaf1ed52e81594a5ea50964785fab	Mixed	ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/098/SRR22957198/SRR22957198.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR229/098/SRR22957198																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR229/098/SRR22957198/SRR22957198.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM6914628					GSM6914628_r7				PI was added prior to sorting to exclude non-viable cells. Live CD45+ and CD45- populations were sorted and adjusted to 1 x 103/ml. Samples with >85% cell viability were processed at the Genomics Birmingham Sequencing Facility (University of Birmingham, UK) for gene expression profiling using the 10X Genomics platform. Around 1.7 x 104 cells per sample were processed using the Chromium Controller (10X Genomics) for a recovery of 1 x 104 cells per sample, and library preparation was performed using the Chromium Single Cell 3 Library & Gel Bead Kit v2 according to manufacturer's instructions. Library quantification and quality control was performed using TapeStation (Agilent). Samples were sequenced on an Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell. Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell.		GSM6914628_r1							env_tax;env_tax:terrestrial	2023-03-01				9606									SRR22957198												GSE222078					Adjacent normal Esophagus																																													
SRR22957199	SRX18913982	SAMN32543533	PRJNA917632	SRS16341796	SRP415592			NextSeq 500 sequencing: GSM6914628: s7, scRNAseq Homo sapiens RNA-Seq	s7, scRNAseq	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	s7, scRNAseq	GSM6914628	RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	20321575	1828941750	Homo sapiens		2023-03-01	2023-03-14	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	SRA1568393					cDNA												1128151827.0								1060266323	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR229/099/SRR22957199											ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/099/SRR22957199/SRR22957199.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR229/099/SRR22957199		b6fea6130581d4d84768f98d99fd9d44																			NextSeq 500 sequencing: GSM6914628: s7, scRNAseq Homo sapiens RNA-Seq							c53cfd1ffd6303468a4cf9303c8e280e	Mixed	ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/099/SRR22957199/SRR22957199.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR229/099/SRR22957199																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR229/099/SRR22957199/SRR22957199.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM6914628					GSM6914628_r8				PI was added prior to sorting to exclude non-viable cells. Live CD45+ and CD45- populations were sorted and adjusted to 1 x 103/ml. Samples with >85% cell viability were processed at the Genomics Birmingham Sequencing Facility (University of Birmingham, UK) for gene expression profiling using the 10X Genomics platform. Around 1.7 x 104 cells per sample were processed using the Chromium Controller (10X Genomics) for a recovery of 1 x 104 cells per sample, and library preparation was performed using the Chromium Single Cell 3 Library & Gel Bead Kit v2 according to manufacturer's instructions. Library quantification and quality control was performed using TapeStation (Agilent). Samples were sequenced on an Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell. Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell.		GSM6914628_r1							env_tax;env_tax:terrestrial	2023-03-01				9606									SRR22957199												GSE222078					Adjacent normal Esophagus																																													
SRR22957200	SRX18913982	SAMN32543533	PRJNA917632	SRS16341796	SRP415592			NextSeq 500 sequencing: GSM6914628: s7, scRNAseq Homo sapiens RNA-Seq	s7, scRNAseq	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	s7, scRNAseq	GSM6914628	RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	19866034	1787943060	Homo sapiens		2023-03-01	2023-03-16	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	SRA1568393					cDNA												1125567386.0								1059542285	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR229/000/SRR22957200											ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/000/SRR22957200/SRR22957200.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR229/000/SRR22957200		8adca87bb360fc4283c0aecc5d1c2fca																			NextSeq 500 sequencing: GSM6914628: s7, scRNAseq Homo sapiens RNA-Seq							8f6f4c91c7166b8a76a7eab9cfbf29fe	Mixed	ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/000/SRR22957200/SRR22957200.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR229/000/SRR22957200																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR229/000/SRR22957200/SRR22957200.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM6914628					GSM6914628_r9				PI was added prior to sorting to exclude non-viable cells. Live CD45+ and CD45- populations were sorted and adjusted to 1 x 103/ml. Samples with >85% cell viability were processed at the Genomics Birmingham Sequencing Facility (University of Birmingham, UK) for gene expression profiling using the 10X Genomics platform. Around 1.7 x 104 cells per sample were processed using the Chromium Controller (10X Genomics) for a recovery of 1 x 104 cells per sample, and library preparation was performed using the Chromium Single Cell 3 Library & Gel Bead Kit v2 according to manufacturer's instructions. Library quantification and quality control was performed using TapeStation (Agilent). Samples were sequenced on an Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell. Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell.		GSM6914628_r1							env_tax;env_tax:terrestrial	2023-03-01				9606									SRR22957200												GSE222078					Adjacent normal Esophagus																																													
SRR22957247	SRX18913985	SAMN32543531	PRJNA917632	SRS16341799	SRP415592			NextSeq 500 sequencing: GSM6914630: s9, scRNAseq Homo sapiens RNA-Seq	s9, scRNAseq	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	s9, scRNAseq	GSM6914630	RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	18994851	1709536590	Homo sapiens		2023-03-01	2023-03-14	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	SRA1568393					cDNA												1043284559.0								896014590	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR229/047/SRR22957247											ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/047/SRR22957247/SRR22957247.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR229/047/SRR22957247		52bd30999b41a6b8116c2bcbdee05616																			NextSeq 500 sequencing: GSM6914630: s9, scRNAseq Homo sapiens RNA-Seq							974bda91a678689812be2c40a0baa521	Mixed	ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/047/SRR22957247/SRR22957247.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR229/047/SRR22957247																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR229/047/SRR22957247/SRR22957247.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM6914630					GSM6914630_r1				PI was added prior to sorting to exclude non-viable cells. Live CD45+ and CD45- populations were sorted and adjusted to 1 x 103/ml. Samples with >85% cell viability were processed at the Genomics Birmingham Sequencing Facility (University of Birmingham, UK) for gene expression profiling using the 10X Genomics platform. Around 1.7 x 104 cells per sample were processed using the Chromium Controller (10X Genomics) for a recovery of 1 x 104 cells per sample, and library preparation was performed using the Chromium Single Cell 3 Library & Gel Bead Kit v2 according to manufacturer's instructions. Library quantification and quality control was performed using TapeStation (Agilent). Samples were sequenced on an Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell. Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell.		GSM6914630_r1							env_tax;env_tax:terrestrial	2023-03-01				9606									SRR22957247												GSE222078					Adjacent normal Esophagus																																													
SRR22957248	SRX18913985	SAMN32543531	PRJNA917632	SRS16341799	SRP415592			NextSeq 500 sequencing: GSM6914630: s9, scRNAseq Homo sapiens RNA-Seq	s9, scRNAseq	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	s9, scRNAseq	GSM6914630	RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	20746125	1867151250	Homo sapiens		2023-03-01	2023-03-16	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	SRA1568393					cDNA												1167058268.0								1004818207	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR229/048/SRR22957248											ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/048/SRR22957248/SRR22957248.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR229/048/SRR22957248		ba8459d4fe6cd3707253cdf37236a4a6																			NextSeq 500 sequencing: GSM6914630: s9, scRNAseq Homo sapiens RNA-Seq							461348e8ec248a5a3da2839ae2a4f77a	Mixed	ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/048/SRR22957248/SRR22957248.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR229/048/SRR22957248																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR229/048/SRR22957248/SRR22957248.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM6914630					GSM6914630_r10				PI was added prior to sorting to exclude non-viable cells. Live CD45+ and CD45- populations were sorted and adjusted to 1 x 103/ml. Samples with >85% cell viability were processed at the Genomics Birmingham Sequencing Facility (University of Birmingham, UK) for gene expression profiling using the 10X Genomics platform. Around 1.7 x 104 cells per sample were processed using the Chromium Controller (10X Genomics) for a recovery of 1 x 104 cells per sample, and library preparation was performed using the Chromium Single Cell 3 Library & Gel Bead Kit v2 according to manufacturer's instructions. Library quantification and quality control was performed using TapeStation (Agilent). Samples were sequenced on an Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell. Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell.		GSM6914630_r1							env_tax;env_tax:terrestrial	2023-03-01				9606									SRR22957248												GSE222078					Adjacent normal Esophagus																																													
SRR22957249	SRX18913985	SAMN32543531	PRJNA917632	SRS16341799	SRP415592			NextSeq 500 sequencing: GSM6914630: s9, scRNAseq Homo sapiens RNA-Seq	s9, scRNAseq	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	s9, scRNAseq	GSM6914630	RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	21278454	1915060860	Homo sapiens		2023-03-01	2023-03-14	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	SRA1568393					cDNA												1202807480.0								1036596423	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR229/049/SRR22957249											ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/049/SRR22957249/SRR22957249.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR229/049/SRR22957249		3bbdaf24cdf3559f785974aa60aee341																			NextSeq 500 sequencing: GSM6914630: s9, scRNAseq Homo sapiens RNA-Seq							32c43f256623657cdfe3bdf50316a087	Mixed	ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/049/SRR22957249/SRR22957249.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR229/049/SRR22957249																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR229/049/SRR22957249/SRR22957249.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM6914630					GSM6914630_r11				PI was added prior to sorting to exclude non-viable cells. Live CD45+ and CD45- populations were sorted and adjusted to 1 x 103/ml. Samples with >85% cell viability were processed at the Genomics Birmingham Sequencing Facility (University of Birmingham, UK) for gene expression profiling using the 10X Genomics platform. Around 1.7 x 104 cells per sample were processed using the Chromium Controller (10X Genomics) for a recovery of 1 x 104 cells per sample, and library preparation was performed using the Chromium Single Cell 3 Library & Gel Bead Kit v2 according to manufacturer's instructions. Library quantification and quality control was performed using TapeStation (Agilent). Samples were sequenced on an Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell. Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell.		GSM6914630_r1							env_tax;env_tax:terrestrial	2023-03-01				9606									SRR22957249												GSE222078					Adjacent normal Esophagus																																													
SRR22957250	SRX18913985	SAMN32543531	PRJNA917632	SRS16341799	SRP415592			NextSeq 500 sequencing: GSM6914630: s9, scRNAseq Homo sapiens RNA-Seq	s9, scRNAseq	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	s9, scRNAseq	GSM6914630	RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	21082184	1897396560	Homo sapiens		2023-03-01	2023-03-16	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	SRA1568393					cDNA												1190471544.0								1025454278	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR229/050/SRR22957250											ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/050/SRR22957250/SRR22957250.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR229/050/SRR22957250		cb8f1cd83b84a786e9c4f47cd5aa4a75																			NextSeq 500 sequencing: GSM6914630: s9, scRNAseq Homo sapiens RNA-Seq							974ce6fecacaa0998bfb0031a19807de	Mixed	ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/050/SRR22957250/SRR22957250.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR229/050/SRR22957250																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR229/050/SRR22957250/SRR22957250.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM6914630					GSM6914630_r12				PI was added prior to sorting to exclude non-viable cells. Live CD45+ and CD45- populations were sorted and adjusted to 1 x 103/ml. Samples with >85% cell viability were processed at the Genomics Birmingham Sequencing Facility (University of Birmingham, UK) for gene expression profiling using the 10X Genomics platform. Around 1.7 x 104 cells per sample were processed using the Chromium Controller (10X Genomics) for a recovery of 1 x 104 cells per sample, and library preparation was performed using the Chromium Single Cell 3 Library & Gel Bead Kit v2 according to manufacturer's instructions. Library quantification and quality control was performed using TapeStation (Agilent). Samples were sequenced on an Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell. Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell.		GSM6914630_r1							env_tax;env_tax:terrestrial	2023-03-01				9606									SRR22957250												GSE222078					Adjacent normal Esophagus																																													
SRR22957251	SRX18913985	SAMN32543531	PRJNA917632	SRS16341799	SRP415592			NextSeq 500 sequencing: GSM6914630: s9, scRNAseq Homo sapiens RNA-Seq	s9, scRNAseq	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	s9, scRNAseq	GSM6914630	RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	18663096	1679678640	Homo sapiens		2023-03-01	2023-03-14	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	SRA1568393					cDNA												1024685785.0								879461204	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR229/051/SRR22957251											ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/051/SRR22957251/SRR22957251.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR229/051/SRR22957251		7357f6c749365a2af702404ec5367a16																			NextSeq 500 sequencing: GSM6914630: s9, scRNAseq Homo sapiens RNA-Seq							8978356ac58b0d251c319c85b273e9b4	Mixed	ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/051/SRR22957251/SRR22957251.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR229/051/SRR22957251																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR229/051/SRR22957251/SRR22957251.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM6914630					GSM6914630_r2				PI was added prior to sorting to exclude non-viable cells. Live CD45+ and CD45- populations were sorted and adjusted to 1 x 103/ml. Samples with >85% cell viability were processed at the Genomics Birmingham Sequencing Facility (University of Birmingham, UK) for gene expression profiling using the 10X Genomics platform. Around 1.7 x 104 cells per sample were processed using the Chromium Controller (10X Genomics) for a recovery of 1 x 104 cells per sample, and library preparation was performed using the Chromium Single Cell 3 Library & Gel Bead Kit v2 according to manufacturer's instructions. Library quantification and quality control was performed using TapeStation (Agilent). Samples were sequenced on an Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell. Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell.		GSM6914630_r1							env_tax;env_tax:terrestrial	2023-03-01				9606									SRR22957251												GSE222078					Adjacent normal Esophagus																																													
SRR22957252	SRX18913985	SAMN32543531	PRJNA917632	SRS16341799	SRP415592			NextSeq 500 sequencing: GSM6914630: s9, scRNAseq Homo sapiens RNA-Seq	s9, scRNAseq	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	s9, scRNAseq	GSM6914630	RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	19165072	1724856480	Homo sapiens		2023-03-01	2023-03-14	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	SRA1568393					cDNA												1057812207.0								909338617	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR229/052/SRR22957252											ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/052/SRR22957252/SRR22957252.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR229/052/SRR22957252		2c037c40d3800440908e1d33a1eb624d																			NextSeq 500 sequencing: GSM6914630: s9, scRNAseq Homo sapiens RNA-Seq							bb60cfe4b133705c9cf36330e0753ef1	Mixed	ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/052/SRR22957252/SRR22957252.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR229/052/SRR22957252																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR229/052/SRR22957252/SRR22957252.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM6914630					GSM6914630_r3				PI was added prior to sorting to exclude non-viable cells. Live CD45+ and CD45- populations were sorted and adjusted to 1 x 103/ml. Samples with >85% cell viability were processed at the Genomics Birmingham Sequencing Facility (University of Birmingham, UK) for gene expression profiling using the 10X Genomics platform. Around 1.7 x 104 cells per sample were processed using the Chromium Controller (10X Genomics) for a recovery of 1 x 104 cells per sample, and library preparation was performed using the Chromium Single Cell 3 Library & Gel Bead Kit v2 according to manufacturer's instructions. Library quantification and quality control was performed using TapeStation (Agilent). Samples were sequenced on an Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell. Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell.		GSM6914630_r1							env_tax;env_tax:terrestrial	2023-03-01				9606									SRR22957252												GSE222078					Adjacent normal Esophagus																																													
SRR22957253	SRX18913985	SAMN32543531	PRJNA917632	SRS16341799	SRP415592			NextSeq 500 sequencing: GSM6914630: s9, scRNAseq Homo sapiens RNA-Seq	s9, scRNAseq	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	s9, scRNAseq	GSM6914630	RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	18798380	1691854200	Homo sapiens		2023-03-01	2023-03-16	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	SRA1568393					cDNA												1034479675.0								888086853	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR229/053/SRR22957253											ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/053/SRR22957253/SRR22957253.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR229/053/SRR22957253		04fbf46737233305b0ea7ef974ffb522																			NextSeq 500 sequencing: GSM6914630: s9, scRNAseq Homo sapiens RNA-Seq							411abff9d32a0f947058200241ae57fa	Mixed	ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/053/SRR22957253/SRR22957253.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR229/053/SRR22957253																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR229/053/SRR22957253/SRR22957253.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM6914630					GSM6914630_r4				PI was added prior to sorting to exclude non-viable cells. Live CD45+ and CD45- populations were sorted and adjusted to 1 x 103/ml. Samples with >85% cell viability were processed at the Genomics Birmingham Sequencing Facility (University of Birmingham, UK) for gene expression profiling using the 10X Genomics platform. Around 1.7 x 104 cells per sample were processed using the Chromium Controller (10X Genomics) for a recovery of 1 x 104 cells per sample, and library preparation was performed using the Chromium Single Cell 3 Library & Gel Bead Kit v2 according to manufacturer's instructions. Library quantification and quality control was performed using TapeStation (Agilent). Samples were sequenced on an Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell. Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell.		GSM6914630_r1							env_tax;env_tax:terrestrial	2023-03-01				9606									SRR22957253												GSE222078					Adjacent normal Esophagus																																													
SRR22957254	SRX18913985	SAMN32543531	PRJNA917632	SRS16341799	SRP415592			NextSeq 500 sequencing: GSM6914630: s9, scRNAseq Homo sapiens RNA-Seq	s9, scRNAseq	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	s9, scRNAseq	GSM6914630	RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	21162071	1904586390	Homo sapiens		2023-03-01	2023-03-14	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	SRA1568393					cDNA												1161559450.0								995344052	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR229/054/SRR22957254											ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/054/SRR22957254/SRR22957254.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR229/054/SRR22957254		9f3b0da40ed7fd886d4f7b33b3e7c134																			NextSeq 500 sequencing: GSM6914630: s9, scRNAseq Homo sapiens RNA-Seq							6e7ca388181ea73f81b1fba16c6a0952	Mixed	ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/054/SRR22957254/SRR22957254.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR229/054/SRR22957254																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR229/054/SRR22957254/SRR22957254.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM6914630					GSM6914630_r5				PI was added prior to sorting to exclude non-viable cells. Live CD45+ and CD45- populations were sorted and adjusted to 1 x 103/ml. Samples with >85% cell viability were processed at the Genomics Birmingham Sequencing Facility (University of Birmingham, UK) for gene expression profiling using the 10X Genomics platform. Around 1.7 x 104 cells per sample were processed using the Chromium Controller (10X Genomics) for a recovery of 1 x 104 cells per sample, and library preparation was performed using the Chromium Single Cell 3 Library & Gel Bead Kit v2 according to manufacturer's instructions. Library quantification and quality control was performed using TapeStation (Agilent). Samples were sequenced on an Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell. Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell.		GSM6914630_r1							env_tax;env_tax:terrestrial	2023-03-01				9606									SRR22957254												GSE222078					Adjacent normal Esophagus																																													
SRR22957255	SRX18913985	SAMN32543531	PRJNA917632	SRS16341799	SRP415592			NextSeq 500 sequencing: GSM6914630: s9, scRNAseq Homo sapiens RNA-Seq	s9, scRNAseq	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	s9, scRNAseq	GSM6914630	RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	21020201	1891818090	Homo sapiens		2023-03-01	2023-03-14	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	SRA1568393					cDNA												1156839281.0								991354685	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR229/055/SRR22957255											ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/055/SRR22957255/SRR22957255.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR229/055/SRR22957255		00ac026d7493df331c4228485d423335																			NextSeq 500 sequencing: GSM6914630: s9, scRNAseq Homo sapiens RNA-Seq							c83cd54cf88c42b266382416b93b5e9a	Mixed	ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/055/SRR22957255/SRR22957255.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR229/055/SRR22957255																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR229/055/SRR22957255/SRR22957255.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM6914630					GSM6914630_r6				PI was added prior to sorting to exclude non-viable cells. Live CD45+ and CD45- populations were sorted and adjusted to 1 x 103/ml. Samples with >85% cell viability were processed at the Genomics Birmingham Sequencing Facility (University of Birmingham, UK) for gene expression profiling using the 10X Genomics platform. Around 1.7 x 104 cells per sample were processed using the Chromium Controller (10X Genomics) for a recovery of 1 x 104 cells per sample, and library preparation was performed using the Chromium Single Cell 3 Library & Gel Bead Kit v2 according to manufacturer's instructions. Library quantification and quality control was performed using TapeStation (Agilent). Samples were sequenced on an Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell. Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell.		GSM6914630_r1							env_tax;env_tax:terrestrial	2023-03-01				9606									SRR22957255												GSE222078					Adjacent normal Esophagus																																													
SRR22957256	SRX18913985	SAMN32543531	PRJNA917632	SRS16341799	SRP415592			NextSeq 500 sequencing: GSM6914630: s9, scRNAseq Homo sapiens RNA-Seq	s9, scRNAseq	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	s9, scRNAseq	GSM6914630	RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	21390229	1925120610	Homo sapiens		2023-03-01	2023-03-14	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	SRA1568393					cDNA												1178204113.0								1009352703	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR229/056/SRR22957256											ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/056/SRR22957256/SRR22957256.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR229/056/SRR22957256		817495d092837ac15b67d6609fa33aff																			NextSeq 500 sequencing: GSM6914630: s9, scRNAseq Homo sapiens RNA-Seq							715fcc8badefd3e943e4c909ef264f45	Mixed	ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/056/SRR22957256/SRR22957256.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR229/056/SRR22957256																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR229/056/SRR22957256/SRR22957256.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM6914630					GSM6914630_r7				PI was added prior to sorting to exclude non-viable cells. Live CD45+ and CD45- populations were sorted and adjusted to 1 x 103/ml. Samples with >85% cell viability were processed at the Genomics Birmingham Sequencing Facility (University of Birmingham, UK) for gene expression profiling using the 10X Genomics platform. Around 1.7 x 104 cells per sample were processed using the Chromium Controller (10X Genomics) for a recovery of 1 x 104 cells per sample, and library preparation was performed using the Chromium Single Cell 3 Library & Gel Bead Kit v2 according to manufacturer's instructions. Library quantification and quality control was performed using TapeStation (Agilent). Samples were sequenced on an Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell. Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell.		GSM6914630_r1							env_tax;env_tax:terrestrial	2023-03-01				9606									SRR22957256												GSE222078					Adjacent normal Esophagus																																													
SRR22957257	SRX18913985	SAMN32543531	PRJNA917632	SRS16341799	SRP415592			NextSeq 500 sequencing: GSM6914630: s9, scRNAseq Homo sapiens RNA-Seq	s9, scRNAseq	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	s9, scRNAseq	GSM6914630	RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	21308419	1917757710	Homo sapiens		2023-03-01	2023-03-16	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	SRA1568393					cDNA												1173564244.0								1005454465	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR229/057/SRR22957257											ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/057/SRR22957257/SRR22957257.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR229/057/SRR22957257		55c18755092a48dad77ec236e3aac69b																			NextSeq 500 sequencing: GSM6914630: s9, scRNAseq Homo sapiens RNA-Seq							e5efe96a68ac0046e6fe7f94cff07119	Mixed	ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/057/SRR22957257/SRR22957257.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR229/057/SRR22957257																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR229/057/SRR22957257/SRR22957257.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM6914630					GSM6914630_r8				PI was added prior to sorting to exclude non-viable cells. Live CD45+ and CD45- populations were sorted and adjusted to 1 x 103/ml. Samples with >85% cell viability were processed at the Genomics Birmingham Sequencing Facility (University of Birmingham, UK) for gene expression profiling using the 10X Genomics platform. Around 1.7 x 104 cells per sample were processed using the Chromium Controller (10X Genomics) for a recovery of 1 x 104 cells per sample, and library preparation was performed using the Chromium Single Cell 3 Library & Gel Bead Kit v2 according to manufacturer's instructions. Library quantification and quality control was performed using TapeStation (Agilent). Samples were sequenced on an Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell. Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell.		GSM6914630_r1							env_tax;env_tax:terrestrial	2023-03-01				9606									SRR22957257												GSE222078					Adjacent normal Esophagus																																													
SRR22957258	SRX18913985	SAMN32543531	PRJNA917632	SRS16341799	SRP415592			NextSeq 500 sequencing: GSM6914630: s9, scRNAseq Homo sapiens RNA-Seq	s9, scRNAseq	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	s9, scRNAseq	GSM6914630	RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	20894407	1880496630	Homo sapiens		2023-03-01	2023-03-16	The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy	SRA1568393					cDNA												1174925240.0								1011613008	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR229/058/SRR22957258											ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/058/SRR22957258/SRR22957258.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR229/058/SRR22957258		8c53449c425e053dab018c9b5c2f3b7f																			NextSeq 500 sequencing: GSM6914630: s9, scRNAseq Homo sapiens RNA-Seq							4ee1c99d8dc5a07007eb7d82eb924813	Mixed	ftp.sra.ebi.ac.uk/vol1/fastq/SRR229/058/SRR22957258/SRR22957258.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR229/058/SRR22957258																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR229/058/SRR22957258/SRR22957258.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM6914630					GSM6914630_r9				PI was added prior to sorting to exclude non-viable cells. Live CD45+ and CD45- populations were sorted and adjusted to 1 x 103/ml. Samples with >85% cell viability were processed at the Genomics Birmingham Sequencing Facility (University of Birmingham, UK) for gene expression profiling using the 10X Genomics platform. Around 1.7 x 104 cells per sample were processed using the Chromium Controller (10X Genomics) for a recovery of 1 x 104 cells per sample, and library preparation was performed using the Chromium Single Cell 3 Library & Gel Bead Kit v2 according to manufacturer's instructions. Library quantification and quality control was performed using TapeStation (Agilent). Samples were sequenced on an Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell. Illumina NextSeq 500 (150 bps, paired-end) at a sequencing depth of >50,000 raw reads/cell.		GSM6914630_r1							env_tax;env_tax:terrestrial	2023-03-01				9606									SRR22957258												GSE222078					Adjacent normal Esophagus																																													
ERR1141671	ERX1220520	SAMEA3670207	PRJEB11797	ERS977356	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	B01	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	B01	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	23196446	4685682092	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141671/LNC_B01_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141671/LNC_B01_R2.fastq.gz						2966640890.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141671/LNC_B01_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141671/LNC_B01_R2.fastq.gz			1882255253;1908629562	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/001/ERR1141671		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141671/LNC_B01_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141671/LNC_B01_R2.fastq.gz							df828455ff15bfcfa06c9ed60b185206;9298c2abde0def3f571948b743b50819	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141671/ERR1141671_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141671/ERR1141671_2.fastq.gz				1806962192;1831975083					ftp.sra.ebi.ac.uk/vol1/err/ERR114/001/ERR1141671		a0573158230eb0c2d58c71426f1fc71f;b9444ce7131b4f5cabf66745c813c057																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						9d83f9e28ed9fcc9355f85990d400f1e		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141671/ERR1141671_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141671/ERR1141671_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/001/ERR1141671											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/001/ERR1141671/ERR1141671_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/001/ERR1141671/ERR1141671_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:B01					E-MTAB-4054:LNC_B01_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:B01		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141671												E-MTAB-4054																																																		
ERR1141672	ERX1220521	SAMEA3670208	PRJEB11797	ERS977357	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	B02	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	B02	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	20810083	4203636766	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141672/LNC_B02_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141672/LNC_B02_R2.fastq.gz						2678547616.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141672/LNC_B02_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141672/LNC_B02_R2.fastq.gz			1710663173;1741564965	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/002/ERR1141672		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141672/LNC_B02_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141672/LNC_B02_R2.fastq.gz							50b0c896e07fb866c48d925c24e4036c;a9ecf828c84c52b5f06295844ceb6519	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141672/ERR1141672_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141672/ERR1141672_2.fastq.gz				1643163053;1673005258					ftp.sra.ebi.ac.uk/vol1/err/ERR114/002/ERR1141672		d810b3761e3038344f73911736cae254;8c753ef8f925f3a2530bfca0264c5ad5																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						30823032bf9bdd09049e5e930c899799		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141672/ERR1141672_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141672/ERR1141672_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/002/ERR1141672											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/002/ERR1141672/ERR1141672_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/002/ERR1141672/ERR1141672_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:B02					E-MTAB-4054:LNC_B02_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:B02		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141672												E-MTAB-4054																																																		
ERR1141673	ERX1220522	SAMEA3670209	PRJEB11797	ERS977358	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	B03	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	B03	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	22253886	4495284972	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141673/LNC_B03_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141673/LNC_B03_R2.fastq.gz						3100029029.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141673/LNC_B03_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141673/LNC_B03_R2.fastq.gz			1967108910;1977504982	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/003/ERR1141673		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141673/LNC_B03_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141673/LNC_B03_R2.fastq.gz							f2f5d324f3cb1393a004d182382e063e;ffed6ce7f54bc060bacfcd5e54b388cb	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141673/ERR1141673_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141673/ERR1141673_2.fastq.gz				1895703627;1907717193					ftp.sra.ebi.ac.uk/vol1/err/ERR114/003/ERR1141673		9a4d07f4088cd3fd65ba3deefc146a30;41f2ed8470d8ebc844f54623032e70b9																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						b7c51e873031acfc04d286b54d02b080		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141673/ERR1141673_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141673/ERR1141673_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/003/ERR1141673											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/003/ERR1141673/ERR1141673_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/003/ERR1141673/ERR1141673_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:B03					E-MTAB-4054:LNC_B03_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:B03		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141673												E-MTAB-4054																																																		
ERR1141674	ERX1220523	SAMEA3670210	PRJEB11797	ERS977359	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	B04	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	B04	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	20609087	4163035574	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141674/LNC_B04_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141674/LNC_B04_R2.fastq.gz						2665496985.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141674/LNC_B04_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141674/LNC_B04_R2.fastq.gz			1711254877;1740270587	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/004/ERR1141674		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141674/LNC_B04_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141674/LNC_B04_R2.fastq.gz							7c7afc5d01909e35e25bdd7490715986;2158cd4e4beea7cace5f28161011006a	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/004/ERR1141674/ERR1141674_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/004/ERR1141674/ERR1141674_2.fastq.gz				1648416620;1676725900					ftp.sra.ebi.ac.uk/vol1/err/ERR114/004/ERR1141674		db94ad6cfb6d0604d1fe88895d28a84c;b384be5c7ff0125d85895931a256a5f8																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						70d4a3f97a75f66118d7c8aadf9130d9		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/004/ERR1141674/ERR1141674_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/004/ERR1141674/ERR1141674_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/004/ERR1141674											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/004/ERR1141674/ERR1141674_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/004/ERR1141674/ERR1141674_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:B04					E-MTAB-4054:LNC_B04_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:B04		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141674												E-MTAB-4054																																																		
ERR1141675	ERX1220524	SAMEA3670211	PRJEB11797	ERS977360	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	B05	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	B05	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	10562686	2661796872	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141675/LNC_B05_Human_CCGTCC_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141675/LNC_B05_Human_CCGTCC_R2.fastq.gz						1092690809.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141675/LNC_B05_Human_CCGTCC_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141675/LNC_B05_Human_CCGTCC_R2.fastq.gz			719171481;731011126	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/005/ERR1141675		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141675/LNC_B05_Human_CCGTCC_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141675/LNC_B05_Human_CCGTCC_R2.fastq.gz							eb3ded81f2e81a22556ebdda37f66ede;974a35199703a72a60301418eb0ab81a	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/005/ERR1141675/ERR1141675_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/005/ERR1141675/ERR1141675_2.fastq.gz				899156463;912607225					ftp.sra.ebi.ac.uk/vol1/err/ERR114/005/ERR1141675		7267427b2e820dc324762a64fb62f8ab;35d1810e2b69598c0403763d778d5004																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						e67bfeb5e95ba074f20f52e4bf14190b		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/005/ERR1141675/ERR1141675_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/005/ERR1141675/ERR1141675_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/005/ERR1141675											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/005/ERR1141675/ERR1141675_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/005/ERR1141675/ERR1141675_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:B05					E-MTAB-4054:LNC_B05_Human_CCGTCC_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:B05		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141675												E-MTAB-4054																																																		
ERR1141676	ERX1220525	SAMEA3670212	PRJEB11797	ERS977361	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	B05_ rep	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	B05_ rep	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	21516256	4346283712	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141676/LNC_B05_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141676/LNC_B05_R2.fastq.gz						3013361643.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141676/LNC_B05_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141676/LNC_B05_R2.fastq.gz			1870639087;1879199982	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/006/ERR1141676		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141676/LNC_B05_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141676/LNC_B05_R2.fastq.gz							37685d59a4db794e6e78c09adc9d3d2a;394820f90cbc1ddc88333905db70608c	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/006/ERR1141676/ERR1141676_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/006/ERR1141676/ERR1141676_2.fastq.gz				1802801620;1812925132					ftp.sra.ebi.ac.uk/vol1/err/ERR114/006/ERR1141676		d49653ee7b4c4476a6ea592d05325c91;f373be47e25ed9d3914fc7c19d384442																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						e887b178fa5e47aa3350b54998f1bbad		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/006/ERR1141676/ERR1141676_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/006/ERR1141676/ERR1141676_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/006/ERR1141676											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/006/ERR1141676/ERR1141676_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/006/ERR1141676/ERR1141676_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:B05_ rep					E-MTAB-4054:LNC_B05_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:B05_ rep		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141676												E-MTAB-4054																																																		
ERR1141677	ERX1220526	SAMEA3670213	PRJEB11797	ERS977362	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	B06	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	B06	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	54629925	13766741100	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141677/LNC_B06_Human_ATGTCA_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141677/LNC_B06_Human_ATGTCA_R2.fastq.gz						5683298260.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141677/LNC_B06_Human_ATGTCA_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141677/LNC_B06_Human_ATGTCA_R2.fastq.gz			3759446375;3956782422	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/007/ERR1141677		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141677/LNC_B06_Human_ATGTCA_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141677/LNC_B06_Human_ATGTCA_R2.fastq.gz							e884126d3fd58865b4fd056f87c00b45;c85f7a9655f9839e7e6dd068f2cafd55	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/007/ERR1141677/ERR1141677_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/007/ERR1141677/ERR1141677_2.fastq.gz				4592860237;4812801660					ftp.sra.ebi.ac.uk/vol1/err/ERR114/007/ERR1141677		87391c903b8df82daf895843767b7bad;e7502b1d73d3075fa69ae8fee3b32d3e																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						27b83084fdfcfae91c86e053f8cdc233		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/007/ERR1141677/ERR1141677_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/007/ERR1141677/ERR1141677_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/007/ERR1141677											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/007/ERR1141677/ERR1141677_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/007/ERR1141677/ERR1141677_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:B06					E-MTAB-4054:LNC_B06_Human_ATGTCA_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:B06		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141677												E-MTAB-4054																																																		
ERR1141678	ERX1220527	SAMEA3670214	PRJEB11797	ERS977363	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	B06_rep	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	B06_rep	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	27732652	5601995704	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141678/LNC_B06_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141678/LNC_B06_R2.fastq.gz						3870236124.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141678/LNC_B06_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141678/LNC_B06_R2.fastq.gz			2422361179;2449570995	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/008/ERR1141678		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141678/LNC_B06_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141678/LNC_B06_R2.fastq.gz							96f03d87736cbb4b267ea07aa46ad8c3;d318b9376d2233f19044e53bcc7bc0dd	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/008/ERR1141678/ERR1141678_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/008/ERR1141678/ERR1141678_2.fastq.gz				2333561592;2363109456					ftp.sra.ebi.ac.uk/vol1/err/ERR114/008/ERR1141678		f8dee48acbae85778b85fa9b0c7f7040;11bcb39b339f968d99f23c1012c4320b																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						c0bf1e85557de1237f5b360eea38d416		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/008/ERR1141678/ERR1141678_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/008/ERR1141678/ERR1141678_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/008/ERR1141678											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/008/ERR1141678/ERR1141678_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/008/ERR1141678/ERR1141678_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:B06_rep					E-MTAB-4054:LNC_B06_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:B06_rep		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141678												E-MTAB-4054																																																		
ERR1141679	ERX1220528	SAMEA3670215	PRJEB11797	ERS977364	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	B07	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	B07	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	12714100	3203953200	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141679/LNC_B07_Human_GATCAG_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141679/LNC_B07_Human_GATCAG_R2.fastq.gz						1317434752.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141679/LNC_B07_Human_GATCAG_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141679/LNC_B07_Human_GATCAG_R2.fastq.gz			919806023;952785741	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/009/ERR1141679		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141679/LNC_B07_Human_GATCAG_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141679/LNC_B07_Human_GATCAG_R2.fastq.gz							6e7a4ff30ecb0ef235ab5dca16e4e907;4cbd0b7adc7c078e1b40c01ae25a6b25	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/009/ERR1141679/ERR1141679_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/009/ERR1141679/ERR1141679_2.fastq.gz				1083226312;1119001080					ftp.sra.ebi.ac.uk/vol1/err/ERR114/009/ERR1141679		6753438be76820042b948e50861897a4;3be5fe20292760177c195a97e33f9897																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						ac5d1fa0edcc657240ae57c4caddff66		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/009/ERR1141679/ERR1141679_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/009/ERR1141679/ERR1141679_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/009/ERR1141679											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/009/ERR1141679/ERR1141679_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/009/ERR1141679/ERR1141679_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:B07					E-MTAB-4054:LNC_B07_Human_GATCAG_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:B07		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141679												E-MTAB-4054																																																		
ERR1141680	ERX1220529	SAMEA3670216	PRJEB11797	ERS977365	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	B07_rep	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	B07_rep	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	20485723	4138116046	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141680/LNC_B07_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141680/LNC_B07_R2.fastq.gz						2647303960.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141680/LNC_B07_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141680/LNC_B07_R2.fastq.gz			1687433827;1712446949	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/000/ERR1141680		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141680/LNC_B07_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141680/LNC_B07_R2.fastq.gz							2fbf0916d6cebbd458034de544c6cf93;3dce01bfdef2f4bd694cc4a4dda0495e	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/000/ERR1141680/ERR1141680_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/000/ERR1141680/ERR1141680_2.fastq.gz				1624565560;1648938052					ftp.sra.ebi.ac.uk/vol1/err/ERR114/000/ERR1141680		9e8d3012520538abe96f3a479fcf18a6;86c1d7123c0e6935101e988a806fbcf4																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						cf319befcd7991a73e73821821116ee8		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/000/ERR1141680/ERR1141680_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/000/ERR1141680/ERR1141680_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/000/ERR1141680											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/000/ERR1141680/ERR1141680_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/000/ERR1141680/ERR1141680_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:B07_rep					E-MTAB-4054:LNC_B07_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:B07_rep		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141680												E-MTAB-4054																																																		
ERR1141681	ERX1220530	SAMEA3670217	PRJEB11797	ERS977366	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	B08	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	B08	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	29120866	5882414932	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141681/LNC_B08_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141681/LNC_B08_R2.fastq.gz						4074311008.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141681/LNC_B08_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141681/LNC_B08_R2.fastq.gz			2541928279;2560504793	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/001/ERR1141681		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141681/LNC_B08_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141681/LNC_B08_R2.fastq.gz							74c3b61fe42aa2df3374155844be115b;2e728e0eef1b027cd6832dccd1275429	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141681/ERR1141681_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141681/ERR1141681_2.fastq.gz				2450958234;2471993751					ftp.sra.ebi.ac.uk/vol1/err/ERR114/001/ERR1141681		ae9a403303309d876472c9f4b9bd81f3;6dab9a4ee3074f49ab33d7599edd4d9f																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						7b293576c650375edbe56adb2cbdac69		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141681/ERR1141681_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141681/ERR1141681_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/001/ERR1141681											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/001/ERR1141681/ERR1141681_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/001/ERR1141681/ERR1141681_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:B08					E-MTAB-4054:LNC_B08_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:B08		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141681												E-MTAB-4054																																																		
ERR1141682	ERX1220531	SAMEA3670218	PRJEB11797	ERS977367	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	B09	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	B09	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	14489756	3651418512	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141682/LNC_B09_Human_CGTACG_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141682/LNC_B09_Human_CGTACG_R2.fastq.gz						1414222050.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141682/LNC_B09_Human_CGTACG_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141682/LNC_B09_Human_CGTACG_R2.fastq.gz			1002094208;1035542361	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/002/ERR1141682		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141682/LNC_B09_Human_CGTACG_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141682/LNC_B09_Human_CGTACG_R2.fastq.gz							578e2dfc2aad680d8029ca40eca10542;82bb757cda5018dc8fe7d13c3be10152	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141682/ERR1141682_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141682/ERR1141682_2.fastq.gz				1175681353;1212206249					ftp.sra.ebi.ac.uk/vol1/err/ERR114/002/ERR1141682		124b9b6b2ee5c514cb372e0737e1e187;0ce995828f37edc867feb473f1b8a392																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						ac4e02e5584c9e4d9509c66e53f4f41d		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141682/ERR1141682_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141682/ERR1141682_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/002/ERR1141682											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/002/ERR1141682/ERR1141682_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/002/ERR1141682/ERR1141682_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:B09					E-MTAB-4054:LNC_B09_Human_CGTACG_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:B09		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141682												E-MTAB-4054																																																		
ERR1141683	ERX1220532	SAMEA3670219	PRJEB11797	ERS977368	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	B09_rep	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	B09_rep	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	24643254	4977937308	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141683/LNC_B09_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141683/LNC_B09_R2.fastq.gz						3204046690.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141683/LNC_B09_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141683/LNC_B09_R2.fastq.gz			2048095005;2086184427	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/003/ERR1141683		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141683/LNC_B09_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141683/LNC_B09_R2.fastq.gz							06e86f96390872fa7d7d18028d72c522;01c22f18d6fd2536798efcdc20f24139	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141683/ERR1141683_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141683/ERR1141683_2.fastq.gz				1968061235;2005146012					ftp.sra.ebi.ac.uk/vol1/err/ERR114/003/ERR1141683		403b3bad56dbea0a0087d70a63fb44de;8b4356e2035ce23ccfa521ace187aedc																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						aaa192b32ee2938d3612f9643a9821b5		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141683/ERR1141683_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141683/ERR1141683_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/003/ERR1141683											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/003/ERR1141683/ERR1141683_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/003/ERR1141683/ERR1141683_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:B09_rep					E-MTAB-4054:LNC_B09_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:B09_rep		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141683												E-MTAB-4054																																																		
ERR1141684	ERX1220533	SAMEA3670220	PRJEB11797	ERS977369	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	B10	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	B10	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	10808419	2723721588	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141684/LNC_B10_Human_ATTCCT_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141684/LNC_B10_Human_ATTCCT_R2.fastq.gz						1069120252.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141684/LNC_B10_Human_ATTCCT_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141684/LNC_B10_Human_ATTCCT_R2.fastq.gz			748844440;746880899	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/004/ERR1141684		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141684/LNC_B10_Human_ATTCCT_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141684/LNC_B10_Human_ATTCCT_R2.fastq.gz							6c5814cf23fee243fdf9f414122b7778;71f05570a841b2b2a902347fc5e9128e	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/004/ERR1141684/ERR1141684_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/004/ERR1141684/ERR1141684_2.fastq.gz				901842488;897714043					ftp.sra.ebi.ac.uk/vol1/err/ERR114/004/ERR1141684		84edb133c5d1a67c76968bcecae97019;a393dbfd5b7ff0fc173cd9628544d9e8																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						d3e498c5225b9210ba535c15aa8de0cc		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/004/ERR1141684/ERR1141684_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/004/ERR1141684/ERR1141684_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/004/ERR1141684											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/004/ERR1141684/ERR1141684_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/004/ERR1141684/ERR1141684_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:B10					E-MTAB-4054:LNC_B10_Human_ATTCCT_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:B10		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141684												E-MTAB-4054																																																		
ERR1141685	ERX1220534	SAMEA3670221	PRJEB11797	ERS977370	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	B10_rep	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	B10_rep	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	26541150	5361312300	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141685/LNC_B10_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141685/LNC_B10_R2.fastq.gz						3445125560.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141685/LNC_B10_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141685/LNC_B10_R2.fastq.gz			2161157549;2197946519	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/005/ERR1141685		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141685/LNC_B10_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141685/LNC_B10_R2.fastq.gz							1feeceef9eb8414522185d4c8ba11340;7a3372fc607f3fa054a72f50730fb949	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/005/ERR1141685/ERR1141685_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/005/ERR1141685/ERR1141685_2.fastq.gz				2076197892;2111822220					ftp.sra.ebi.ac.uk/vol1/err/ERR114/005/ERR1141685		e72daccc3c4db5392d81e0f86d9a401d;e18a7855d547a77748b49551278d068b																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						ee0ab1998b587cd3dea0e83541bd44f3		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/005/ERR1141685/ERR1141685_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/005/ERR1141685/ERR1141685_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/005/ERR1141685											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/005/ERR1141685/ERR1141685_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/005/ERR1141685/ERR1141685_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:B10_rep					E-MTAB-4054:LNC_B10_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:B10_rep		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141685												E-MTAB-4054																																																		
ERR1141686	ERX1220535	SAMEA3670222	PRJEB11797	ERS977371	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	B11	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	B11	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	5850026	1474206552	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141686/LNC_B11_Human_GTGGCC_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141686/LNC_B11_Human_GTGGCC_R2.fastq.gz						599920499.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141686/LNC_B11_Human_GTGGCC_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141686/LNC_B11_Human_GTGGCC_R2.fastq.gz			425979662;430398392	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/006/ERR1141686		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141686/LNC_B11_Human_GTGGCC_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141686/LNC_B11_Human_GTGGCC_R2.fastq.gz							2cc257e3634041a731b002f36cb3aa55;067e0ce25af2f4c2e5b711717c367e1c	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/006/ERR1141686/ERR1141686_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/006/ERR1141686/ERR1141686_2.fastq.gz				501604718;505614515					ftp.sra.ebi.ac.uk/vol1/err/ERR114/006/ERR1141686		a12629f8365717cb086dbc986b9fa008;8c94d437fc3635439c0b8af832f5bd31																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						ec2519003d1f56a5f591777dff8842b9		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/006/ERR1141686/ERR1141686_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/006/ERR1141686/ERR1141686_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/006/ERR1141686											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/006/ERR1141686/ERR1141686_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/006/ERR1141686/ERR1141686_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:B11					E-MTAB-4054:LNC_B11_Human_GTGGCC_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:B11		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141686												E-MTAB-4054																																																		
ERR1141687	ERX1220536	SAMEA3670223	PRJEB11797	ERS977372	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	B12	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	B12	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	3859997	972719244	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141687/LNC_B12_Human_TTAGGC_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141687/LNC_B12_Human_TTAGGC_R2.fastq.gz						375710469.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141687/LNC_B12_Human_TTAGGC_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141687/LNC_B12_Human_TTAGGC_R2.fastq.gz			266097238;268954074	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/007/ERR1141687		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141687/LNC_B12_Human_TTAGGC_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141687/LNC_B12_Human_TTAGGC_R2.fastq.gz							efd9c0950ffa3a8191352f0ac237f806;dc745538add7e46a2f753705cd2182e4	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/007/ERR1141687/ERR1141687_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/007/ERR1141687/ERR1141687_2.fastq.gz				315833391;318676330					ftp.sra.ebi.ac.uk/vol1/err/ERR114/007/ERR1141687		4629f7e75300a956a2170d9090e77753;70ecb46d8510c54dc7c68926edbc1864																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						3204cff099cf865481b13af4172a3b25		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/007/ERR1141687/ERR1141687_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/007/ERR1141687/ERR1141687_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/007/ERR1141687											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/007/ERR1141687/ERR1141687_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/007/ERR1141687/ERR1141687_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:B12					E-MTAB-4054:LNC_B12_Human_TTAGGC_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:B12		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141687												E-MTAB-4054																																																		
ERR1141688	ERX1220537	SAMEA3670224	PRJEB11797	ERS977373	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	B13	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	B13	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	4490039	1131489828	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141688/LNC_B13_Human_ACTTGA_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141688/LNC_B13_Human_ACTTGA_R2.fastq.gz						438383207.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141688/LNC_B13_Human_ACTTGA_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141688/LNC_B13_Human_ACTTGA_R2.fastq.gz			303141323;308988299	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/008/ERR1141688		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141688/LNC_B13_Human_ACTTGA_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141688/LNC_B13_Human_ACTTGA_R2.fastq.gz							95def4d683280cbf5be5441007288f80;67ebf21a349335964bff8499eb070bc3	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/008/ERR1141688/ERR1141688_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/008/ERR1141688/ERR1141688_2.fastq.gz				366168369;371398240					ftp.sra.ebi.ac.uk/vol1/err/ERR114/008/ERR1141688		26ffb6479832058ca6589972f572ae52;f9febde2b38cd2a4ceba6b4b504b4fdd																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						92f6ac86aa658d4f45cf5c5740ab43b2		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/008/ERR1141688/ERR1141688_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/008/ERR1141688/ERR1141688_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/008/ERR1141688											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/008/ERR1141688/ERR1141688_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/008/ERR1141688/ERR1141688_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:B13					E-MTAB-4054:LNC_B13_Human_ACTTGA_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:B13		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141688												E-MTAB-4054																																																		
ERR1141689	ERX1220538	SAMEA3670225	PRJEB11797	ERS977374	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LG01	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LG01	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	6497673	1637413596	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141689/LNC_LG01_Human_CAGATC_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141689/LNC_LG01_Human_CAGATC_R2.fastq.gz						671065426.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141689/LNC_LG01_Human_CAGATC_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141689/LNC_LG01_Human_CAGATC_R2.fastq.gz			467837884;481395756	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/009/ERR1141689		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141689/LNC_LG01_Human_CAGATC_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141689/LNC_LG01_Human_CAGATC_R2.fastq.gz							45c1df42f4b1d28ff81d78d874355530;d2e1a766b568dca167a42be2cdd1218d	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/009/ERR1141689/ERR1141689_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/009/ERR1141689/ERR1141689_2.fastq.gz				552593775;567497897					ftp.sra.ebi.ac.uk/vol1/err/ERR114/009/ERR1141689		b3a5b67922a444a01e0f0d20f0524d5c;ede18aecad984a465d4772041b698511																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						422c9e28e4d961d99ae47b19b27b836b		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/009/ERR1141689/ERR1141689_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/009/ERR1141689/ERR1141689_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/009/ERR1141689											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/009/ERR1141689/ERR1141689_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/009/ERR1141689/ERR1141689_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LG01					E-MTAB-4054:LNC_LG01_Human_CAGATC_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LG01		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141689												E-MTAB-4054																																																		
ERR1141690	ERX1220539	SAMEA3670226	PRJEB11797	ERS977375	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LG01S	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LG01S	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	6350412	1600303824	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141690/LNC_LG01S_Human_ACTTGA_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141690/LNC_LG01S_Human_ACTTGA_R2.fastq.gz						655969934.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141690/LNC_LG01S_Human_ACTTGA_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141690/LNC_LG01S_Human_ACTTGA_R2.fastq.gz			455152333;462831692	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/000/ERR1141690		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141690/LNC_LG01S_Human_ACTTGA_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141690/LNC_LG01S_Human_ACTTGA_R2.fastq.gz							7058ab81e163776db862aec9bdf7226d;a3130b7bb07483f4d727276824116175	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/000/ERR1141690/ERR1141690_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/000/ERR1141690/ERR1141690_2.fastq.gz				542876724;550206008					ftp.sra.ebi.ac.uk/vol1/err/ERR114/000/ERR1141690		4c6413864b2243439d96975f4edbaa92;bedc4a9d942158491ccfbb8ff802eca6																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						b11ef577c9ca87b84aa215f848d3d71e		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/000/ERR1141690/ERR1141690_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/000/ERR1141690/ERR1141690_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/000/ERR1141690											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/000/ERR1141690/ERR1141690_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/000/ERR1141690/ERR1141690_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LG01S					E-MTAB-4054:LNC_LG01S_Human_ACTTGA_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LG01S		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141690												E-MTAB-4054																																																		
ERR1141691	ERX1220540	SAMEA3670227	PRJEB11797	ERS977376	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LG02	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LG02	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	6042371	1522677492	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141691/LNC_LG02_Human_AGTCAA_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141691/LNC_LG02_Human_AGTCAA_R2.fastq.gz						628593610.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141691/LNC_LG02_Human_AGTCAA_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141691/LNC_LG02_Human_AGTCAA_R2.fastq.gz			443871008;444447810	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/001/ERR1141691		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141691/LNC_LG02_Human_AGTCAA_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141691/LNC_LG02_Human_AGTCAA_R2.fastq.gz							25cbf9bb5b758b067715a1fe0e4c9ed5;a8bf8de61b2185180cf305e44588757f	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141691/ERR1141691_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141691/ERR1141691_2.fastq.gz				524191135;524255591					ftp.sra.ebi.ac.uk/vol1/err/ERR114/001/ERR1141691		f2fa062ac5bf8c017c657553c535f176;820d14ca9097fe4ac312453ea5b690ff																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						36978359786619a6b6f1e8f3d9c92c65		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141691/ERR1141691_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141691/ERR1141691_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/001/ERR1141691											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/001/ERR1141691/ERR1141691_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/001/ERR1141691/ERR1141691_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LG02					E-MTAB-4054:LNC_LG02_Human_AGTCAA_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LG02		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141691												E-MTAB-4054																																																		
ERR1141692	ERX1220541	SAMEA3670228	PRJEB11797	ERS977377	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LG02S	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LG02S	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	6692286	1686456072	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141692/LNC_LG02S_Human_TAGCTT_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141692/LNC_LG02S_Human_TAGCTT_R2.fastq.gz						691958480.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141692/LNC_LG02S_Human_TAGCTT_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141692/LNC_LG02S_Human_TAGCTT_R2.fastq.gz			483459681;493550798	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/002/ERR1141692		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141692/LNC_LG02S_Human_TAGCTT_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141692/LNC_LG02S_Human_TAGCTT_R2.fastq.gz							ddcb0b7b37c798688df31b238f430554;6a3f991c1168a2783579e5acca377054	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141692/ERR1141692_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141692/ERR1141692_2.fastq.gz				572356755;582441824					ftp.sra.ebi.ac.uk/vol1/err/ERR114/002/ERR1141692		1a408e3ca375d71b504b43cc114eb207;fc6426f5e964c68df9fe9410c1ffc6e9																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						4ff5ccc74de6628447af6d80f17c7c92		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141692/ERR1141692_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141692/ERR1141692_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/002/ERR1141692											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/002/ERR1141692/ERR1141692_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/002/ERR1141692/ERR1141692_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LG02S					E-MTAB-4054:LNC_LG02S_Human_TAGCTT_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LG02S		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141692												E-MTAB-4054																																																		
ERR1141693	ERX1220542	SAMEA3670229	PRJEB11797	ERS977378	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LG03	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LG03	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	5813512	1465005024	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141693/LNC_LG03_Human_AGTTCC_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141693/LNC_LG03_Human_AGTTCC_R2.fastq.gz						599142211.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141693/LNC_LG03_Human_AGTTCC_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141693/LNC_LG03_Human_AGTTCC_R2.fastq.gz			420420616;431692163	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/003/ERR1141693		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141693/LNC_LG03_Human_AGTTCC_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141693/LNC_LG03_Human_AGTTCC_R2.fastq.gz							5f0921ba02de1dca5201281dc39599eb;e897035084bcc4baaef35bb2259eff24	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141693/ERR1141693_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141693/ERR1141693_2.fastq.gz				494848998;506960446					ftp.sra.ebi.ac.uk/vol1/err/ERR114/003/ERR1141693		5370995b102cf54bef9c1fd0cf05f3d2;caf369548783839bc4602b56cc032dea																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						d8c3b446931111280eac6ad2dd159a35		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141693/ERR1141693_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141693/ERR1141693_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/003/ERR1141693											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/003/ERR1141693/ERR1141693_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/003/ERR1141693/ERR1141693_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LG03					E-MTAB-4054:LNC_LG03_Human_AGTTCC_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LG03		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141693												E-MTAB-4054																																																		
ERR1141694	ERX1220543	SAMEA3670230	PRJEB11797	ERS977379	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LG03B	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LG03B	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	5998290	1511569080	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141694/LNC_LG03B_Human_GGCTAC_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141694/LNC_LG03B_Human_GGCTAC_R2.fastq.gz						626107961.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141694/LNC_LG03B_Human_GGCTAC_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141694/LNC_LG03B_Human_GGCTAC_R2.fastq.gz			435931648;441111870	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/004/ERR1141694		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141694/LNC_LG03B_Human_GGCTAC_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141694/LNC_LG03B_Human_GGCTAC_R2.fastq.gz							e725ce0766d90228a9a09b69828cf458;727cc4c4e18cde41fe2ee108e45a979d	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/004/ERR1141694/ERR1141694_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/004/ERR1141694/ERR1141694_2.fastq.gz				518821249;523803407					ftp.sra.ebi.ac.uk/vol1/err/ERR114/004/ERR1141694		211f279cf135c7a090a231e2ccadd4ac;1843f843f3c2a4b3f9a8f540782e1904																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						2eb5bcd70157b6db732c3e027a2e0e62		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/004/ERR1141694/ERR1141694_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/004/ERR1141694/ERR1141694_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/004/ERR1141694											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/004/ERR1141694/ERR1141694_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/004/ERR1141694/ERR1141694_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LG03B					E-MTAB-4054:LNC_LG03B_Human_GGCTAC_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LG03B		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141694												E-MTAB-4054																																																		
ERR1141695	ERX1220544	SAMEA3670231	PRJEB11797	ERS977380	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LG04	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LG04	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	7579261	1909973772	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141695/LNC_LG04_Human_GTGAAA_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141695/LNC_LG04_Human_GTGAAA_R2.fastq.gz						800047216.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141695/LNC_LG04_Human_GTGAAA_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141695/LNC_LG04_Human_GTGAAA_R2.fastq.gz			553096073;556705455	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/005/ERR1141695		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141695/LNC_LG04_Human_GTGAAA_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141695/LNC_LG04_Human_GTGAAA_R2.fastq.gz							af32a68ae85e672bf0e83f829f25b0f1;10896cb6f211983e284edf2855f8277d	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/005/ERR1141695/ERR1141695_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/005/ERR1141695/ERR1141695_2.fastq.gz				662708099;664995512					ftp.sra.ebi.ac.uk/vol1/err/ERR114/005/ERR1141695		5f672782236efad47ffc92acc6af0646;d0318d53d21959beebcf3bfaaf45106e																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						2a81e2a421eea75115ce209a9886f966		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/005/ERR1141695/ERR1141695_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/005/ERR1141695/ERR1141695_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/005/ERR1141695											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/005/ERR1141695/ERR1141695_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/005/ERR1141695/ERR1141695_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LG04					E-MTAB-4054:LNC_LG04_Human_GTGAAA_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LG04		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141695												E-MTAB-4054																																																		
ERR1141696	ERX1220545	SAMEA3670232	PRJEB11797	ERS977381	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LG05	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LG05	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	4351176	1096496352	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141696/LNC_LG05_Human_GTGGCC_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141696/LNC_LG05_Human_GTGGCC_R2.fastq.gz						424069077.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141696/LNC_LG05_Human_GTGGCC_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141696/LNC_LG05_Human_GTGGCC_R2.fastq.gz			299584178;303382087	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/006/ERR1141696		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141696/LNC_LG05_Human_GTGGCC_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141696/LNC_LG05_Human_GTGGCC_R2.fastq.gz							5fdc79bd34574712b448da7e2ff983e3;d3653be298b03c44868e7bcb676440d3	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/006/ERR1141696/ERR1141696_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/006/ERR1141696/ERR1141696_2.fastq.gz				355945015;359554051					ftp.sra.ebi.ac.uk/vol1/err/ERR114/006/ERR1141696		063da22aceaf6514e17683707d8f00c3;54d77571ce9946872befee7912105cb9																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						1d8d6edd53be4450ccf4751bc3c80217		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/006/ERR1141696/ERR1141696_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/006/ERR1141696/ERR1141696_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/006/ERR1141696											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/006/ERR1141696/ERR1141696_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/006/ERR1141696/ERR1141696_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LG05					E-MTAB-4054:LNC_LG05_Human_GTGGCC_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LG05		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141696												E-MTAB-4054																																																		
ERR1141697	ERX1220546	SAMEA3670233	PRJEB11797	ERS977382	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LG05S	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LG05S	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	5062246	1275685992	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141697/LNC_LG05S_Human_GATCAG_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141697/LNC_LG05S_Human_GATCAG_R2.fastq.gz						493724126.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141697/LNC_LG05S_Human_GATCAG_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141697/LNC_LG05S_Human_GATCAG_R2.fastq.gz			341295400;350717973	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/007/ERR1141697		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141697/LNC_LG05S_Human_GATCAG_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141697/LNC_LG05S_Human_GATCAG_R2.fastq.gz							78a925d1e1c58914c2861075fe175493;a1eb387b9d5ce23d2a113bb53490ea99	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/007/ERR1141697/ERR1141697_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/007/ERR1141697/ERR1141697_2.fastq.gz				410883837;420331571					ftp.sra.ebi.ac.uk/vol1/err/ERR114/007/ERR1141697		85f26b7ea04de5ea387dfc8284700218;4284d4eb5cd6212f57ab867822d8b578																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						a7b36a47a2ba71e6f411a99f0a2238da		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/007/ERR1141697/ERR1141697_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/007/ERR1141697/ERR1141697_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/007/ERR1141697											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/007/ERR1141697/ERR1141697_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/007/ERR1141697/ERR1141697_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LG05S					E-MTAB-4054:LNC_LG05S_Human_GATCAG_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LG05S		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141697												E-MTAB-4054																																																		
ERR1141698	ERX1220547	SAMEA3670234	PRJEB11797	ERS977383	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LG06	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LG06	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	4708818	1186622136	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141698/LNC_LG06_Human_GTTTCG_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141698/LNC_LG06_Human_GTTTCG_R2.fastq.gz						459142290.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141698/LNC_LG06_Human_GTTTCG_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141698/LNC_LG06_Human_GTTTCG_R2.fastq.gz			311974243;321568131	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/008/ERR1141698		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141698/LNC_LG06_Human_GTTTCG_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141698/LNC_LG06_Human_GTTTCG_R2.fastq.gz							0a87bf75285ec7464e21c5ba8b859560;6c1d88fe0ff208de3d23fa55c8a59d2c	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/008/ERR1141698/ERR1141698_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/008/ERR1141698/ERR1141698_2.fastq.gz				380300263;390539817					ftp.sra.ebi.ac.uk/vol1/err/ERR114/008/ERR1141698		4a732b4ec73e9a2078cc26e54a3d588c;fdb64e5c197494cc240f82e4cc5b973a																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						fb6f41a97a6cc1eac794ac92390c8354		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/008/ERR1141698/ERR1141698_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/008/ERR1141698/ERR1141698_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/008/ERR1141698											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/008/ERR1141698/ERR1141698_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/008/ERR1141698/ERR1141698_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LG06					E-MTAB-4054:LNC_LG06_Human_GTTTCG_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LG06		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141698												E-MTAB-4054																																																		
ERR1141699	ERX1220548	SAMEA3670235	PRJEB11797	ERS977384	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LG06S	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LG06S	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	4372863	1101961476	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141699/LNC_LG06S_Human_TAGCTT_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141699/LNC_LG06S_Human_TAGCTT_R2.fastq.gz						425629727.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141699/LNC_LG06S_Human_TAGCTT_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141699/LNC_LG06S_Human_TAGCTT_R2.fastq.gz			298937009;304278260	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/009/ERR1141699		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141699/LNC_LG06S_Human_TAGCTT_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141699/LNC_LG06S_Human_TAGCTT_R2.fastq.gz							5b72a6728058323b89686893d5b8b057;a383f13a047cfe175b334a3931c7d9fe	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/009/ERR1141699/ERR1141699_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/009/ERR1141699/ERR1141699_2.fastq.gz				357200486;362040980					ftp.sra.ebi.ac.uk/vol1/err/ERR114/009/ERR1141699		c83934b7fcfd9a0395380118a4af9d3f;03fee2d6cf1cfd613bb0d1fba1338337																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						45efb2e7dbd68d3f8ab28329e16e1af9		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/009/ERR1141699/ERR1141699_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/009/ERR1141699/ERR1141699_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/009/ERR1141699											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/009/ERR1141699/ERR1141699_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/009/ERR1141699/ERR1141699_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LG06S					E-MTAB-4054:LNC_LG06S_Human_TAGCTT_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LG06S		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141699												E-MTAB-4054																																																		
ERR1141700	ERX1220549	SAMEA3670236	PRJEB11797	ERS977385	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LG06T	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LG06T	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	4054657	1021773564	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141700/LNC_LG06T_Human_ACAGTG_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141700/LNC_LG06T_Human_ACAGTG_R2.fastq.gz						394088685.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141700/LNC_LG06T_Human_ACAGTG_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141700/LNC_LG06T_Human_ACAGTG_R2.fastq.gz			275132565;283795122	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/000/ERR1141700		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141700/LNC_LG06T_Human_ACAGTG_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141700/LNC_LG06T_Human_ACAGTG_R2.fastq.gz							3daa118d767f356ac8925939f5ee7547;e74809e0d74b6e567f03f43cb2ed2a37	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/000/ERR1141700/ERR1141700_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/000/ERR1141700/ERR1141700_2.fastq.gz				263440817;272032517					ftp.sra.ebi.ac.uk/vol1/err/ERR114/000/ERR1141700		11013a2c312a3bfc92632af4383fe425;0d6ab8613c87d8c470a539368929678f																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						1076045550fc5b0d52a5b750eae48f65		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/000/ERR1141700/ERR1141700_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/000/ERR1141700/ERR1141700_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/000/ERR1141700											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/000/ERR1141700/ERR1141700_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/000/ERR1141700/ERR1141700_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LG06T					E-MTAB-4054:LNC_LG06T_Human_ACAGTG_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LG06T		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141700												E-MTAB-4054																																																		
ERR1141701	ERX1220550	SAMEA3670237	PRJEB11797	ERS977386	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LG07	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LG07	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	5579752	1406097504	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141701/LNC_LG07_Human_GAGTGG_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141701/LNC_LG07_Human_GAGTGG_R2.fastq.gz						536846850.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141701/LNC_LG07_Human_GAGTGG_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141701/LNC_LG07_Human_GAGTGG_R2.fastq.gz			373252034;392083541	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/001/ERR1141701		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141701/LNC_LG07_Human_GAGTGG_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141701/LNC_LG07_Human_GAGTGG_R2.fastq.gz							fc182f60d2987022fd88be876b01d7c3;5c70eba5181e2452c52cd4138bcf8999	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141701/ERR1141701_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141701/ERR1141701_2.fastq.gz				442673551;463823652					ftp.sra.ebi.ac.uk/vol1/err/ERR114/001/ERR1141701		a5a6ecd5f82b7f349999e1c11a9ff77a;6b5a423432eca8ca357d05975237b6a4																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						a891d0840f6d8de955b3adae6308868e		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141701/ERR1141701_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141701/ERR1141701_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/001/ERR1141701											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/001/ERR1141701/ERR1141701_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/001/ERR1141701/ERR1141701_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LG07					E-MTAB-4054:LNC_LG07_Human_GAGTGG_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LG07		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141701												E-MTAB-4054																																																		
ERR1141702	ERX1220551	SAMEA3670238	PRJEB11797	ERS977387	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LG08	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LG08	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	5361207	1351024164	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141702/LNC_LG08_Human_ACTGAT_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141702/LNC_LG08_Human_ACTGAT_R2.fastq.gz						523703124.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141702/LNC_LG08_Human_ACTGAT_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141702/LNC_LG08_Human_ACTGAT_R2.fastq.gz			372712141;373918072	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/002/ERR1141702		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141702/LNC_LG08_Human_ACTGAT_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141702/LNC_LG08_Human_ACTGAT_R2.fastq.gz							ddae52325b0e298caa174a031ef2b404;fba39119f6d17cf1f923ae44824888c6	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141702/ERR1141702_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141702/ERR1141702_2.fastq.gz				441601600;442163659					ftp.sra.ebi.ac.uk/vol1/err/ERR114/002/ERR1141702		f885f23de3ab06a5478a01d0c699d214;6097984dd8079d9715931791c00f2d54																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						4f58ce392ad217868bf1368bd12eab73		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141702/ERR1141702_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141702/ERR1141702_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/002/ERR1141702											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/002/ERR1141702/ERR1141702_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/002/ERR1141702/ERR1141702_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LG08					E-MTAB-4054:LNC_LG08_Human_ACTGAT_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LG08		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141702												E-MTAB-4054																																																		
ERR1141703	ERX1220552	SAMEA3670239	PRJEB11797	ERS977388	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LG09S	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LG09S	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	3879431	977616612	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141703/LNC_LG09S_Human_GGCTAC_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141703/LNC_LG09S_Human_GGCTAC_R2.fastq.gz						379418684.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141703/LNC_LG09S_Human_GGCTAC_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141703/LNC_LG09S_Human_GGCTAC_R2.fastq.gz			265245850;269164828	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/003/ERR1141703		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141703/LNC_LG09S_Human_GGCTAC_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141703/LNC_LG09S_Human_GGCTAC_R2.fastq.gz							0deb627f5baaf118e5dfa26a269d6e32;a45bde22e7a25e4023d18f33afd20cfc	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141703/ERR1141703_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141703/ERR1141703_2.fastq.gz				317697551;321450437					ftp.sra.ebi.ac.uk/vol1/err/ERR114/003/ERR1141703		83b1cc6bc788be1b15df88141c90b2b4;3f908c005698f458e2844f8a4534c0b6																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						476412575b3e873baa98cb195620e173		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141703/ERR1141703_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141703/ERR1141703_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/003/ERR1141703											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/003/ERR1141703/ERR1141703_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/003/ERR1141703/ERR1141703_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LG09S					E-MTAB-4054:LNC_LG09S_Human_GGCTAC_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LG09S		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141703												E-MTAB-4054																																																		
ERR1141704	ERX1220553	SAMEA3670240	PRJEB11797	ERS977389	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LNC01	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LNC01	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	8301181	2091897612	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141704/LNC_01_Human_CGATGT_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141704/LNC_01_Human_CGATGT_R2.fastq.gz						853661855.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141704/LNC_01_Human_CGATGT_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141704/LNC_01_Human_CGATGT_R2.fastq.gz			590522329;617856607	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/004/ERR1141704		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141704/LNC_01_Human_CGATGT_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141704/LNC_01_Human_CGATGT_R2.fastq.gz							881e7579ec59197a078f6ffe752503f4;9f9b01386266a78303442df105c8bf6c	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/004/ERR1141704/ERR1141704_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/004/ERR1141704/ERR1141704_2.fastq.gz				696550856;726735022					ftp.sra.ebi.ac.uk/vol1/err/ERR114/004/ERR1141704		1b56400468607d780b5d75a0ac6947b7;06933be9d91c1adb3cb0ace508bf72ad																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						41aa5cd3367440995a612353ccc915b4		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/004/ERR1141704/ERR1141704_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/004/ERR1141704/ERR1141704_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/004/ERR1141704											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/004/ERR1141704/ERR1141704_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/004/ERR1141704/ERR1141704_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LNC01					E-MTAB-4054:LNC_01_Human_CGATGT_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LNC01		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141704												E-MTAB-4054																																																		
ERR1141705	ERX1220554	SAMEA3670241	PRJEB11797	ERS977390	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LNC02	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LNC02	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	6750053	1701013356	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141705/LNC_02_Human_TGACCA_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141705/LNC_02_Human_TGACCA_R2.fastq.gz						730260421.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141705/LNC_02_Human_TGACCA_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141705/LNC_02_Human_TGACCA_R2.fastq.gz			514952619;510484204	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/005/ERR1141705		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141705/LNC_02_Human_TGACCA_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141705/LNC_02_Human_TGACCA_R2.fastq.gz							d986c1942a2ded7ac1406a25014ff642;defd581718745dfce14cb7009d174c5c	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/005/ERR1141705/ERR1141705_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/005/ERR1141705/ERR1141705_2.fastq.gz				605565549;599285615					ftp.sra.ebi.ac.uk/vol1/err/ERR114/005/ERR1141705		6b56e3a7cb69eb9237a54bc205779058;954ca66e8d1c04072482e2cc5894101e																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						a259c2ead9584e8be074888463669797		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/005/ERR1141705/ERR1141705_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/005/ERR1141705/ERR1141705_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/005/ERR1141705											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/005/ERR1141705/ERR1141705_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/005/ERR1141705/ERR1141705_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LNC02					E-MTAB-4054:LNC_02_Human_TGACCA_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LNC02		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141705												E-MTAB-4054																																																		
ERR1141706	ERX1220555	SAMEA3670242	PRJEB11797	ERS977391	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LNC03	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LNC03	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	6959202	1753718904	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141706/LNC_03_Human_ACAGTG_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141706/LNC_03_Human_ACAGTG_R2.fastq.gz						737914915.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141706/LNC_03_Human_ACAGTG_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141706/LNC_03_Human_ACAGTG_R2.fastq.gz			525038122;537665973	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/006/ERR1141706		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141706/LNC_03_Human_ACAGTG_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141706/LNC_03_Human_ACAGTG_R2.fastq.gz							a7994a36edcbcc2ec73c0cab7aad1652;82cb6357b8fbc12a0a38188ac7ba8cd5	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/006/ERR1141706/ERR1141706_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/006/ERR1141706/ERR1141706_2.fastq.gz				605482593;619479560					ftp.sra.ebi.ac.uk/vol1/err/ERR114/006/ERR1141706		39e63f76d9339bca9549860323606c89;c575d4e644b4e676bb6e1d8915804eda																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						9224dc082cfe9dfe2116e419183bb31e		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/006/ERR1141706/ERR1141706_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/006/ERR1141706/ERR1141706_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/006/ERR1141706											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/006/ERR1141706/ERR1141706_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/006/ERR1141706/ERR1141706_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LNC03					E-MTAB-4054:LNC_03_Human_ACAGTG_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LNC03		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141706												E-MTAB-4054																																																		
ERR1141707	ERX1220556	SAMEA3670243	PRJEB11797	ERS977392	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LNC04	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LNC04	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	3683988	928364976	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141707/LNC_04_Human_CGATGT_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141707/LNC_04_Human_CGATGT_R2.fastq.gz						361810231.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141707/LNC_04_Human_CGATGT_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141707/LNC_04_Human_CGATGT_R2.fastq.gz			255050944;263762464	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/007/ERR1141707		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141707/LNC_04_Human_CGATGT_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141707/LNC_04_Human_CGATGT_R2.fastq.gz							7ae5b917436d3a265146f1de45d4fdce;e6fe368bb82b89dfa3294847a7b74871	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/007/ERR1141707/ERR1141707_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/007/ERR1141707/ERR1141707_2.fastq.gz				299946635;309513672					ftp.sra.ebi.ac.uk/vol1/err/ERR114/007/ERR1141707		83cab089e950ece08feada3eb12392c5;947d4b61903ae3b36b675a42ad80d58f																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						3cf051beba07b0e61ce7a97fbbe3227e		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/007/ERR1141707/ERR1141707_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/007/ERR1141707/ERR1141707_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/007/ERR1141707											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/007/ERR1141707/ERR1141707_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/007/ERR1141707/ERR1141707_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LNC04					E-MTAB-4054:LNC_04_Human_CGATGT_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LNC04		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141707												E-MTAB-4054																																																		
ERR1141708	ERX1220557	SAMEA3670244	PRJEB11797	ERS977393	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LNC09	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LNC09	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	25772591	5206063382	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141708/LNC_09_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141708/LNC_09_R2.fastq.gz						3582871120.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141708/LNC_09_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141708/LNC_09_R2.fastq.gz			2271491979;2282606995	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/008/ERR1141708		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141708/LNC_09_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141708/LNC_09_R2.fastq.gz							3e8b50329bdbf4c9a39cdd8c1aa2f7f8;5daeb672e8c5ab1d6ef0175b4e5d3da3	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/008/ERR1141708/ERR1141708_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/008/ERR1141708/ERR1141708_2.fastq.gz				2189819391;2202856039					ftp.sra.ebi.ac.uk/vol1/err/ERR114/008/ERR1141708		4502c29b1290a948005fe3ca071fd934;5ce2c028bea92138459b98ec9b363d4b																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						d7ee0b28ff32a04f0e01b563fc315113		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/008/ERR1141708/ERR1141708_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/008/ERR1141708/ERR1141708_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/008/ERR1141708											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/008/ERR1141708/ERR1141708_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/008/ERR1141708/ERR1141708_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LNC09					E-MTAB-4054:LNC_09_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LNC09		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141708												E-MTAB-4054																																																		
ERR1141709	ERX1220558	SAMEA3670245	PRJEB11797	ERS977394	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LNC09_rep	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LNC09_rep	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	4573225	1152452700	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141709/LNC_09_Human_TGACCA_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141709/LNC_09_Human_TGACCA_R2.fastq.gz						450100262.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141709/LNC_09_Human_TGACCA_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141709/LNC_09_Human_TGACCA_R2.fastq.gz			321388067;320046632	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/009/ERR1141709		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141709/LNC_09_Human_TGACCA_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141709/LNC_09_Human_TGACCA_R2.fastq.gz							366e36433b6576cfc59554e849ddd6fc;b0a8e2a9d4a08c931947afdb41449e4e	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/009/ERR1141709/ERR1141709_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/009/ERR1141709/ERR1141709_2.fastq.gz				381045198;378802003					ftp.sra.ebi.ac.uk/vol1/err/ERR114/009/ERR1141709		7b2c1b6f37a5133fee4d99b208a50ae0;942e7614804af6f58857f10032eea8a9																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						fb0d7e2911dc2759a6b491fa254c69ac		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/009/ERR1141709/ERR1141709_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/009/ERR1141709/ERR1141709_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/009/ERR1141709											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/009/ERR1141709/ERR1141709_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/009/ERR1141709/ERR1141709_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LNC09_rep					E-MTAB-4054:LNC_09_Human_TGACCA_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LNC09_rep		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141709												E-MTAB-4054																																																		
ERR1141710	ERX1220559	SAMEA3670246	PRJEB11797	ERS977395	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LNC10	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LNC10	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	10117836	2549694672	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141710/LNC_10_Human_GCCAAT_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141710/LNC_10_Human_GCCAAT_R2.fastq.gz						1059825921.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141710/LNC_10_Human_GCCAAT_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141710/LNC_10_Human_GCCAAT_R2.fastq.gz			748917417;756809259	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/000/ERR1141710		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141710/LNC_10_Human_GCCAAT_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141710/LNC_10_Human_GCCAAT_R2.fastq.gz							8e7051b7d4ddd21800776d03f28dd4da;357b47eaf3c088e646f4cdff9c568573	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/000/ERR1141710/ERR1141710_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/000/ERR1141710/ERR1141710_2.fastq.gz				880494206;889454498					ftp.sra.ebi.ac.uk/vol1/err/ERR114/000/ERR1141710		1d203c9a4a2abf19e3f8ce7b777ced2c;272e5ff3ae1e6aaddc010ceb97cd9a0b																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						940b15d95bddbef2c492c45cf5b6200c		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/000/ERR1141710/ERR1141710_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/000/ERR1141710/ERR1141710_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/000/ERR1141710											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/000/ERR1141710/ERR1141710_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/000/ERR1141710/ERR1141710_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LNC10					E-MTAB-4054:LNC_10_Human_GCCAAT_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LNC10		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141710												E-MTAB-4054																																																		
ERR1141711	ERX1220560	SAMEA3670247	PRJEB11797	ERS977396	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LNC10_rep	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LNC10_rep	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	24134846	4875238892	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141711/LNC_10_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141711/LNC_10_R2.fastq.gz						3364171396.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141711/LNC_10_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141711/LNC_10_R2.fastq.gz			2155809516;2173967380	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/001/ERR1141711		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141711/LNC_10_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141711/LNC_10_R2.fastq.gz							25e10814d6d6e161fcec5f20ce3885fa;687a1d497c5be712cef8a96a14dcdb98	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141711/ERR1141711_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141711/ERR1141711_2.fastq.gz				2078196213;2098108498					ftp.sra.ebi.ac.uk/vol1/err/ERR114/001/ERR1141711		3478045f1e3ddfda13769d7e5b3d3d18;17d7980ec280a0168d697127cd0e0bef																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						b464ab5bd4a4fc2c5b4e386e0a122f48		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141711/ERR1141711_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141711/ERR1141711_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/001/ERR1141711											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/001/ERR1141711/ERR1141711_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/001/ERR1141711/ERR1141711_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LNC10_rep					E-MTAB-4054:LNC_10_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LNC10_rep		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141711												E-MTAB-4054																																																		
ERR1141712	ERX1220561	SAMEA3670248	PRJEB11797	ERS977397	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LNC11	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LNC11	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	17604817	4436413884	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141712/LNC_11_Human_GCCAAT_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141712/LNC_11_Human_GCCAAT_R2.fastq.gz						1771149397.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141712/LNC_11_Human_GCCAAT_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141712/LNC_11_Human_GCCAAT_R2.fastq.gz			1280960823;1287898640	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/002/ERR1141712		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141712/LNC_11_Human_GCCAAT_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141712/LNC_11_Human_GCCAAT_R2.fastq.gz							05fcc05db9d4bbbbc09629c675464a55;ef863a1679ceb51d5cdf6bc8f697d8f8	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141712/ERR1141712_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141712/ERR1141712_2.fastq.gz				1481953181;1487927592					ftp.sra.ebi.ac.uk/vol1/err/ERR114/002/ERR1141712		3d2e7daf1cb6f7c405c819cfcf3845cc;cea137bcde4c4eee0aecf56d4576bcf2																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						72abd38bcdeb5f9080c0c6d9e488321a		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141712/ERR1141712_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141712/ERR1141712_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/002/ERR1141712											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/002/ERR1141712/ERR1141712_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/002/ERR1141712/ERR1141712_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LNC11					E-MTAB-4054:LNC_11_Human_GCCAAT_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LNC11		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141712												E-MTAB-4054																																																		
ERR1141713	ERX1220562	SAMEA3670249	PRJEB11797	ERS977398	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LNC11_rep	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LNC11_rep	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	22086459	4461464718	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141713/LNC_11_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141713/LNC_11_R2.fastq.gz						2821155820.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141713/LNC_11_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141713/LNC_11_R2.fastq.gz			1816216327;1843641703	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/003/ERR1141713		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141713/LNC_11_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141713/LNC_11_R2.fastq.gz							f4fb488f33c325d3e21c8af44f816a07;8cea9037a4cf224c611ee431fc0ae555	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141713/ERR1141713_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141713/ERR1141713_2.fastq.gz				1744734161;1771013089					ftp.sra.ebi.ac.uk/vol1/err/ERR114/003/ERR1141713		22a41bb57f12a632925865779b516453;363a686090a80825f29295aa59d82640																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						987f2e79deb7f361eeadc91062ea7d83		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141713/ERR1141713_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141713/ERR1141713_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/003/ERR1141713											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/003/ERR1141713/ERR1141713_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/003/ERR1141713/ERR1141713_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LNC11_rep					E-MTAB-4054:LNC_11_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LNC11_rep		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141713												E-MTAB-4054																																																		
ERR1141714	ERX1220563	SAMEA3670250	PRJEB11797	ERS977399	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LNC12	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LNC12	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	10649926	2683781352	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141714/LNC_12_Human_CTTGTA_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141714/LNC_12_Human_CTTGTA_R2.fastq.gz						1102053355.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141714/LNC_12_Human_CTTGTA_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141714/LNC_12_Human_CTTGTA_R2.fastq.gz			755608598;788491928	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/004/ERR1141714		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141714/LNC_12_Human_CTTGTA_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141714/LNC_12_Human_CTTGTA_R2.fastq.gz							d66e481a16915ada84ad41a785112694;d410db5255caa0b1c2ac6bc842482161	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/004/ERR1141714/ERR1141714_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/004/ERR1141714/ERR1141714_2.fastq.gz				899566220;937447243					ftp.sra.ebi.ac.uk/vol1/err/ERR114/004/ERR1141714		bd2e4508578f6b3fb3dd23a44c9c2b3a;c5819e7992f5d0b1a083257bcf41e511																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						275ff4f430cc2b4270718a432f1a6364		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/004/ERR1141714/ERR1141714_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/004/ERR1141714/ERR1141714_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/004/ERR1141714											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/004/ERR1141714/ERR1141714_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/004/ERR1141714/ERR1141714_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LNC12					E-MTAB-4054:LNC_12_Human_CTTGTA_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LNC12		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141714												E-MTAB-4054																																																		
ERR1141715	ERX1220564	SAMEA3670251	PRJEB11797	ERS977400	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LNC12_rep	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LNC12_rep	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	31175928	6297537456	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141715/LNC_12_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141715/LNC_12_R2.fastq.gz						4337809085.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141715/LNC_12_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141715/LNC_12_R2.fastq.gz			2753252746;2776868978	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/005/ERR1141715		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141715/LNC_12_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141715/LNC_12_R2.fastq.gz							1f6b3b9f1b7e3b53f45767323702290d;aa5871fe917ccfd922551a2e05c85bbe	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/005/ERR1141715/ERR1141715_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/005/ERR1141715/ERR1141715_2.fastq.gz				2652033901;2677857750					ftp.sra.ebi.ac.uk/vol1/err/ERR114/005/ERR1141715		ab4deb50571aaef415b828cd83caddab;aa8e4ee4d1791bd5c168a0128298773f																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						5495edac517e55ce16de42ec2ddc5d4d		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/005/ERR1141715/ERR1141715_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/005/ERR1141715/ERR1141715_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/005/ERR1141715											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/005/ERR1141715/ERR1141715_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/005/ERR1141715/ERR1141715_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LNC12_rep					E-MTAB-4054:LNC_12_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LNC12_rep		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141715												E-MTAB-4054																																																		
ERR1141716	ERX1220565	SAMEA3670252	PRJEB11797	ERS977401	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LNC13	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LNC13	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	28263328	5709192256	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141716/LNC_13_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141716/LNC_13_R2.fastq.gz						3591523578.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141716/LNC_13_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141716/LNC_13_R2.fastq.gz			2322585239;2345554792	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/006/ERR1141716		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141716/LNC_13_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141716/LNC_13_R2.fastq.gz							bf194b44ab1a62625984bae6e37193bb;3b282859011d0140bfb56173ad84a924	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/006/ERR1141716/ERR1141716_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/006/ERR1141716/ERR1141716_2.fastq.gz				2230286912;2251903993					ftp.sra.ebi.ac.uk/vol1/err/ERR114/006/ERR1141716		c088a5bdb2249316ef4619c71ca69ff7;e1c77d18a748049b45279a05a6c6e82c																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						5bb3468f41adddb44c04ef35f11cb216		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/006/ERR1141716/ERR1141716_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/006/ERR1141716/ERR1141716_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/006/ERR1141716											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/006/ERR1141716/ERR1141716_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/006/ERR1141716/ERR1141716_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LNC13					E-MTAB-4054:LNC_13_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LNC13		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141716												E-MTAB-4054																																																		
ERR1141717	ERX1220566	SAMEA3670253	PRJEB11797	ERS977402	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LNC14	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LNC14	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	19202937	4839140124	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141717/LNC_14_Human_GTGAAA_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141717/LNC_14_Human_GTGAAA_R2.fastq.gz						1942073026.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141717/LNC_14_Human_GTGAAA_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141717/LNC_14_Human_GTGAAA_R2.fastq.gz			1356627693;1348377248	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/007/ERR1141717		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141717/LNC_14_Human_GTGAAA_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141717/LNC_14_Human_GTGAAA_R2.fastq.gz							0f706b9ebf9a7f96bb43b0e09d53912a;d25593b9653bf3315cea54e13d0c4ceb	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/007/ERR1141717/ERR1141717_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/007/ERR1141717/ERR1141717_2.fastq.gz				1625861700;1617970735					ftp.sra.ebi.ac.uk/vol1/err/ERR114/007/ERR1141717		b188841c4cec3b6e700269f39d354007;927ce612afe8a81fe649cdf42418186f																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						36dcf37504de6b9562cbcc1ba248036a		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/007/ERR1141717/ERR1141717_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/007/ERR1141717/ERR1141717_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/007/ERR1141717											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/007/ERR1141717/ERR1141717_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/007/ERR1141717/ERR1141717_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LNC14					E-MTAB-4054:LNC_14_Human_GTGAAA_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LNC14		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141717												E-MTAB-4054																																																		
ERR1141718	ERX1220567	SAMEA3670254	PRJEB11797	ERS977403	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LNC14_rep	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LNC14_rep	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	34290195	6926619390	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141718/LNC_14_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141718/LNC_14_R2.fastq.gz						4764016162.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141718/LNC_14_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141718/LNC_14_R2.fastq.gz			3024209414;3045620038	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/008/ERR1141718		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141718/LNC_14_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141718/LNC_14_R2.fastq.gz							4b2d6a86c52b8a6342b46c0c25c93128;2f4398e121d9e7d881f46aded4bd7e0b	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/008/ERR1141718/ERR1141718_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/008/ERR1141718/ERR1141718_2.fastq.gz				2913096359;2936913631					ftp.sra.ebi.ac.uk/vol1/err/ERR114/008/ERR1141718		643003ea52793b2c4f2d2f413918f957;cd39dd5b3ec12ce9d72cedd3499dcd0d																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						9a47b247c6abce642d39ed94cb67674a		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/008/ERR1141718/ERR1141718_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/008/ERR1141718/ERR1141718_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/008/ERR1141718											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/008/ERR1141718/ERR1141718_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/008/ERR1141718/ERR1141718_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LNC14_rep					E-MTAB-4054:LNC_14_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LNC14_rep		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141718												E-MTAB-4054																																																		
ERR1141719	ERX1220568	SAMEA3670255	PRJEB11797	ERS977404	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LNC15	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LNC15	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	25936544	5239181888	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141719/LNC_15_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141719/LNC_15_R2.fastq.gz						3287623215.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141719/LNC_15_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141719/LNC_15_R2.fastq.gz			2141459158;2159605224	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/009/ERR1141719		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141719/LNC_15_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141719/LNC_15_R2.fastq.gz							cee70c21771b1c37c7107fe6ff2b2412;da884b6f9c70237d898fb149fa033386	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/009/ERR1141719/ERR1141719_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/009/ERR1141719/ERR1141719_2.fastq.gz				2057039474;2074078834					ftp.sra.ebi.ac.uk/vol1/err/ERR114/009/ERR1141719		be39ebab8cdb0104414bb17fae316615;ced24ab658a5d4c056359bb9e1e9a2bf																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						ef5110c192dd7d1005786322651811d7		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/009/ERR1141719/ERR1141719_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/009/ERR1141719/ERR1141719_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/009/ERR1141719											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/009/ERR1141719/ERR1141719_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/009/ERR1141719/ERR1141719_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LNC15					E-MTAB-4054:LNC_15_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LNC15		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141719												E-MTAB-4054																																																		
ERR1141720	ERX1220569	SAMEA3670256	PRJEB11797	ERS977405	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LNC_06S	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LNC_06S	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	4988575	1257120900	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141720/LNC_06S_Human_ATCACG_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141720/LNC_06S_Human_ATCACG_R2.fastq.gz						538812092.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141720/LNC_06S_Human_ATCACG_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141720/LNC_06S_Human_ATCACG_R2.fastq.gz			382676307;377055835	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/000/ERR1141720		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141720/LNC_06S_Human_ATCACG_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141720/LNC_06S_Human_ATCACG_R2.fastq.gz							5d43a6449dd9d06dfdb169e569ee21c8;cefc7f13588322c4c35978462cb5c0a4	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/000/ERR1141720/ERR1141720_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/000/ERR1141720/ERR1141720_2.fastq.gz				451572690;444027092					ftp.sra.ebi.ac.uk/vol1/err/ERR114/000/ERR1141720		b9bc6601fe28c55eba863dd7729e063c;983fa3ce9f80b3504a3efbea6f86263a																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						c77a7df55173a74c73500dc408cb4d84		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/000/ERR1141720/ERR1141720_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/000/ERR1141720/ERR1141720_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/000/ERR1141720											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/000/ERR1141720/ERR1141720_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/000/ERR1141720/ERR1141720_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LNC_06S					E-MTAB-4054:LNC_06S_Human_ATCACG_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LNC_06S		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141720												E-MTAB-4054																																																		
ERR1141721	ERX1220570	SAMEA3670257	PRJEB11797	ERS977406	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LNC_07S	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LNC_07S	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	5139540	1295164080	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141721/LNC_07S_Human_TTAGGC_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141721/LNC_07S_Human_TTAGGC_R2.fastq.gz						532970498.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141721/LNC_07S_Human_TTAGGC_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141721/LNC_07S_Human_TTAGGC_R2.fastq.gz			370572004;376019758	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/001/ERR1141721		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141721/LNC_07S_Human_TTAGGC_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141721/LNC_07S_Human_TTAGGC_R2.fastq.gz							b49f97e45e2b728c4134e26eeebc797d;c528bfc997df85a0756c6443b3e689c2	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141721/ERR1141721_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141721/ERR1141721_2.fastq.gz				441277583;447054344					ftp.sra.ebi.ac.uk/vol1/err/ERR114/001/ERR1141721		5e9eb322b8d0f0c6d534065ee66e0683;cf27539f14c3fabcd24edbfea30b2307																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						e9df91710fa26385cef324f720ce03c1		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141721/ERR1141721_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141721/ERR1141721_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/001/ERR1141721											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/001/ERR1141721/ERR1141721_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/001/ERR1141721/ERR1141721_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LNC_07S					E-MTAB-4054:LNC_07S_Human_TTAGGC_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LNC_07S		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141721												E-MTAB-4054																																																		
ERR1141722	ERX1220571	SAMEA3670258	PRJEB11797	ERS977407	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	LNC_09S	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	LNC_09S	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	17456455	3526203910	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141722/LNC_09S_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141722/LNC_09S_R2.fastq.gz						2230805702.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141722/LNC_09S_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141722/LNC_09S_R2.fastq.gz			1417458410;1437949770	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/002/ERR1141722		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141722/LNC_09S_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141722/LNC_09S_R2.fastq.gz							1acac082713c9f44bdbf0514f8815263;ae143979b502dc9217c432af3fdcada2	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141722/ERR1141722_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141722/ERR1141722_2.fastq.gz				1361323657;1380790582					ftp.sra.ebi.ac.uk/vol1/err/ERR114/002/ERR1141722		55274128721f703520ce7d8716d4661c;21b29ffc585b885071ad03e3d32a5ab5																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						6f48a3c9b5f7e580a7fa85916debe1ca		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141722/ERR1141722_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141722/ERR1141722_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/002/ERR1141722											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/002/ERR1141722/ERR1141722_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/002/ERR1141722/ERR1141722_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:LNC_09S					E-MTAB-4054:LNC_09S_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:LNC_09S		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141722												E-MTAB-4054																																																		
ERR1141723	ERX1220572	SAMEA3670259	PRJEB11797	ERS977408	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	N01	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	N01	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	21498932	4342784264	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141723/LNC_N01_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141723/LNC_N01_R2.fastq.gz						2755937630.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141723/LNC_N01_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141723/LNC_N01_R2.fastq.gz			1743051787;1771155302	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/003/ERR1141723		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141723/LNC_N01_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141723/LNC_N01_R2.fastq.gz							fd4fd3666ed224fb56e832e634031bf7;1718919cb6e1ae41e61627435ea7cc19	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141723/ERR1141723_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141723/ERR1141723_2.fastq.gz				1673547983;1700501869					ftp.sra.ebi.ac.uk/vol1/err/ERR114/003/ERR1141723		a3c4a4418a9c9359655fc7507a673892;46d69be2869947ac52d34734fae237e2																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						1faeb35e82e9a9b36be5317a580202e5		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141723/ERR1141723_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141723/ERR1141723_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/003/ERR1141723											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/003/ERR1141723/ERR1141723_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/003/ERR1141723/ERR1141723_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:N01					E-MTAB-4054:LNC_N01_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:N01		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141723												E-MTAB-4054																																																		
ERR1141724	ERX1220573	SAMEA3670260	PRJEB11797	ERS977409	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	N02	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	N02	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	25359857	5122691114	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141724/LNC_N02_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141724/LNC_N02_R2.fastq.gz						3239945491.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141724/LNC_N02_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141724/LNC_N02_R2.fastq.gz			2060642295;2084113810	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/004/ERR1141724		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141724/LNC_N02_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141724/LNC_N02_R2.fastq.gz							3def61ac49e540c0e3393dec3ccfaeea;bdc4de0007a0928debd33f4e85ac989d	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/004/ERR1141724/ERR1141724_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/004/ERR1141724/ERR1141724_2.fastq.gz				1978449135;2000684962					ftp.sra.ebi.ac.uk/vol1/err/ERR114/004/ERR1141724		d4f93fb4ec7d54b6afc385bf4037f920;ce35a96bc792d7807ec3f3180201160f																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						39d366087d3c3f2455a53fbfae3f14cf		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/004/ERR1141724/ERR1141724_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/004/ERR1141724/ERR1141724_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/004/ERR1141724											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/004/ERR1141724/ERR1141724_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/004/ERR1141724/ERR1141724_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:N02					E-MTAB-4054:LNC_N02_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:N02		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141724												E-MTAB-4054																																																		
ERR1141725	ERX1220574	SAMEA3670261	PRJEB11797	ERS977410	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	N03	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	N03	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	17667885	3568912770	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141725/LNC_N03_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141725/LNC_N03_R2.fastq.gz						2456184246.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141725/LNC_N03_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141725/LNC_N03_R2.fastq.gz			1551328633;1552364251	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/005/ERR1141725		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141725/LNC_N03_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141725/LNC_N03_R2.fastq.gz							5d6412ba955b56ef3a74551ce358b2ca;8467c6953424d9039780e2d23f055779	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/005/ERR1141725/ERR1141725_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/005/ERR1141725/ERR1141725_2.fastq.gz				1494966130;1497224694					ftp.sra.ebi.ac.uk/vol1/err/ERR114/005/ERR1141725		944d8de2bfc17e28736147ee6c817370;fd0b9dd7a2fee08a1ab88dbd5ea3da11																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						26c3bc78df471995f86d04276488ebdc		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/005/ERR1141725/ERR1141725_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/005/ERR1141725/ERR1141725_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/005/ERR1141725											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/005/ERR1141725/ERR1141725_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/005/ERR1141725/ERR1141725_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:N03					E-MTAB-4054:LNC_N03_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:N03		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141725												E-MTAB-4054																																																		
ERR1141726	ERX1220575	SAMEA3670262	PRJEB11797	ERS977411	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	N04	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	N04	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	24053804	6061558608	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141726/LNC_N04_Human_AGTTCC_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141726/LNC_N04_Human_AGTTCC_R2.fastq.gz						2364575203.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141726/LNC_N04_Human_AGTTCC_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141726/LNC_N04_Human_AGTTCC_R2.fastq.gz			1611403397;1672016282	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/006/ERR1141726		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141726/LNC_N04_Human_AGTTCC_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141726/LNC_N04_Human_AGTTCC_R2.fastq.gz							409b74b12f13ac3fcb03d29952a56bd3;176c3d0e2728859f2985c178ce092052	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/006/ERR1141726/ERR1141726_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/006/ERR1141726/ERR1141726_2.fastq.gz				1949037733;2016850818					ftp.sra.ebi.ac.uk/vol1/err/ERR114/006/ERR1141726		30877abdb646ba00e6f2320ee36042b4;a3bb8d65e7ada340fd7fd7298927b33f																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						515759d15945ca5148fc64e3ca6fec80		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/006/ERR1141726/ERR1141726_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/006/ERR1141726/ERR1141726_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/006/ERR1141726											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/006/ERR1141726/ERR1141726_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/006/ERR1141726/ERR1141726_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:N04					E-MTAB-4054:LNC_N04_Human_AGTTCC_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:N04		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141726												E-MTAB-4054																																																		
ERR1141727	ERX1220576	SAMEA3670263	PRJEB11797	ERS977412	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	N04_rep	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	N04_rep	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	22406813	4526176226	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141727/LNC_N04_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141727/LNC_N04_R2.fastq.gz						3121763786.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141727/LNC_N04_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141727/LNC_N04_R2.fastq.gz			1976020550;1991098720	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/007/ERR1141727		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141727/LNC_N04_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141727/LNC_N04_R2.fastq.gz							99a5984cf8aa787ccc95ef490397b466;76545f6b1d9c7bc5ec7ee14a40025e5c	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/007/ERR1141727/ERR1141727_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/007/ERR1141727/ERR1141727_2.fastq.gz				1904088415;1920942878					ftp.sra.ebi.ac.uk/vol1/err/ERR114/007/ERR1141727		dda98668afde4db468a4cf6ac2b60cf4;bde3c7db667afb205a1ae5ccdc760993																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						32dc59fa430823e30439f3a69b61f273		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/007/ERR1141727/ERR1141727_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/007/ERR1141727/ERR1141727_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/007/ERR1141727											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/007/ERR1141727/ERR1141727_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/007/ERR1141727/ERR1141727_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:N04_rep					E-MTAB-4054:LNC_N04_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:N04_rep		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141727												E-MTAB-4054																																																		
ERR1141728	ERX1220577	SAMEA3670264	PRJEB11797	ERS977413	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	N05	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	N05	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	13630223	2753305046	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141728/LNC_N05_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141728/LNC_N05_R2.fastq.gz						1897283013.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141728/LNC_N05_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141728/LNC_N05_R2.fastq.gz			1199546458;1206514438	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/008/ERR1141728		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141728/LNC_N05_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141728/LNC_N05_R2.fastq.gz							7e8ff73c9799a893961f4562a6892082;00c73455fa4c479ed62c55094a981810	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/008/ERR1141728/ERR1141728_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/008/ERR1141728/ERR1141728_2.fastq.gz				1156512582;1164484883					ftp.sra.ebi.ac.uk/vol1/err/ERR114/008/ERR1141728		4d9b89b7e5376d6d6f0f2ffdf3d3c566;35be201bf47c52b9fb54972b42707058																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						69f1d6313ca6392324619ad36a56fa86		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/008/ERR1141728/ERR1141728_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/008/ERR1141728/ERR1141728_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/008/ERR1141728											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/008/ERR1141728/ERR1141728_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/008/ERR1141728/ERR1141728_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:N05					E-MTAB-4054:LNC_N05_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:N05		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141728												E-MTAB-4054																																																		
ERR1141729	ERX1220578	SAMEA3670265	PRJEB11797	ERS977414	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	N06	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	N06	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	25481668	5147296936	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141729/LNC_N06_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141729/LNC_N06_R2.fastq.gz						3548523580.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141729/LNC_N06_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141729/LNC_N06_R2.fastq.gz			2241362412;2248581724	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/009/ERR1141729		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141729/LNC_N06_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141729/LNC_N06_R2.fastq.gz							167444c464e0130a064bb95d5bbc37fe;c14378db1a09889c9cfcb2b71cd2f1d2	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/009/ERR1141729/ERR1141729_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/009/ERR1141729/ERR1141729_2.fastq.gz				2159776011;2169008810					ftp.sra.ebi.ac.uk/vol1/err/ERR114/009/ERR1141729		641d8a4ffa5281a7976f8f2ecef26171;1e40429a10652408059ae21b2ea4a241																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						227c7ec85631145badf93744c2700817		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/009/ERR1141729/ERR1141729_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/009/ERR1141729/ERR1141729_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/009/ERR1141729											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/009/ERR1141729/ERR1141729_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/009/ERR1141729/ERR1141729_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:N06					E-MTAB-4054:LNC_N06_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:N06		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141729												E-MTAB-4054																																																		
ERR1141730	ERX1220579	SAMEA3670266	PRJEB11797	ERS977415	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	N08	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	N08	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	27318469	6884254188	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141730/LNC_N08_Human_CCGTCC_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141730/LNC_N08_Human_CCGTCC_R2.fastq.gz						2942218576.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141730/LNC_N08_Human_CCGTCC_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141730/LNC_N08_Human_CCGTCC_R2.fastq.gz			2057410192;2082100859	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/000/ERR1141730		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141730/LNC_N08_Human_CCGTCC_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141730/LNC_N08_Human_CCGTCC_R2.fastq.gz							b56a7714c69e7bf6d4c822bdb9beef89;ed06b8901eda26aba2f40a6bc1c32e16	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/000/ERR1141730/ERR1141730_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/000/ERR1141730/ERR1141730_2.fastq.gz				2423425752;2446079454					ftp.sra.ebi.ac.uk/vol1/err/ERR114/000/ERR1141730		9d96a4887e0b15539b7c21203f7ad088;c10ef42ffd105d405f346c72286da612																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						4adc34150b163b64b6334f37bf4de288		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/000/ERR1141730/ERR1141730_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/000/ERR1141730/ERR1141730_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/000/ERR1141730											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/000/ERR1141730/ERR1141730_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/000/ERR1141730/ERR1141730_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:N08					E-MTAB-4054:LNC_N08_Human_CCGTCC_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:N08		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141730												E-MTAB-4054																																																		
ERR1141731	ERX1220580	SAMEA3670267	PRJEB11797	ERS977416	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	N08_rep	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	N08_rep	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	27998762	5655749924	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141731/LNC_N08_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141731/LNC_N08_R2.fastq.gz						3590622898.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141731/LNC_N08_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141731/LNC_N08_R2.fastq.gz			2284361000;2313503635	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/001/ERR1141731		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141731/LNC_N08_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141731/LNC_N08_R2.fastq.gz							436f495562b417f77e5e174d6d876904;3c46f0220a8dcdf279e955351c5cc602	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141731/ERR1141731_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141731/ERR1141731_2.fastq.gz				2193177401;2220944383					ftp.sra.ebi.ac.uk/vol1/err/ERR114/001/ERR1141731		cb5ec8baf029982678a8ed512e94048b;44159dcb4df8cf8298ef5c7820661082																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						2714262ff74c2f82802f5d7412870b74		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141731/ERR1141731_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/001/ERR1141731/ERR1141731_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/001/ERR1141731											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/001/ERR1141731/ERR1141731_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/001/ERR1141731/ERR1141731_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:N08_rep					E-MTAB-4054:LNC_N08_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:N08_rep		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141731												E-MTAB-4054																																																		
ERR1141732	ERX1220581	SAMEA3670268	PRJEB11797	ERS977417	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	N09	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	N09	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	21978924	4439742648	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141732/LNC_N09_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141732/LNC_N09_R2.fastq.gz						2810180321.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141732/LNC_N09_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141732/LNC_N09_R2.fastq.gz			1786455911;1806801005	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/002/ERR1141732		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141732/LNC_N09_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141732/LNC_N09_R2.fastq.gz							6f3a103acf2c828081537c10d7a635fe;f417c749522046c64158ab3a474f6a4c	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141732/ERR1141732_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141732/ERR1141732_2.fastq.gz				1715311339;1734542852					ftp.sra.ebi.ac.uk/vol1/err/ERR114/002/ERR1141732		ea4b603eed63f9d07c56f3b5f2c5dacc;969a246c09d05d3130ee47712a6c4dda																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						b9409e04e04f1a39fb516d5120ace2ff		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141732/ERR1141732_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/002/ERR1141732/ERR1141732_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/002/ERR1141732											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/002/ERR1141732/ERR1141732_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/002/ERR1141732/ERR1141732_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:N09					E-MTAB-4054:LNC_N09_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:N09		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141732												E-MTAB-4054																																																		
ERR1141733	ERX1220582	SAMEA3670269	PRJEB11797	ERS977418	ERP013206			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	N10	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	Protocols: The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.	N10	RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	27171708	5488685016	Homo sapiens		2017-07-23	2018-11-16	Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	ERA535277					RANDOM						ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141733/LNC_N10_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141733/LNC_N10_R2.fastq.gz						3473703879.0					ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141733/LNC_N10_R1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/run/ERR114/ERR1141733/LNC_N10_R2.fastq.gz			2208995148;2238562916	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/err/ERR114/003/ERR1141733		fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141733/LNC_N10_R1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/run/ERR114/ERR1141733/LNC_N10_R2.fastq.gz							38fb2e540b4cf0957d3509162d6196f4;cb82ad29a893a91d3cdc32615e234aea	ERC000011	ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141733/ERR1141733_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141733/ERR1141733_2.fastq.gz				2120386123;2148650481					ftp.sra.ebi.ac.uk/vol1/err/ERR114/003/ERR1141733		2c9f4695e1b1bd372ea624f11881ef0f;27d0774cb29110bb381d4b2dad71e1e3																			Illumina HiSeq 2500 paired end sequencing: Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's	29.0						b638070b139f90d8eda98b461e43bda5		ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141733/ERR1141733_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/ERR114/003/ERR1141733/ERR1141733_2.fastq.gz			ArrayExpress						ftp.sra.ebi.ac.uk/vol1/err/ERR114/003/ERR1141733											dcc_arrayexpress									290.0			public			fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/003/ERR1141733/ERR1141733_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/ERR114/003/ERR1141733/ERR1141733_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			E-MTAB-4054:N10					E-MTAB-4054:LNC_N10_R			PAIRED;PAIRED	The NSq, BE, LGD tissue samples were collected at endoscopies performed at St Vincents Hospital, Sydney, Australia. These were obtained from patients prospectively enrolled in an Australia-wide research collaboration entitled PROBE-NET: Progression of Barretts Esophagus to Esophageal Adenocarcinoma Network. The EAC specimens were either obtained from patients at St Vincents Hospital or the Department of Surgery at Flinders University, Adelaide, Australia. All cancer specimens were pre-treatment, biopsies from radio-chemotherapy naive patients. All tissue samples were collected from the tubular esophagus at or above the gastroesophageal junction, which was defined as the proximal border of the gastric rugal folds. In patients with BE or LGD, a columnar mucosal segment of at least 1 cm was required for inclusion in the present study. Prior to RNA isolation, histologic sections of all tissue specimens were reviewed by three experienced GI-pathologists to verify the correct diagnosis and determined tissue cellularity. Samples had to contain a minimum of 50% diagnosis defining specialized epithelium to be deemed suitable for RNA extraction. RNA extraction and quality control prior to cDNA library construction After tissue-homogenization using a Polytron Homogenizer PT 3100 (Thomas Scientific, Swedesboro, NJ) RNA extraction was performed using the QIAGEN RNeasy Mini Kit, (Cat #74104, QIAGEN, Valencia, CA) following the manufacturers protocol. RNA yield and quality was measured using a BioSpec nano spectrophotometer (Shimadzu Scientific Instruments, Sydney, Australia) and integrity was verified on a Bioanalyzer separation chip (Agilent Technologies, Forest Hill, Victoria, Australia). 260/280 ratios were > 2.0 for all cases and a minimum RNA Integrity Number (RIN) of 6 required for samples to be taken forward to library preparation for RNA sequencing. Median RNA yield per sample was 5.9 g (IQR 3.3 10.5g) with a median amount of RNA sequenced per sample being 3.3 g (2.1 4.0g). 500ng of total RNA was used as input material for library preparation using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, USA) according to manufacturers instructions. Individual libraries were indexed as recommended by Illumina. Indexed DNA libraries were analyzed individually using an Agilent Technologies 2100 Bioanalyzer with the DNA 1000 kit according to the manufacturers instructions (Agilent Technologies, USA). Libraries were diluted and pooled to a final concentration of 10 nM each in nuclease-free H2O (Ambion, USA). Pooled libraries were quantitated using a Life Technologies Qubit 2.0 Fluorometer with the Qubit dsDNA HS Assay Kit (Life Technologies, USA) and further diluted to 2 nM. Final DNA library concentration was confirmed using a Qubit dsDNA HS Assay Kit. PCR-competent library DNA concentration was verified using the universal KAPA Library Quantification Kit for Illumina Sequencing Platforms according to manufacturers instructions (KAPA Biosystems, USA). An Applied Biosystems 7900HT Fast Real-Time PCR machine (Life Technologies, USA) was used for quantitative real-time PCR.		E-MTAB-4054:N10		European Bioinformatics Institute;Garvan Institute of Medical Research					env_tax;env_tax:terrestrial	2015-11-17				9606	FASTQ;FASTQ								ERR1141733												E-MTAB-4054																																																		
SRR5230942	SRX2539420	SAMN06299372	PRJNA371455	SRS1959132	SRP098903			Illumina HiSeq 2500 sequencing: GSM2477948: EAC RNA-Seq #1 Homo sapiens RNA-Seq	EAC RNA-Seq #1	Epigenetic repression via DNA methylation and trimethylation of H3K27 alters gene expression in esophageal adenocarcinoma [RNA-Seq]	EAC RNA-Seq #1		RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	114929398	8274916656	Homo sapiens		2019-02-09	2019-02-09	Homo sapiens	SRA535784					cDNA												3086413289.0								2264609728;2501014400	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR523/002/SRR5230942											ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/002/SRR5230942/SRR5230942_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/002/SRR5230942/SRR5230942_2.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR523/002/SRR5230942		a497ad28dee4f15831abd3689f066512;388bc3d95a6a1c6f18b249a235efb193																			Illumina HiSeq 2500 sequencing: GSM2477948: EAC RNA-Seq #1 Homo sapiens RNA-Seq							f00df2243053d12382497b7509ac23bf		ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/002/SRR5230942/SRR5230942_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/002/SRR5230942/SRR5230942_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR523/002/SRR5230942							adult																public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR523/002/SRR5230942/SRR5230942_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR523/002/SRR5230942/SRR5230942_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM2477948					GSM2477948_r1				Total RNA was extracted using TRIzol reagent (Invitrogen/Life Technologies #15596-026). Libraries were prepared according to instructions forIllumina RNA-Seq library preparation kit with Ribozero.		GSM2477948		GEO					env_tax;env_tax:terrestrial	2019-02-09				9606									SRR5230942												GSE94544					esophagus																																													
SRR5230943	SRX2539420	SAMN06299372	PRJNA371455	SRS1959132	SRP098903			Illumina HiSeq 2500 sequencing: GSM2477948: EAC RNA-Seq #1 Homo sapiens RNA-Seq	EAC RNA-Seq #1	Epigenetic repression via DNA methylation and trimethylation of H3K27 alters gene expression in esophageal adenocarcinoma [RNA-Seq]	EAC RNA-Seq #1		RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	6562858	472525776	Homo sapiens		2019-02-09	2019-02-09	Homo sapiens	SRA535784					cDNA												164241678.0								121652146;131683867	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR523/003/SRR5230943											ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/003/SRR5230943/SRR5230943_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/003/SRR5230943/SRR5230943_2.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR523/003/SRR5230943		b0ee99f507e79979ca9a90b5298cf4ec;063e0c7d0cebb74de85740c750dba6c0																			Illumina HiSeq 2500 sequencing: GSM2477948: EAC RNA-Seq #1 Homo sapiens RNA-Seq							f27f8f9f84a57a83b275dcce8b0db6b7		ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/003/SRR5230943/SRR5230943_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/003/SRR5230943/SRR5230943_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR523/003/SRR5230943							adult																public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR523/003/SRR5230943/SRR5230943_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR523/003/SRR5230943/SRR5230943_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM2477948					GSM2477948_r2				Total RNA was extracted using TRIzol reagent (Invitrogen/Life Technologies #15596-026). Libraries were prepared according to instructions forIllumina RNA-Seq library preparation kit with Ribozero.		GSM2477948		GEO					env_tax;env_tax:terrestrial	2019-02-09				9606									SRR5230943												GSE94544					esophagus																																													
SRR5230944	SRX2539421	SAMN06299373	PRJNA371455	SRS1959133	SRP098903			Illumina HiSeq 2500 sequencing: GSM2477949: EAC RNA-Seq #2 Homo sapiens RNA-Seq	EAC RNA-Seq #2	Epigenetic repression via DNA methylation and trimethylation of H3K27 alters gene expression in esophageal adenocarcinoma [RNA-Seq]	EAC RNA-Seq #2		RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	4946529	356150088	Homo sapiens		2019-02-09	2019-02-09	Homo sapiens	SRA535784					cDNA												141309532.0								101173160;109411164	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR523/004/SRR5230944											ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/004/SRR5230944/SRR5230944_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/004/SRR5230944/SRR5230944_2.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR523/004/SRR5230944		fab722ebf4b3e61f6af2a28335c4befb;f81d019a9ce28d45cf0c215f6f95fa9a																			Illumina HiSeq 2500 sequencing: GSM2477949: EAC RNA-Seq #2 Homo sapiens RNA-Seq							2c7824598735da3c049a32bf081f5f7d		ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/004/SRR5230944/SRR5230944_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/004/SRR5230944/SRR5230944_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR523/004/SRR5230944							adult																public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR523/004/SRR5230944/SRR5230944_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR523/004/SRR5230944/SRR5230944_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM2477949					GSM2477949_r1				Total RNA was extracted using TRIzol reagent (Invitrogen/Life Technologies #15596-026). Libraries were prepared according to instructions forIllumina RNA-Seq library preparation kit with Ribozero.		GSM2477949		GEO					env_tax;env_tax:terrestrial	2019-02-09				9606									SRR5230944												GSE94544					esophagus																																													
SRR5230945	SRX2539421	SAMN06299373	PRJNA371455	SRS1959133	SRP098903			Illumina HiSeq 2500 sequencing: GSM2477949: EAC RNA-Seq #2 Homo sapiens RNA-Seq	EAC RNA-Seq #2	Epigenetic repression via DNA methylation and trimethylation of H3K27 alters gene expression in esophageal adenocarcinoma [RNA-Seq]	EAC RNA-Seq #2		RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	162602085	11707350120	Homo sapiens		2019-02-09	2019-02-09	Homo sapiens	SRA535784					cDNA												4314723336.0								3094567594;3240765884	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR523/005/SRR5230945											ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/005/SRR5230945/SRR5230945_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/005/SRR5230945/SRR5230945_2.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR523/005/SRR5230945		888ab2478eb4efd9cb4a8fcd78782a6f;7d98b2f4a4f7436ec31133d0f9677fea																			Illumina HiSeq 2500 sequencing: GSM2477949: EAC RNA-Seq #2 Homo sapiens RNA-Seq							f612450677a6acec6d71d45be4609aa4		ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/005/SRR5230945/SRR5230945_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/005/SRR5230945/SRR5230945_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR523/005/SRR5230945							adult																public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR523/005/SRR5230945/SRR5230945_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR523/005/SRR5230945/SRR5230945_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM2477949					GSM2477949_r2				Total RNA was extracted using TRIzol reagent (Invitrogen/Life Technologies #15596-026). Libraries were prepared according to instructions forIllumina RNA-Seq library preparation kit with Ribozero.		GSM2477949		GEO					env_tax;env_tax:terrestrial	2019-02-09				9606									SRR5230945												GSE94544					esophagus																																													
SRR5230946	SRX2539421	SAMN06299373	PRJNA371455	SRS1959133	SRP098903			Illumina HiSeq 2500 sequencing: GSM2477949: EAC RNA-Seq #2 Homo sapiens RNA-Seq	EAC RNA-Seq #2	Epigenetic repression via DNA methylation and trimethylation of H3K27 alters gene expression in esophageal adenocarcinoma [RNA-Seq]	EAC RNA-Seq #2		RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	4632018	333505296	Homo sapiens		2019-02-09	2019-02-09	Homo sapiens	SRA535784					cDNA												136546269.0								94967543;107740434	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR523/006/SRR5230946											ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/006/SRR5230946/SRR5230946_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/006/SRR5230946/SRR5230946_2.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR523/006/SRR5230946		b1c31b3b25f214e4ff253abd019059d9;0196d9c61b7d224e45a0b3e8eac8a6b7																			Illumina HiSeq 2500 sequencing: GSM2477949: EAC RNA-Seq #2 Homo sapiens RNA-Seq							582410fa41e6e36ac14c3444a972f0f7		ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/006/SRR5230946/SRR5230946_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/006/SRR5230946/SRR5230946_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR523/006/SRR5230946							adult																public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR523/006/SRR5230946/SRR5230946_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR523/006/SRR5230946/SRR5230946_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM2477949					GSM2477949_r3				Total RNA was extracted using TRIzol reagent (Invitrogen/Life Technologies #15596-026). Libraries were prepared according to instructions forIllumina RNA-Seq library preparation kit with Ribozero.		GSM2477949		GEO					env_tax;env_tax:terrestrial	2019-02-09				9606									SRR5230946												GSE94544					esophagus																																													
SRR5230947	SRX2539422	SAMN06299371	PRJNA371455	SRS1959134	SRP098903			Illumina HiSeq 2500 sequencing: GSM2477950: Control RNA-Seq Homo sapiens RNA-Seq	Control RNA-Seq	Epigenetic repression via DNA methylation and trimethylation of H3K27 alters gene expression in esophageal adenocarcinoma [RNA-Seq]	Control RNA-Seq		RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	85298784	6141512448	Homo sapiens		2019-02-09	2019-02-09	Homo sapiens	SRA535784					cDNA												2253426595.0								1595671827;1673720894	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR523/007/SRR5230947											ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/007/SRR5230947/SRR5230947_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/007/SRR5230947/SRR5230947_2.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR523/007/SRR5230947		c3cb7449359e07e4ba06b4334a5965f6;93ddbd0212bc9c3a58d25c68e29937f4																			Illumina HiSeq 2500 sequencing: GSM2477950: Control RNA-Seq Homo sapiens RNA-Seq							2d35c6cfb16b909f835427d49301409b		ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/007/SRR5230947/SRR5230947_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/007/SRR5230947/SRR5230947_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR523/007/SRR5230947							adult																public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR523/007/SRR5230947/SRR5230947_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR523/007/SRR5230947/SRR5230947_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM2477950					GSM2477950_r1				Total RNA was extracted using TRIzol reagent (Invitrogen/Life Technologies #15596-026). Libraries were prepared according to instructions forIllumina RNA-Seq library preparation kit with Ribozero.		GSM2477950		GEO					env_tax;env_tax:terrestrial	2019-02-09				9606									SRR5230947												GSE94544					esophagus																																													
SRR5230948	SRX2539422	SAMN06299371	PRJNA371455	SRS1959134	SRP098903			Illumina HiSeq 2500 sequencing: GSM2477950: Control RNA-Seq Homo sapiens RNA-Seq	Control RNA-Seq	Epigenetic repression via DNA methylation and trimethylation of H3K27 alters gene expression in esophageal adenocarcinoma [RNA-Seq]	Control RNA-Seq		RNA-Seq	TRANSCRIPTOMIC	PAIRED	Illumina HiSeq 2500	7240810	521338320	Homo sapiens		2019-02-09	2019-02-09	Homo sapiens	SRA535784					cDNA												184601726.0								125190310;137443521	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR523/008/SRR5230948											ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/008/SRR5230948/SRR5230948_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/008/SRR5230948/SRR5230948_2.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR523/008/SRR5230948		f4d7de2fb402d1b94edf57ec42e00181;6a32ad6d23e075af5a2cd7fca42132d3																			Illumina HiSeq 2500 sequencing: GSM2477950: Control RNA-Seq Homo sapiens RNA-Seq							98837c6a302ec79473334ed060e3868b		ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/008/SRR5230948/SRR5230948_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR523/008/SRR5230948/SRR5230948_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR523/008/SRR5230948							adult																public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR523/008/SRR5230948/SRR5230948_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR523/008/SRR5230948/SRR5230948_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM2477950					GSM2477950_r2				Total RNA was extracted using TRIzol reagent (Invitrogen/Life Technologies #15596-026). Libraries were prepared according to instructions forIllumina RNA-Seq library preparation kit with Ribozero.		GSM2477950		GEO					env_tax;env_tax:terrestrial	2019-02-09				9606									SRR5230948												GSE94544					esophagus																																													
SRR14447349	SRX10798367	SAMN19025613	PRJNA727596	SRS8885036	SRP318653			NextSeq 500 sequencing: GSM5283361: OAC44N Homo sapiens RNA-Seq	OAC44N	Single Cell RNA sequencing (DropSeq) of esophageal adenocarcinoma and matched normal samples	OAC44N		RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	100513442	7035940940	Homo sapiens		2021-05-09	2021-05-09	Single Cell RNA sequencing (DropSeq) of esophageal adenocarcinoma and matched normal samples	SRA1229013					cDNA												3356669663.0								1654098093;3835579951	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR144/049/SRR14447349											ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/049/SRR14447349/SRR14447349_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/049/SRR14447349/SRR14447349_2.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR144/049/SRR14447349		1028641263dccd4bea46730a9ed3b945;fd308b60f882b01b2a8cb8e0a3e9a6a4																			NextSeq 500 sequencing: GSM5283361: OAC44N Homo sapiens RNA-Seq							7407b5e71d5d5aab4924ed073877a019		ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/049/SRR14447349/SRR14447349_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/049/SRR14447349/SRR14447349_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR144/049/SRR14447349																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR144/049/SRR14447349/SRR14447349_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR144/049/SRR14447349/SRR14447349_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5283361					GSM5283361_r1				Samples were relocated to the laboratory and placed in a tissue culture hood, moved to a petri dish and washed with PBS-A and then minced with a scalpel to approximately 1mm chunks. Minced tissue was transferred to a 50ml Falcon tube with 5ml of DMEM complete 100 ul of 150 U/ml Collagenase P and 100 ul of10 mg/ml DNase. The samples were placed in an incubator at 37o C with agitation for 60 minutes and disturbed at 15 minutes and 30 minutes with pipettes. Samples were then passed through a 70 um strainer and 10 ml of empty DMEM added. Cells were then pelleted using centrifugation and media aspirated. Cells were resuspended in RBC lysis solution and incubated at 4oC for 10 minutes, 10 ml of empty DMEM was added and the suspension was passed through a 40 um strainer before being pelleted and resuspended in either 1 ml PBS or 1 ml of cell suspension buffer. 10 ul of cells in suspension and 10 ul of trypan blue was mixed together and cells were counted on a C-chip Fuchs-Rosenthal haemocytometer. A 150,000-cell aliquot was made up to 1.5 mls with cell suspension buffer and prepared for DropSeq. scRNA-seq		GSM5283361		GEO					env_tax;env_tax:terrestrial	2021-05-09				9606									SRR14447349												GSE173950					Normal Esophagus																																													
SRR14447351	SRX10798369	SAMN19025611	PRJNA727596	SRS8885034	SRP318653			NextSeq 500 sequencing: GSM5283363: OAC46N Homo sapiens RNA-Seq	OAC46N	Single Cell RNA sequencing (DropSeq) of esophageal adenocarcinoma and matched normal samples	OAC46N		RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	94641583	6624910810	Homo sapiens		2021-05-09	2021-05-09	Single Cell RNA sequencing (DropSeq) of esophageal adenocarcinoma and matched normal samples	SRA1229013					cDNA												2882290026.0								1609517020;3131777514	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR144/051/SRR14447351											ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/051/SRR14447351/SRR14447351_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/051/SRR14447351/SRR14447351_2.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR144/051/SRR14447351		c89dabb5a1f42d1afce763960790aa75;af364281eafed8925fb87ebda8b234e3																			NextSeq 500 sequencing: GSM5283363: OAC46N Homo sapiens RNA-Seq							5f2e813a861f964571cfdc21af4f2006		ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/051/SRR14447351/SRR14447351_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/051/SRR14447351/SRR14447351_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR144/051/SRR14447351																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR144/051/SRR14447351/SRR14447351_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR144/051/SRR14447351/SRR14447351_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5283363					GSM5283363_r1				Samples were relocated to the laboratory and placed in a tissue culture hood, moved to a petri dish and washed with PBS-A and then minced with a scalpel to approximately 1mm chunks. Minced tissue was transferred to a 50ml Falcon tube with 5ml of DMEM complete 100 ul of 150 U/ml Collagenase P and 100 ul of10 mg/ml DNase. The samples were placed in an incubator at 37o C with agitation for 60 minutes and disturbed at 15 minutes and 30 minutes with pipettes. Samples were then passed through a 70 um strainer and 10 ml of empty DMEM added. Cells were then pelleted using centrifugation and media aspirated. Cells were resuspended in RBC lysis solution and incubated at 4oC for 10 minutes, 10 ml of empty DMEM was added and the suspension was passed through a 40 um strainer before being pelleted and resuspended in either 1 ml PBS or 1 ml of cell suspension buffer. 10 ul of cells in suspension and 10 ul of trypan blue was mixed together and cells were counted on a C-chip Fuchs-Rosenthal haemocytometer. A 150,000-cell aliquot was made up to 1.5 mls with cell suspension buffer and prepared for DropSeq. scRNA-seq		GSM5283363		GEO					env_tax;env_tax:terrestrial	2021-05-09				9606									SRR14447351												GSE173950					Normal Esophagus																																													
SRR14447355	SRX10798373	SAMN19025607	PRJNA727596	SRS8885040	SRP318653			NextSeq 500 sequencing: GSM5283367: OAC55N Homo sapiens RNA-Seq	OAC55N	Single Cell RNA sequencing (DropSeq) of esophageal adenocarcinoma and matched normal samples	OAC55N		RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	107625660	7533796200	Homo sapiens		2021-05-09	2021-05-09	Single Cell RNA sequencing (DropSeq) of esophageal adenocarcinoma and matched normal samples	SRA1229013					cDNA												3595464799.0								1769252108;4117323545	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR144/055/SRR14447355											ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/055/SRR14447355/SRR14447355_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/055/SRR14447355/SRR14447355_2.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR144/055/SRR14447355		b0dff20bdbfc5e3903b9ca85a7300e0a;0edd1b0250a3159072d43d93391be11c																			NextSeq 500 sequencing: GSM5283367: OAC55N Homo sapiens RNA-Seq							19f07b06f047e9d9f8338ff282fb5149		ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/055/SRR14447355/SRR14447355_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/055/SRR14447355/SRR14447355_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR144/055/SRR14447355																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR144/055/SRR14447355/SRR14447355_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR144/055/SRR14447355/SRR14447355_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5283367					GSM5283367_r1				Samples were relocated to the laboratory and placed in a tissue culture hood, moved to a petri dish and washed with PBS-A and then minced with a scalpel to approximately 1mm chunks. Minced tissue was transferred to a 50ml Falcon tube with 5ml of DMEM complete 100 ul of 150 U/ml Collagenase P and 100 ul of10 mg/ml DNase. The samples were placed in an incubator at 37o C with agitation for 60 minutes and disturbed at 15 minutes and 30 minutes with pipettes. Samples were then passed through a 70 um strainer and 10 ml of empty DMEM added. Cells were then pelleted using centrifugation and media aspirated. Cells were resuspended in RBC lysis solution and incubated at 4oC for 10 minutes, 10 ml of empty DMEM was added and the suspension was passed through a 40 um strainer before being pelleted and resuspended in either 1 ml PBS or 1 ml of cell suspension buffer. 10 ul of cells in suspension and 10 ul of trypan blue was mixed together and cells were counted on a C-chip Fuchs-Rosenthal haemocytometer. A 150,000-cell aliquot was made up to 1.5 mls with cell suspension buffer and prepared for DropSeq. scRNA-seq		GSM5283367		GEO					env_tax;env_tax:terrestrial	2021-05-09				9606									SRR14447355												GSE173950					Normal Esophagus																																													
SRR14447356	SRX10798374	SAMN19025606	PRJNA727596	SRS8885041	SRP318653			NextSeq 500 sequencing: GSM5283368: OAC55N2 Homo sapiens RNA-Seq	OAC55N2	Single Cell RNA sequencing (DropSeq) of esophageal adenocarcinoma and matched normal samples	OAC55N2		RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	24969077	1747835390	Homo sapiens		2021-05-09	2021-05-09	Single Cell RNA sequencing (DropSeq) of esophageal adenocarcinoma and matched normal samples	SRA1229013					cDNA												839447276.0								406203819;958499095	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR144/056/SRR14447356											ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/056/SRR14447356/SRR14447356_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/056/SRR14447356/SRR14447356_2.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR144/056/SRR14447356		556afd275c3dc3a2a834e925ae7f9754;8fa2e6f575349aa0b99ac68c0b8a67d3																			NextSeq 500 sequencing: GSM5283368: OAC55N2 Homo sapiens RNA-Seq							909e6852777c70584156fbb74aee15a8		ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/056/SRR14447356/SRR14447356_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/056/SRR14447356/SRR14447356_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR144/056/SRR14447356																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR144/056/SRR14447356/SRR14447356_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR144/056/SRR14447356/SRR14447356_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5283368					GSM5283368_r1				Samples were relocated to the laboratory and placed in a tissue culture hood, moved to a petri dish and washed with PBS-A and then minced with a scalpel to approximately 1mm chunks. Minced tissue was transferred to a 50ml Falcon tube with 5ml of DMEM complete 100 ul of 150 U/ml Collagenase P and 100 ul of10 mg/ml DNase. The samples were placed in an incubator at 37o C with agitation for 60 minutes and disturbed at 15 minutes and 30 minutes with pipettes. Samples were then passed through a 70 um strainer and 10 ml of empty DMEM added. Cells were then pelleted using centrifugation and media aspirated. Cells were resuspended in RBC lysis solution and incubated at 4oC for 10 minutes, 10 ml of empty DMEM was added and the suspension was passed through a 40 um strainer before being pelleted and resuspended in either 1 ml PBS or 1 ml of cell suspension buffer. 10 ul of cells in suspension and 10 ul of trypan blue was mixed together and cells were counted on a C-chip Fuchs-Rosenthal haemocytometer. A 150,000-cell aliquot was made up to 1.5 mls with cell suspension buffer and prepared for DropSeq. scRNA-seq		GSM5283368		GEO					env_tax;env_tax:terrestrial	2021-05-09				9606									SRR14447356												GSE173950					Normal Esophagus																																													
SRR14447359	SRX10798377	SAMN19025584	PRJNA727596	SRS8885044	SRP318653			NextSeq 500 sequencing: GSM5283371: OAC174N Homo sapiens RNA-Seq	OAC174N	Single Cell RNA sequencing (DropSeq) of esophageal adenocarcinoma and matched normal samples	OAC174N		RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	109196637	7643764590	Homo sapiens		2021-05-09	2021-05-09	Single Cell RNA sequencing (DropSeq) of esophageal adenocarcinoma and matched normal samples	SRA1229013					cDNA												3265557020.0								1785976273;3535741718	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR144/059/SRR14447359											ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/059/SRR14447359/SRR14447359_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/059/SRR14447359/SRR14447359_2.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR144/059/SRR14447359		9bd43c41024d53f461501d6c9247ff8b;ff1040b1ec8682842e0a4eadeade757f																			NextSeq 500 sequencing: GSM5283371: OAC174N Homo sapiens RNA-Seq							1851a6fa3b04f4863bef567bb2451d7b		ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/059/SRR14447359/SRR14447359_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/059/SRR14447359/SRR14447359_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR144/059/SRR14447359																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR144/059/SRR14447359/SRR14447359_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR144/059/SRR14447359/SRR14447359_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5283371					GSM5283371_r1				Samples were relocated to the laboratory and placed in a tissue culture hood, moved to a petri dish and washed with PBS-A and then minced with a scalpel to approximately 1mm chunks. Minced tissue was transferred to a 50ml Falcon tube with 5ml of DMEM complete 100 ul of 150 U/ml Collagenase P and 100 ul of10 mg/ml DNase. The samples were placed in an incubator at 37o C with agitation for 60 minutes and disturbed at 15 minutes and 30 minutes with pipettes. Samples were then passed through a 70 um strainer and 10 ml of empty DMEM added. Cells were then pelleted using centrifugation and media aspirated. Cells were resuspended in RBC lysis solution and incubated at 4oC for 10 minutes, 10 ml of empty DMEM was added and the suspension was passed through a 40 um strainer before being pelleted and resuspended in either 1 ml PBS or 1 ml of cell suspension buffer. 10 ul of cells in suspension and 10 ul of trypan blue was mixed together and cells were counted on a C-chip Fuchs-Rosenthal haemocytometer. A 150,000-cell aliquot was made up to 1.5 mls with cell suspension buffer and prepared for DropSeq. scRNA-seq		GSM5283371		GEO					env_tax;env_tax:terrestrial	2021-05-09				9606									SRR14447359												GSE173950					Normal Esophagus																																													
SRR14447361	SRX10798379	SAMN19025581	PRJNA727596	SRS8885047	SRP318653			NextSeq 500 sequencing: GSM5283373: OAC233NC Homo sapiens RNA-Seq	OAC233NC	Single Cell RNA sequencing (DropSeq) of esophageal adenocarcinoma and matched normal samples	OAC233NC		RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	41676304	2917341280	Homo sapiens		2021-05-09	2021-05-09	Single Cell RNA sequencing (DropSeq) of esophageal adenocarcinoma and matched normal samples	SRA1229013					cDNA												1467617960.0								745434160;1637549913	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR144/061/SRR14447361											ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/061/SRR14447361/SRR14447361_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/061/SRR14447361/SRR14447361_2.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR144/061/SRR14447361		bf8d48ff75bb5be9a6297af597d9dbbb;fa447b3d808f993704b6eb087602192c																			NextSeq 500 sequencing: GSM5283373: OAC233NC Homo sapiens RNA-Seq							d27605d70e37e6713b1e18284766a762		ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/061/SRR14447361/SRR14447361_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/061/SRR14447361/SRR14447361_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR144/061/SRR14447361																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR144/061/SRR14447361/SRR14447361_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR144/061/SRR14447361/SRR14447361_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5283373					GSM5283373_r1				Samples were relocated to the laboratory and placed in a tissue culture hood, moved to a petri dish and washed with PBS-A and then minced with a scalpel to approximately 1mm chunks. Minced tissue was transferred to a 50ml Falcon tube with 5ml of DMEM complete 100 ul of 150 U/ml Collagenase P and 100 ul of10 mg/ml DNase. The samples were placed in an incubator at 37o C with agitation for 60 minutes and disturbed at 15 minutes and 30 minutes with pipettes. Samples were then passed through a 70 um strainer and 10 ml of empty DMEM added. Cells were then pelleted using centrifugation and media aspirated. Cells were resuspended in RBC lysis solution and incubated at 4oC for 10 minutes, 10 ml of empty DMEM was added and the suspension was passed through a 40 um strainer before being pelleted and resuspended in either 1 ml PBS or 1 ml of cell suspension buffer. 10 ul of cells in suspension and 10 ul of trypan blue was mixed together and cells were counted on a C-chip Fuchs-Rosenthal haemocytometer. A 150,000-cell aliquot was made up to 1.5 mls with cell suspension buffer and prepared for DropSeq. scRNA-seq		GSM5283373		GEO					env_tax;env_tax:terrestrial	2021-05-09				9606									SRR14447361												GSE173950					Normal Esophagus																																													
SRR14447365	SRX10798383	SAMN19025575	PRJNA727596	SRS8885050	SRP318653			NextSeq 500 sequencing: GSM5283377: OAC263N Homo sapiens RNA-Seq	OAC263N	Single Cell RNA sequencing (DropSeq) of esophageal adenocarcinoma and matched normal samples	OAC263N		RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	43859845	3070189150	Homo sapiens		2021-05-09	2021-05-09	Single Cell RNA sequencing (DropSeq) of esophageal adenocarcinoma and matched normal samples	SRA1229013					cDNA												1546998808.0								787492323;1722436118	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR144/065/SRR14447365											ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/065/SRR14447365/SRR14447365_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/065/SRR14447365/SRR14447365_2.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR144/065/SRR14447365		ac9bd9d1e1ab9e2f3fdb6b9f1b395326;416ddc2edd10f903b1c9e779f3b5c226																			NextSeq 500 sequencing: GSM5283377: OAC263N Homo sapiens RNA-Seq							6a2cadaa5b5c89d18e47ffbe73e04a66		ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/065/SRR14447365/SRR14447365_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/065/SRR14447365/SRR14447365_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR144/065/SRR14447365																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR144/065/SRR14447365/SRR14447365_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR144/065/SRR14447365/SRR14447365_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5283377					GSM5283377_r1				Samples were relocated to the laboratory and placed in a tissue culture hood, moved to a petri dish and washed with PBS-A and then minced with a scalpel to approximately 1mm chunks. Minced tissue was transferred to a 50ml Falcon tube with 5ml of DMEM complete 100 ul of 150 U/ml Collagenase P and 100 ul of10 mg/ml DNase. The samples were placed in an incubator at 37o C with agitation for 60 minutes and disturbed at 15 minutes and 30 minutes with pipettes. Samples were then passed through a 70 um strainer and 10 ml of empty DMEM added. Cells were then pelleted using centrifugation and media aspirated. Cells were resuspended in RBC lysis solution and incubated at 4oC for 10 minutes, 10 ml of empty DMEM was added and the suspension was passed through a 40 um strainer before being pelleted and resuspended in either 1 ml PBS or 1 ml of cell suspension buffer. 10 ul of cells in suspension and 10 ul of trypan blue was mixed together and cells were counted on a C-chip Fuchs-Rosenthal haemocytometer. A 150,000-cell aliquot was made up to 1.5 mls with cell suspension buffer and prepared for DropSeq. scRNA-seq		GSM5283377		GEO					env_tax;env_tax:terrestrial	2021-05-09				9606									SRR14447365												GSE173950					Normal Esophagus																																													
SRR14447377	SRX10798395	SAMN19025562	PRJNA727596	SRS8885061	SRP318653			NextSeq 500 sequencing: GSM5283389: OAC1411NT Homo sapiens RNA-Seq	OAC1411NT	Single Cell RNA sequencing (DropSeq) of esophageal adenocarcinoma and matched normal samples	OAC1411NT		RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	56796744	3975772080	Homo sapiens		2021-05-09	2021-05-09	Single Cell RNA sequencing (DropSeq) of esophageal adenocarcinoma and matched normal samples	SRA1229013					cDNA												1739842329.0								895443484;1941566377	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR144/077/SRR14447377											ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/077/SRR14447377/SRR14447377_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/077/SRR14447377/SRR14447377_2.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR144/077/SRR14447377		dd86a47136667dabb6752845de8045a3;1c230509e640eaba32d8dc9a751a6da3																			NextSeq 500 sequencing: GSM5283389: OAC1411NT Homo sapiens RNA-Seq							4ad298a92be454516add4f555dde1a3b		ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/077/SRR14447377/SRR14447377_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/077/SRR14447377/SRR14447377_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR144/077/SRR14447377																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR144/077/SRR14447377/SRR14447377_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR144/077/SRR14447377/SRR14447377_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5283389					GSM5283389_r1				Samples were relocated to the laboratory and placed in a tissue culture hood, moved to a petri dish and washed with PBS-A and then minced with a scalpel to approximately 1mm chunks. Minced tissue was transferred to a 50ml Falcon tube with 5ml of DMEM complete 100 ul of 150 U/ml Collagenase P and 100 ul of10 mg/ml DNase. The samples were placed in an incubator at 37o C with agitation for 60 minutes and disturbed at 15 minutes and 30 minutes with pipettes. Samples were then passed through a 70 um strainer and 10 ml of empty DMEM added. Cells were then pelleted using centrifugation and media aspirated. Cells were resuspended in RBC lysis solution and incubated at 4oC for 10 minutes, 10 ml of empty DMEM was added and the suspension was passed through a 40 um strainer before being pelleted and resuspended in either 1 ml PBS or 1 ml of cell suspension buffer. 10 ul of cells in suspension and 10 ul of trypan blue was mixed together and cells were counted on a C-chip Fuchs-Rosenthal haemocytometer. A 150,000-cell aliquot was made up to 1.5 mls with cell suspension buffer and prepared for DropSeq. scRNA-seq		GSM5283389		GEO					env_tax;env_tax:terrestrial	2021-05-09				9606									SRR14447377												GSE173950					Normal Esophagus																																													
SRR14447380	SRX10798398	SAMN19025604	PRJNA727596	SRS8885065	SRP318653			NextSeq 500 sequencing: GSM5283392: OAC1710N1T Homo sapiens RNA-Seq	OAC1710N1T	Single Cell RNA sequencing (DropSeq) of esophageal adenocarcinoma and matched normal samples	OAC1710N1T		RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	77202798	5404195860	Homo sapiens		2021-05-09	2021-05-09	Single Cell RNA sequencing (DropSeq) of esophageal adenocarcinoma and matched normal samples	SRA1229013					cDNA												2575372251.0								1243552490;2871055183	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR144/080/SRR14447380											ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/080/SRR14447380/SRR14447380_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/080/SRR14447380/SRR14447380_2.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR144/080/SRR14447380		85befdaeb97bea2f73767f320cf450cc;8704e96e27c1dbe1323cda085270f40f																			NextSeq 500 sequencing: GSM5283392: OAC1710N1T Homo sapiens RNA-Seq							dd23986a30bf93b69f58ee6a4a1d9214		ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/080/SRR14447380/SRR14447380_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/080/SRR14447380/SRR14447380_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR144/080/SRR14447380																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR144/080/SRR14447380/SRR14447380_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR144/080/SRR14447380/SRR14447380_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5283392					GSM5283392_r1				Samples were relocated to the laboratory and placed in a tissue culture hood, moved to a petri dish and washed with PBS-A and then minced with a scalpel to approximately 1mm chunks. Minced tissue was transferred to a 50ml Falcon tube with 5ml of DMEM complete 100 ul of 150 U/ml Collagenase P and 100 ul of10 mg/ml DNase. The samples were placed in an incubator at 37o C with agitation for 60 minutes and disturbed at 15 minutes and 30 minutes with pipettes. Samples were then passed through a 70 um strainer and 10 ml of empty DMEM added. Cells were then pelleted using centrifugation and media aspirated. Cells were resuspended in RBC lysis solution and incubated at 4oC for 10 minutes, 10 ml of empty DMEM was added and the suspension was passed through a 40 um strainer before being pelleted and resuspended in either 1 ml PBS or 1 ml of cell suspension buffer. 10 ul of cells in suspension and 10 ul of trypan blue was mixed together and cells were counted on a C-chip Fuchs-Rosenthal haemocytometer. A 150,000-cell aliquot was made up to 1.5 mls with cell suspension buffer and prepared for DropSeq. scRNA-seq		GSM5283392		GEO					env_tax;env_tax:terrestrial	2021-05-09				9606									SRR14447380												GSE173950					Normal Esophagus																																													
SRR14447383	SRX10798401	SAMN19025601	PRJNA727596	SRS8885067	SRP318653			NextSeq 500 sequencing: GSM5283395: OAC1711N Homo sapiens RNA-Seq	OAC1711N	Single Cell RNA sequencing (DropSeq) of esophageal adenocarcinoma and matched normal samples	OAC1711N		RNA-Seq	TRANSCRIPTOMIC	PAIRED	NextSeq 500	80221374	5615496180	Homo sapiens		2021-05-09	2021-05-09	Single Cell RNA sequencing (DropSeq) of esophageal adenocarcinoma and matched normal samples	SRA1229013					cDNA												2396569647.0								1267362851;2637623594	ILLUMINA				fasp.sra.ebi.ac.uk:/vol1/srr/SRR144/083/SRR14447383											ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/083/SRR14447383/SRR14447383_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/083/SRR14447383/SRR14447383_2.fastq.gz								Generic	ftp.sra.ebi.ac.uk/vol1/srr/SRR144/083/SRR14447383		3a4ee2349a42cac815652ee586453a1c;f518760410584385b7a6b2cf8287f7f1																			NextSeq 500 sequencing: GSM5283395: OAC1711N Homo sapiens RNA-Seq							418382f69c3f45da3e5dfc7d9b8b091d		ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/083/SRR14447383/SRR14447383_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR144/083/SRR14447383/SRR14447383_2.fastq.gz									ftp.sra.ebi.ac.uk/vol1/srr/SRR144/083/SRR14447383																							public			fasp.sra.ebi.ac.uk:/vol1/fastq/SRR144/083/SRR14447383/SRR14447383_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR144/083/SRR14447383/SRR14447383_2.fastq.gz	1;131567;2759;33154;33208;6072;33213;33511;7711;89593;7742;7776;117570;117571;8287;1338369;32523;32524;40674;32525;9347;1437010;314146;9443;376913;314293;9526;314295;9604;207598;9605;9606			GSM5283395					GSM5283395_r1				Samples were relocated to the laboratory and placed in a tissue culture hood, moved to a petri dish and washed with PBS-A and then minced with a scalpel to approximately 1mm chunks. Minced tissue was transferred to a 50ml Falcon tube with 5ml of DMEM complete 100 ul of 150 U/ml Collagenase P and 100 ul of10 mg/ml DNase. The samples were placed in an incubator at 37o C with agitation for 60 minutes and disturbed at 15 minutes and 30 minutes with pipettes. Samples were then passed through a 70 um strainer and 10 ml of empty DMEM added. Cells were then pelleted using centrifugation and media aspirated. Cells were resuspended in RBC lysis solution and incubated at 4oC for 10 minutes, 10 ml of empty DMEM was added and the suspension was passed through a 40 um strainer before being pelleted and resuspended in either 1 ml PBS or 1 ml of cell suspension buffer. 10 ul of cells in suspension and 10 ul of trypan blue was mixed together and cells were counted on a C-chip Fuchs-Rosenthal haemocytometer. A 150,000-cell aliquot was made up to 1.5 mls with cell suspension buffer and prepared for DropSeq. scRNA-seq		GSM5283395		GEO					env_tax;env_tax:terrestrial	2021-05-09				9606									SRR14447383												GSE173950					Normal Esophagus																																													
